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Age-associated Changes in the Germinal Centre Response upon Vaccination 
Alyssa Silva Cayetano 
Vaccination efficacy is reduced in older individuals due to diminished immune system 
function with advancing age. The germinal centre (GC) response plays a crucial role in 
generating protective immunity upon vaccination through the production of memory B cells 
and long-lived antibody-secreting plasma cells. However, the GC response deteriorates with 
age contributing to poor humoral immunity after vaccination and therefore to increased 
susceptibility to infections in older individuals. I aimed to assess the age-dependent cellular 
changes of the GC response using a combination of in vivo and in silico tools to determine the 
key mechanisms driving the GC deterioration with age. After immunisation, aged (24-month 
old) BALB/c and C57BL/6 mice had a decrease in frequency of GC B cells and an accumulation 
of T follicular helper (Tfh) cells compared to adult (2-month old) mice. This indicated a 
reduction in the magnitude of the GC response with age. The quality of the GC was also 
impaired as aged mice had lower serum titres of high-affinity antigen-specific antibodies. 
Confocal imaging revealed that the structure of GCs is altered with age. The GC is segregated 
into two specialised compartments: the dark zone (DZ) where B cells proliferate and the light 
zone (LZ) which contains the follicular dendritic cell (FDC) network and Tfh cells that facilitate 
the selection of high affinity GC B cells. I found that the size of the FDC network is significantly 
reduced and that Tfh cells are overrepresented in the DZ of the GC in aged mice.  
I hypothesised a B cell intrinsic defect was responsible for the decrease in GC 
magnitude in aged mice. However, adoptive transfer of SWHEL B cells from 24-month old mice 
refuted this hypothesis. To understand which cellular factor(s) may be causing the poor GC 
response in aged mice I used in silico modelling of the GC. This revealed that a combination 
of a reduced FDC network and an aberrant localisation of Tfh cells in the DZ is responsible for 
the poor GC response in aged mice. This altered localisation of Tfh cells corresponded with a 
higher expression of CXCR4 on Tfh cells from aged mice and increased sensitivity to CXCL12. 
I investigated the role of CXCR4 on Tfh function by adoptive transfer of CXCR4 deficient 
CD4+ T cells. Upon immunisation, these cells were capable of differentiating into 
phenotypically intact Tfh cells and were restricted to the LZ area of the GC. This finding 
suggests CXCR4 expression by Tfh cells is required for DZ localisation and overexpression of 
CXCR4 in aged Tfh cells may have deleterious effects on the GC response by driving Tfh cell 
localisation towards the DZ. Together, I have shown that the age-dependent GC deterioration 
is a multifactorial process, likely driven by a reduction in FDC network size and aberrant Tfh 
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1.1 The immune system 
 
1.1.1 Innate and adaptive immunity 
 
The immune system is a complex network of cells and molecules that protect the body 
against a variety of infectious agents. The immune system is divided into two distinct yet 
closely linked, branches known as the innate and adaptive immune systems. Innate immunity 
is the first-line of host defence against a pathogen (Hoffmann et al., 1999). The innate immune 
response can be triggered rapidly upon recognition of conserved molecular arrays on pathogens, 
known as pathogen-associated molecular patterns (PAMPs), such as bacterial DNA (Medzhitov 
and Janeway  Jr., 2000). These molecular patterns are recognized by a set of germline-encoded 
pattern recognition receptors (PRRs) on innate cells, which initiate an inflammatory response 
(Janeway  Jr. and Medzhitov, 2002). In addition, PRRs also promote inflammatory pathways 
through the recognition of damage-associated molecular patterns (DAMPs) which are 
endogenous danger signals released by stressed or dying cells (Tang et al., 2012). However, as 
the specificity of these PRRs is genetically predetermined it limits their pathogen recognition 
repertoire to molecules that are common to multiple pathogens and therefore lacks the ability 
to uniquely identify specific pathogens. 
The adaptive immune system is unique to vertebrates and unlike the innate immune 
response it requires several days after infection to be established (Litman, Rast and Fugmann, 
2010). The adaptive response is initiated via innate cells known as antigen-presenting cells 
(APCs) that express co-stimulatory molecules and activate the effector cells of the adaptive 
immune system (Banchereau and Steinman, 1998; Medzhitov and Janeway  Jr., 1998). The key 
effector cells in adaptive immunity are T and B lymphocytes, which arise from hematopoietic 
stem cells in the bone marrow. In contrast to innate cells, lymphocytes have evolved to 
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recognize a vast variety of molecules, generally known as antigens, from a wide range of 
disease-causing pathogens as well as distinguishing self-antigen (Litman, Rast and Fugmann, 
2010). This high level of recognition is possible through the expression of specialised antigen 
receptors on lymphocytes, known as immunoglobulins (Ig) on the surface of B cells and T-cell 
receptors (TCR) on the surface of T cells. These receptors are not germline encoded but instead 
are assembled de novo in developing lymphocytes through somatic gene rearrangement 
(Litman, Rast and Fugmann, 2010). Each receptor contains an antigen-binding site located 
within a variable (V) region and is encoded by several V, diversity (D) and joining (J) gene 
segments that are randomly rearranged during a process known as V(D)J recombination 
(Tonegawa, 1983; Gellert, 2002). This process generates a large repertoire of receptors, which 
will then undergo selection based on their self-reactivity and on their affinity for antigen 
(Nemazee, 2000). Lymphocytes with self-reactive antigen receptors are eliminated and those 
with receptors that have intermediate affinity and are not self-reactive receive survival signals 
to finalize their development (Burnet, 1959; Nemazee, 2000). This process of development 
takes place in primary lymphoid organs, which provide a specialised microenvironment for 
stem cell precursors to differentiate into mature lymphocytes resulting in the generation of a 
lymphocyte repertoire capable of recognising a variety of foreign antigens.  
1.1.2 Development of B and T lymphocytes in primary lymphoid organs 
 
B and T lymphocytes develop and mature in primary lymphoid organs; the bone marrow 
and the thymus respectively. Both lymphocytes are derived from hematopoietic stem cells 
(HSCs) that are generated in the bone marrow (Hardy and Hayakawa, 2001; Koch and Radtke, 
2011). HSCs give rise to common lymphoid progenitor (CLP) cells from which lymphocytes 
develop through a series of stages that culminate in the adequate assembly and expression of 
functional antigen receptors (Kondo, Weissman and Akashi, 1997). Once these antigen 
receptors are formed, immature lymphocytes undergo rigorous testing that will ensure the 
selection of cells expressing beneficial antigen receptors and exclude cells bearing self-reactive 
receptors (Takahama, 2006; Pelanda and Torres, 2012). The surviving cells are then able to 
mature and migrate to peripheral lymphoid organs.  
B cells are continually replenished in the bone marrow, where a network of non-
lymphoid connective-tissue stromal cells supply requisite signals to switch on key genes that 
direct the B cell developmental program (Nagasawa, 2006). The earliest B cell precursors can 
be identified by their expression of the lineage marker B220 and require the coordinated 
expression of the transcription factors Ikaros, E2A, early B cell factor (EBF) and Pax5 to ensure 
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B cell-lineage commitment (Barberis et al., 1990; Jacobs et al., 1994; Lin and Grosschedl, 
1995; Zhuang, Cheng and Weintraub, 1996; Nutt et al., 1999; Kirstetter et al., 2002; Heizmann, 
Kastner and Chan, 2013). Additionally, stromal cells provide critical secreted factors such as 
CXCL12, IL-7 and stem cell factor (SCF) (Peschon et al., 1994; von Freeden-Jeffry et al., 1995; 
Nagasawa et al., 1996; Egawa et al., 2001; Waskow et al., 2002; Dias et al., 2005). During the 
first phase of development, progenitor B cells known as pro-B cells, begin to rearrange their 
immunoglobulin (Ig) genes. This rearrangement starts at the heavy-chain locus whereby D gene 
segments are first joined to J segments and DJH sequences are then joined to VH gene 
segments(Hardy et al., 1991; Li et al., 1996). At this stage the expression of Rag-1 and Rag-2 
is essential for the generation of double stranded breaks in DNA during Ig rearrangement 
(Oettinger et al., 1990; Mombaerts et al., 1992; Shinkai et al., 1992). After the generation of 
these DNA breaks, it is essential for DNA repair complexes to re-join DNA efficiently during 
Ig rearrangement, as the absence of such complexes can result in lymphopenia as demonstrated 
in SCID mice (Reichman-Fried, Hardy and Bosma, 1990; Blunt et al., 1995). Successful VDJH 
rearrangement gives rise to a complete Ig heavy chain after which the production of intact µ 
heavy chains begins, and the cell becomes a pre-B cell (Hardy et al., 1991). At the pre-B cell 
stage, a pre-B cell receptor (preBCR) is assembled by the association of a complete heavy chain 
with µ heavy chains and a surrogate light chain made up of the l5 and VpreB genes 
(Karasuyama, Kudo and Melchers, 1990; Karasuyama, Rolink and Melchers, 1993). The 
preBCR associates with the Iga and Igb proteins to signal the halt of heavy chain rearrangement 
and induce proliferation (Karasuyama, Rolink and Melchers, 1996). Once the cells stop 
dividing, the Rag-1 and Rag-2 proteins are re-expressed, and rearrangement of the light chain 
gene begins (Hardy et al., 1991). A successfully rearranged light chain will then replace the 
surrogate light chain in the preBCR complex forming a complete B cell receptor in the form of 
an IgM molecule (Hardy and Hayakawa, 2001). Immature IgM+ B cells will then interact with 
antigens to undergo negative selection based on their specificity for self-antigen (Pelanda and 
Torres, 2012).  Immature B cells that are self-reactive are eliminated by apoptosis during a 
process known as clonal deletion (Hartley et al., 1991, 1993). Alternatively, autoreactive 
immature B cells can switch on their Ig gene rearrangement program to “edit” the receptor away 
from autoreactivity, a process known as receptor editing (Gay et al., 1993; Radic et al., 1993; 
Tiegs, Russell and Nemazee, 1993). Immature B cells that pass negative selection continue to 
differentiate and acquire mature cell-surface markers such as IgD, CD21 and CD23 (Su and 
Rawlings, 2002; Tarlinton et al., 2003). Mature IgD+IgM+ B cells are then able to migrate into 
the periphery and are ready for activation by foreign antigen, though roughly 20% of B cells 
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that exit the bone marrow are still self-reactive indicating that the process of negative selection 
is not entirely flawless (Wardemann et al., 2003).  
T cells develop in the thymus which provides multiple stromal niches for the dynamic 
relocation of thymocytes at various stages of development (Takahama, 2006). Once the earliest 
T cell progenitors have migrated from the bone marrow into the thymus, they can be identified 
by their lack of CD4 and CD8 expression. These progenitors are known as double negative 
(DN) cells and are made up of four subsets: DN1-DN4 that can be distinguished from each 
other by differential expression of CD25 and CD44 (Koch and Radtke, 2011). DN1 cells reside 
in the corticomedullary junction where they proliferate and gradually become restricted to T 
cell-lineage commitment via the critical signalling of transcription factor Notch1, which 
inhibits alternative cell fates (Radtke et al., 1999; Han et al., 2002; Porritt, Gordon and Petrie, 
2003; Tan et al., 2005).  These cells then move deeper into the thymus cortex where they 
differentiate into DN2 cells upon receiving stimulatory signals from cortical thymic epithelial 
cells (cTECs) and fibroblasts (Takahama, 2006; Petrie and Zuniga-Pflucker, 2007). This stage 
is also characterised by further restriction of alternative cell fates and marks the beginning of 
TCRb chain gene rearrangement for which expression of Rag-1 and Rag-2 is critical (Capone, 
Hockett  Jr. and Zlotnik, 1998; Livak et al., 1999). DN2 thymocytes then proceed to 
differentiate into the DN3 stage within the subscapsular zone (Koch and Radtke, 2011). DN3 
cells continue to rearrange their receptor genes until they express a functional TCRb chain 
which associates with components of CD3 chains and an invariant pTa chain to form a preTCR 
complex (Burtrum et al., 1996; von Boehmer, 2005). Both Notch1 and preTCR signalling are 
essential at this stage known as b-selection after which all non-T cell lineage options are lost 
(Maillard et al., 2006). DN3 thymocytes then differentiate into the DN4 stage during which 
CD4 and CD8 are upregulated upon preTCR signalling and transition into the double positive 
(DP) stage at the outer cortex of the thymus (Porritt, Gordon and Petrie, 2003; Koch and Radtke, 
2011). DP thymocytes are able to re-express the Rag genes and begin rearrangement of the 
TCRa chain (Koch and Radtke, 2011). The fully rearranged and functional TCRa chain will 
then associate with the TCRb chain to form a fully assembled ab TCR (Koch and Radtke, 
2011). DP thymocytes will then undergo positive selection by testing the ability of their TCR 
to recognise self-peptide-MHC complexes on the surface of medullary thymic epithelial cells 
(mTECs), DCs and fibroblasts (Klein et al., 2009). Only thymocytes capable of interacting with 
self-peptide-MHC-complexes with intermediate avidity can survive and mature. DP cells will 
then undergo CD8 and CD4 single positive (SP) lineage commitment upon recognition of either 
self-MHC class I or MHC class II molecules respectively (Klein et al., 2009). SP cells then 
move further towards the medulla where they undergo negative selection, which eliminates SP 
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thymocytes whose TCRs recognise ubiquitous self-antigens with high affinity (Klein et al., 
2009). SP thymocytes that are not autoreactive are then able to leave the thymus and migrate to 
peripheral lymphoid organs.  
The dynamic movement within the thymus required for the development of T 
lymphocytes is mainly guided by stromal cell-derived secreted factors known as chemokines. 
Indeed, mice deficient in certain chemokines and chemokine receptors have demonstrated that 
the egress of both mature B and T lymphocytes from primary lymphoid organs into the 
periphery heavily relies on chemokine cues (Nagasawa et al., 1996; Plotkin et al., 2003; 
Misslitz et al., 2004; Ueno et al., 2004).  Thus, the guidance of immune cell movement by 
chemokine gradients is a key feature of the immune system.  
After completing development, naïve T and B cells will exit the central lymphoid organs 
and circulate to peripheral lymphoid organs where, upon encountering antigen, they will 
undergo clonal expansion into activated effector lymphocytes in order to eliminate the 
infectious agent (Burnet, 1959). The effector mechanisms of the adaptive immune response are 
tailored according to the mode of infection of different pathogens. B cells recognize antigen 
found in extracellular compartments of the body and can differentiate into plasma cells that 
neutralize the antigen through the secretion of antibodies; this forms the basis of humoral 
immunity (Batista and Harwood, 2009). On the other hand, T cells detect intracellular antigens 
that are presented on Major Histocompatibility Complexes (MHC) on the surface of infected 
or antigen-presenting cells; forming the basis of cell-mediated immunity (Itano and Jenkins, 
2003). There are two distinct types of T cells; CD8+ ‘cytotoxic’ T cells recognize peptide 
antigens presented on MHC-Class I and are able to directly kill infected cells while CD4+ 
‘helper’ T cells will recognize cells presenting antigen on MHC-Class II (Seder and Ahmed, 
2003). Thus, both B and T lymphocytes are critical in mounting adaptive immune responses 
against several infectious agents and as such undergo a tightly controlled developmental 
process. This process of development in primary lymphoid organs results in the generation of 
a lymphocyte repertoire capable of recognising a variety of foreign antigens upon migration to 







1.1.3 Secondary lymphoid organs  
 
Secondary lymphoid organs (SLOs) are the sites where lymphocytes encounter antigen 
and are activated for the initiation of the adaptive immune response. The function of SLOs in 
facilitating lymphocyte activation is dependent on cell migration and their ability to drain 
antigens that enter through different body cavities. SLOs include the spleen which filters 
antigens carried in the blood, lymph nodes (LNs) which acquire antigens in lymph draining 
from skin or mucosal surfaces, and the Peyer’s patches (PPs) which filter antigen from the 
intestinal lumen (Cyster, 2005). LNs and PPs are organised into distinct compartments known 
as B cell follicles and T cell zones while the spleen is split into the red pulp that drains the blood 
and the white pulp that contains the B cell follicles and T cell zones (Schulz et al., 2016). The 
strategic location and specialised compartmentalisation of these organs allows them to serve as 
hubs where circulating lymphocytes can encounter antigen to initiate primary immune 
responses. 
1.1.4 Chemokines and homeostatic immune cell migration to secondary 
lymphoid organs 
 
A key feature of the immune system is the constant migration of immune cells through 
nearly all compartments of the body. The chemokine system coordinates the migration and 
positioning of effector cells between lymphoid and non-lymphoid organs. Chemokines are 
typically secreted chemotactic cytokines that constitute a family of more than 40 small proteins 
with a molecular weight of 7-12 kDa (Kufareva, Salanga and Handel, 2015). Chemokines are 
able to mediate the migration and positioning of immune cells by engaging G protein-coupled 
receptors (GPCRs), expressed on the surface of all immune cells, with high affinity (Schulz et 
al., 2016). Various lymphoid and non-lymphoid cells are able to express chemokines (Schulz 
et al., 2016), however the expression of chemokines by lymphoid stromal cells is critical for 
guiding lymphocytes and dendritic cells (DCs) to secondary lymphoid organs (SLOs) under 
homeostatic conditions and during the initiation of an immune response.  
The homeostatic production of chemokines by specialised stromal cell subsets derived 
from radio-resistant non-hematopoietic precursors is critical for maintaining the architecture of 
these specialised organs (Figure 1.1) (Denton and Linterman, 2017). In the T cell zone, 
fibroblastic reticular cells (FRCs) orchestrate the migration, localization and survival of DCs, 
T cells and B cells by producing CCL19, CCL21 and CXCL12 (Link et al., 2007; Cremasco et 
al., 2014; Denton et al., 2014). Meanwhile in the B cell follicles, follicular dendritic cells 
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(FDCs) that produce CXCL13 and CXCL12-producing reticular cells (CRCs) promote the 
localization of B cells (Miller  3rd and Nossal, 1964; Allen et al., 2004; Rodda et al., 2015).  
The subcapsular sinus (SCS) facilitates the movement of lymph fluid and is lined by marginal 
reticular cells (MRCs), which are FDC precursors and provide structural support (Katakai et 
al., 2008). Additionally, FRCs at the boundary of the T cell zone and follicle can produce B 
cell-activating factor (BAFF) to maintain primary follicle structure (Cremasco et al., 2014). 
The distribution of these stromal cells in specific areas of the SLOs facilitates the continuous 
circulation of lymphocytes that enter the LNs and PPs through high endothelial venules (HEV) 
(Miyasaka and Tanaka, 2004).  
Under homeostatic conditions naïve lymphocytes and antigen presenting cells (APCs) 
migrate and are retained in the SLOs. Naïve T cells express the chemokine receptors CCR7 and 
CXCR4 on their surface. During LN entry, CCR7 binds CCL21 and CCL19 that are produced 
by the FRCs and transcytosed across the HEV for presentation in the endothelial lumen 
(Nakano et al., 1997; Forster et al., 1999; Link et al., 2007; Denton et al., 2014). The expression 
of CXCR4 can also aid LN entry via binding of CXCL12, which is also produced by FRCs and 
presented in the HEV lumen though LN homing through this signal is not as strong as CCR7-
mediated homing as CXCR4 deficient T cells exhibit greater defects in LN homing in the 
absence of CCR7 (Okada et al., 2002). Once in the LN naïve T cells are guided by CCL19/21, 
produced by FRCs, towards the T cell zone where they are able to scan DCs (Link et al., 2007). 
Sustained CCL19 signalling will eventually lead T cells to down regulate CCR7 which allows 
them to migrate toward sphingosine-1 phosphate (S1P), present in the blood and lymph, through 
their expression of S1P receptor 1 (S1PR1) (Kohout et al., 2004; Zidar et al., 2009; Cyster and 
Schwab, 2012). Prolonged S1P signalling desensitizes S1PR1 while CCR7 is upregulated again 
and thus the migration cycle repeats (Lo et al., 2005; Arnon et al., 2011). Similarly, naïve B 
cells also express CCR7 and CXCR4 that allows them to enter the LN through CCL19/21 and 
CXCL12 gradients in the HEV (Okada et al., 2002; Coelho et al., 2013). Additionally, B cells 
express CXCR5 that also promotes LN entry by binding to CXCL13 produced by FDCs that is 
transcytosed and presented in the HEV lumen (Ebisuno et al., 2003). Once in the LN, naïve B 
cells can migrate to the B cell follicles by following CXCL13 gradients produced by FDCs 
(Coelho et al., 2013). Sustained CXCR5 signalling promotes its downregulation and, like in T 
cells, B cells exit the LN by increasing SIPR1 expression which is eventually desensitized for 
the cycle to start anew (Ebisuno et al., 2003; Arnon et al., 2011). Thus, in the absence of an 
immune response chemokine gradients produced by stromal cells of the SLOs are essential for 
the continued migration of lymphocytes. This continued migration facilitates the encounter 
between naïve lymphocytes and antigen. Naïve T cells first encounter antigen on APCs which 
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is a critical first step for their subsequent differentiation into effector cells. Naïve CD4+ helper 
T cells are able to differentiate into several types of effector cells that do not eliminate the cells 
they recognize but rather are activated by them in order to promote distinct types of immune 
responses. This project focuses on CD4+ T cell biology and their role in promoting humoral 





















































Figure 1.1 Lymph node structure is supported by stromal cells  
 
Secondary lymphoid organs are divided into distinct regions through the generation of 
chemokine gradients by resident stromal cells. In the lymph node (LN), these chemokine 
gradients allow the circulation of lymphocytes which enter through high endothelial venules 
(HEV). In the T cell zone, fibroblastic reticular cells (FRCs) generate a CCL19 and CCL21 
gradient which facilitates the migration of T cells and dendritic cells (DCs). The B cell follicles 
contain follicular dendritic cells (FDCs) which generate a CXCL13 gradient that promotes the 
localisation of B cells. Upon infection or immunisation, antigen can enter the LN through the 
subcapsular sinus (SCS) or can be brought by DCs to trigger the activation of lymphocytes. 















1.1.5 CD4+ helper T cells and their role in humoral immunity 
 
Upon recognition of antigen on APCs such as DCs, naïve CD4+ T cells differentiate into 
distinct T helper (Th) cell subsets: Th1, Th2, Th17, and T follicular helper (Tfh) cells (Zhou, 
Chong and Littman, 2009). Commitment of Th cells to different subsets is largely governed by 
their exposure to cytokines in the microenvironment and the up-regulation of ’master regulator’ 
transcription factors that induce the expression of genes involved in promoting specific 
functions for each subset (Zhou, Chong and Littman, 2009; DuPage and Bluestone, 2016).  
Each subset has a distinct type of effector function that is specialised to deal with a particular 
type of infection.   
Th1 cells are essential for responses against intracellular pathogens through their 
production of IFN-γ (O’Shea and Paul, 2002). Th1 cell differentiation is promoted by the 
cytokines IL-12 and IFN-γ, produced by innate immune cells and T cells, which activate the 
signal transducer and activator of transcription (STAT) 4, STAT1 and the transcriptional 
regulator of the Th1 subset: T-bet (Szabo et al., 2000; Morinobu et al., 2002; O’Shea and Paul, 
2002). In contrast, Th2 cells secrete IL-4, IL-5 and IL-13, which are important for the 
elimination of extracellular parasites, such as helminths, by the humoral immune response 
(Murphy et al., 2000; Paul and Zhu, 2010; DuPage and Bluestone, 2016). Differentiation of the 
Th2 cell subset requires the expression of the transcriptional regulator GATA-3 which is 
induced in response to IL-4 and STAT6 signalling (Murphy et al., 2000; Paul and Zhu, 2010).  
Originally, the Th1 and Th2 lineages were believed to have been the two major fates of CD4+ 
T cells, yet within the last two decades the discovery of new T cell fates proved this to be an 
oversimplified view of the role of CD4+ T cells in immune responses (Mosmann et al., 1986; 
Gor, Rose and Greenspan, 2003). Th17 cells emerged as a subset critical in responses against 
extracellular bacteria and fungi at mucosal surfaces through their production of IL-17 (Park et 
al., 2005). Th17 cell differentiation relies on the activation of the transcription factor ROR-γt 
through the phosphorylation of STAT3, which is induced by TGF-β with the pro-inflammatory 
cytokines IL-6, IL-21, and IL-23 (Chen, Laurence and O’Shea, 2007).  
Careful regulation of these T cell effector subsets is critical, as aberrant Th1 and Th17 
cell responses have been associated with autoimmunity while Th2 responses have been linked 
to allergy and asthma (Zhou, Chong and Littman, 2009). Regulatory T (Treg) cells are another 
CD4+ T cell subset that emerged as crucial modulators of immune homeostasis and are 
characterized by the expression of the transcription factor Foxp3 (Fontenot, Gavin and 
Rudensky, 2003; Hori, Nomura and Sakaguchi, 2003; Fontenot et al., 2005). Foxp3+ Treg cells 
can arise from the thymus, known as natural Treg (nTreg) cells, or can be induced in the 
periphery by TGF-β, known as induced Treg (iTreg) cells (Curotto de Lafaille and Lafaille, 
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2009; Josefowicz and Rudensky, 2009). Both types of Treg cells are critical in preventing 
autoimmunity and other pathogenic effects from aberrant T cell responses (Chen et al., 2003).  
One of the later additions to the CD4+ T cell family is the subset known as T follicular 
helper (Tfh) cells (discussed in more detail in section 1.2.3) that are essential for providing help 
to B cells in specialised microanatomical structures known as germinal centres (Crotty, 2014). 
Tfh cells are needed for a successful humoral immune response that generates long-lived 
antibody-secreting plasma cells and can generate immunological memory, through the 
production of memory B cells, which will arm the host against re-infection and play a crucial 
role in generating protective immunity upon vaccination.   
1.1.6 Vaccination relies on immunological memory  
 
Vaccination is one of modern medicine’s most successful intervention against infectious 
disease. Vaccination strategies have made substantial contributions to public health by 
significantly decreasing deaths from infectious diseases in the past century and mediating the 
eradication of smallpox (Kim et al., 2017). These strategies rely on the generation of vaccine-
specific antibodies and immunological memory in order to provide individuals with long-
lasting protection against infectious agents.  
Immunological memory arises during the adaptive immune response whereby small 
populations of effector cells, known as memory cells, remain stored in the body in the absence 
of antigen (Litman, Rast and Fugmann, 2010). Upon re-encounter with a pathogen, memory T 
and B cells are able to differentiate into effector cells once again and clear the infection more 
rapidly and effectively than their naïve counterparts (Zinkernagel, 2002). This is clear in 
secondary B cell responses during which memory B cells are able to produce high titres of 
antibody with increased affinity for antigen more rapidly than primary responses (Ochsenbein 
et al., 2000). The generation of good antibody responses against a pathogen is the basis of most 
effective vaccination strategies (Linterman, 2014). Current vaccines, such as the seasonal 
influenza vaccine, can generate vaccine-specific antibodies via two pathways of which the first 
is extrafollicular that produces an early burst of antibodies after immunisation (Linterman, 
2014). The second pathway is through the specialised microenvironment known as the germinal 
centre (GC) that generates long-lived antibody-secreting plasma cells and memory B cells 
(Zinkernagel, 2003; Mesin, Ersching and Victora, 2016). These cells protect the host through 
the production of antibodies that will neutralize pathogens to prevent further spread of infection. 
Thus, the efficacy of most current vaccines depends on a successful germinal centre response.  
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1.2 The germinal centre response 
1.2.1 Germinal centres  
 
GCs are specialised microanatomical structures that form in secondary lymphoid 
organs, such as the spleen and lymph nodes, upon infection or immunization with a protein 
antigen (Figure 1.2) (MacLennan, 1994). These structures are a vital stage for B cell 
proliferation, somatic hypermutation (SHM), selection and differentiation into long-lived 
antibody secreting plasma cells and memory B cells (Mesin, Ersching and Victora, 2016).  
Activation of the adaptive immune response occurs upon arrival of antigen to the SLOs. 
For the initiation of the GC, both CD4+ T cells and B cells need to be activated by encountering 
cognate antigen. CCR7 mediated migration of CD4+ T cells and DCs to the T cell zone allows 
T cells to encounter antigen presented as peptide-MHC complexes on DCs and subsequently 
become activated (Nakano et al., 1998; Yanagihara et al., 1998; Forster et al., 1999). Thus, the 
FRC networks in the T cell zones promote crucial encounters between rare antigen-specific 
cells through production of the CCR7 ligands, CCL19 and CCL21. B cells localise to the follicle 
via CXCR5-mediated migration enabling them to be close to the SCS where small soluble 
antigens are drained and can directly trigger B cell activation (Bajenoff et al., 2006; Pape et al., 
2007; Roozendaal et al., 2009). Alternatively, antigens drained through the SCS can be captured 
by follicular FDCs which highly express complement receptor 1 (CD35) and FcgRII (CD32) 
that enables them to typically recognize antigen bound by antibody and/or complement, known 
as immune complexes (ICs) (Yoshida, van den Berg and Dijkstra, 1993).  FDCs are able to 
retain antigen in their surface for prolonged periods of time, allowing B cells to scan the 
follicular FDC network for cognate antigen to trigger activation (Suzuki et al., 2009).  In 
addition, B cells can also be activated by DCs outside the follicle (Qi et al., 2008).  
Once both CD4+ T cells and B cells are activated by antigen they must migrate towards 
the T:B interface to undergo cognate interactions that ultimately lead to GC formation. 
Activated CD4+ T cells begin to downregulate CCR7 and upregulate CXCR5 which allows 
them to move away from the CCL19/21-rich T cell zone and towards the interfollicular region 
(Ansel et al., 1999; Leon et al., 2012; Griffith, Sokol and Luster, 2014). Simultaneously, 
activated B cells upregulate CCR7 while maintaining CXCR5 expression that allows them to 
move toward the edge of the follicle at the T:B interface (Reif et al., 2002). Additionally, both 
cell types upregulate Epstein-Barr virus-induced G protein coupled receptor 2 (EBI2) which 
facilitates their localization at the T:B border (Kelly et al., 2011; Gatto and Brink, 2013; Suan 
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et al., 2015). Stromal cells at the inner- and outer-follicle regions produce the oxysterol ligands 
for EBI2 which facilitates the co-localization of EBI2+ T and B cells enabling productive T:B 
interactions during which signals are exchanged in a bidirectional manner (Okada et al., 2005; 
Hannedouche et al., 2011; Liu et al., 2011; Yi et al., 2012; Suan et al., 2015). At this stage, B 
cells can divide at the perimeter of the follicle and will either initiate the GC response or 
differentiate into short-lived extrafollicular plasma cells or memory B cells (Chan et al., 2009; 
Coffey, Alabyev and Manser, 2009). The extrafollicular response consists of the temporary 
generation of antibodies by extrafollicular plasma cells, which then undergo apoptosis within a 
few days (MacLennan et al., 2003). This provides an initial burst of antibodies that are essential 
for early control of infection while the GC response is established (MacLennan et al., 2003).  
The final step for GC formation requires activated CD4+ T cells and B cells that have 
undergone cognate interactions at the T:B border to migrate to the follicle as GC B cells and 
fully differentiated T follicular helper (Tfh) cells. Both CD4+ T cells and B cells downregulate 
CCR7 and EBI2 whilst stably expressing CXCR5 which enables them to escape the chemotactic 
pull of the T cell zone and outer follicle in order to move into the centre of the follicle (Haynes 
et al., 2007; Gatto et al., 2009; Pereira et al., 2009; Suan et al., 2015). Moreover, both CD4+ T 
and B cells upregulate S1P receptor 2 (S1PR2) that supports their localization to the follicle 
centre, where S1P is scarce, by reducing their responsiveness to other chemoattractants (Green 
et al., 2011; Moriyama et al., 2014). Loss of S1PR2 results in B cells losing their ability to 
accurately localize at the centre of the follicle and fewer CD4+ T cells being retained in the GC 
(Green et al., 2011). Furthermore, the combined loss of S1PR2 and CXCR5 results in almost 
no T cell localization within the GC (Moriyama et al., 2014). Once at the center of the follicle, 
signals exchanged between T and B cells provide the final cues for Tfh cell differentiation and 
promote B cell proliferation which seeds the GC. The newly formed GC is divided into two 
distinct compartments known as the dark zone (DZ) and the light zone (LZ) (Allen, Okada and 
Cyster, 2007). The DZ is the site closest to the T cell zone and it contains the rapidly diving 
GC B cells known as centroblasts (Allen et al., 2004; Gabriel D Victora et al., 2010; Victora et 
al., 2012). Centroblasts express high levels of the chemokine receptor CXCR4 whose ligand, 
CXCL12, is expressed by DZ stromal cells that are believed to be responsible for holding the 
centroblasts within the DZ (Allen et al., 2004; Bannard, Robert M Horton, et al., 2013). The 
LZ is distal to the T cell zone and is rich in FDCs that produce CXCL13, which attracts GC B 
cells that exit the DZ as centrocytes, through their expression of CXCR5 (Allen, Okada and 
Cyster, 2007; Gabriel D Victora et al., 2010; Victora et al., 2012). The LZ has a more diverse 
cellular composition than the DZ as it also contains Tfh cells and T follicular regulatory (Tfr) 
cells that are important for the successful and regulated continuation of the GC response (Mesin, 
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Ersching and Victora, 2016). Therefore, these two zones have important functional differences; 
in the DZ centroblasts undergo rapid proliferation and somatic-hypermutation of the genes 
encoding their Ig antigen receptors after which they undergo selection based on their affinity 
for antigen in the LZ through critical interactions with FDCs and Tfh cells (Mesin, Ersching 



















































Figure 1.2 The germinal centre (GC) response  
 
The GC is a specialised microenvironment formed within the B cell follicles of secondary 
lymphoid tissues upon infection or immunisation. The GC is divided into two distinct 
compartments. The dark zone (DZ) that contains a network of CXCL12-producing reticular 
cells (CRCs) and is the site of GC B cell proliferation and somatic hypermutation (SHM). 
Centroblasts then follow a CXCL13 gradient to enter the light zone (LZ) as centrocytes through 
their expression of CXCR5. In the LZ, centrocytes capture antigen presented on follicular 
dendritic cells (FDCs) which they internalise, process and subsequently present to T follicular 
helper (Tfh) cells in order to undergo selection. This process is regulated by T follicular 
regulatory (Tfr) cells which are also present in the LZ. Upon receiving survival signals from 
Tfh cells, centrocytes re-enter the DZ for further rounds of proliferation and SHM after which 
they exit the GC as memory B cells or high-affinity antibody-secreting plasma cells. This figure 







1.2.2 Somatic-hypermutation of GC B cells drives affinity maturation 
 
 The intense cycles of proliferation that lead to the clonal expansion of centroblasts in 
the DZ is accompanied by a process known as somatic hypermutation (SHM). SHM refers to 
the introduction of random point mutations into the variable (V)-region genes of the 
immunoglobulin (Ig) receptor on B cells (Gitlin, Shulman and Nussenzweig, 2014). This 
process is mediated by the enzyme activation-induced deaminase (AID), which is highly 
expressed by centroblasts and induces lesions in the Ig DNA (Berek and Milstein, 1987; M 
Muramatsu et al., 2000). These lesions are repaired by the error-prone DNA polymerase eta 
(Polη), which simultaneously introduces random point mutations during repair (M Muramatsu 
et al., 2000). Within the V-region genes, the segments which encode the part of the BCR that 
directly contacts antigen, known as the complementary determining regions (CDRs), contain 
motifs that are statistically preferred hotspots for mutations (M Muramatsu et al., 2000; 
Kinoshita and Honjo, 2001). For example, immunization studies using the model hapten 4-
hydroxy-3-nitrophenylacetyl (NP) conjugated to a protein carrier reported that 90% of NP 
specific B cells bear the V186.2 heavy chain, within which, a single mutation resulting in the 
amino acid substitution of a tryptophan by a leucine at position 33 in the CDR1 can lead to ten 
times greater affinity for NP (Cumano and Rajewsky, 1986; Allen et al., 1987, 1988). Thus, 
SHM is critical in the generation of B cell clones bearing receptors with high affinity for 
antigen. However, the random nature of SHM can also result in clones completely losing 
affinity for antigen or becoming self-reactive making it necessary for clones to further undergo 
affinity maturation and selection. 
 Affinity maturation is a gradual yet dynamic process during which serum antibodies 
increase their affinity for antigen after infection or immunization. This process relies on GC B 
cells with mutated BCRs being selected upon their affinity for antigen in the GC and then 
differentiating into antibody-secreting plasma cells (Mesin, Ersching and Victora, 2016). After 
undergoing SHM, centroblasts exit the cell cycle, migrate towards the LZ and are referred to as 
centrocytes (Gabriel D Victora et al., 2010). In the LZ, centrocytes test their antigen binding 
affinity and those with high affinity for antigen are selected to either exit the GC or re-enter the 
DZ for further rounds of division and BCR diversification by SHM (Allen, Okada and Cyster, 
2007; Gabriel D Victora et al., 2010; Mesin, Ersching and Victora, 2016). Selection in the LZ 
is mediated by two antigen-based signals. The first signal is from binding antigen itself that is 
held on the surface of FDCs, which populate the LZ in dense networks allowing them to be in 
close contact with centrocytes (Miller et al., 2002).  Centrocytes that are able to successfully 
bind the antigen will then internalise that antigen and present it on MHC Class II to enable the  
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second antigen-dependent signal through cognate interactions with specialised T follicular 
helper (Tfh) cells (Mesin, Ersching and Victora, 2016). 
1.2.3 T follicular helper cells play a central role in GC B cell selection and 
affinity maturation 
 
 Tfh cells are a specialised subset of CD4+ helper T cells that play a central role in the 
formation and maintenance of the GC response (Crotty, 2014). Like with other T cell subsets, 
Tfh cell differentiation is initiated upon the priming of naïve CD4+ T cells by dendritic cells 
(DCs), which provide two essential signals during this process (Moreau and Bousso, 2014). 
The first signal requires the engagement of the TCR by the presentation of antigen peptide 
fragments on MHC-Class II molecules on the surface of DCs (Grakoui et al., 1999). The second 
signal is delivered simultaneously by the ligation of the CD28 receptor on T cells with either 
of its ligands, CD80 or CD86, on DCs (Sharpe and Freeman, 2002). Once activated by DCs, 
primed T cells require multiple signals for the expression of a unique transcriptional profile to 
diverge into the Tfh cell fate. 
 During the interaction with DCs, the ligation of the inducible co-stimulator (ICOS) on 
T cells by ICOS ligand (ICOS-L) on DCs alongside stimulation by the cytokines IL-6 (in mice) 
and IL-12 together with TGF-b (in humans) promotes the first steps into pre-Tfh differentiation 
(Bossaller et al., 2006; Ma et al., 2009, 2012; Simpson, Quezada and Allison, 2010). In mice, 
IL-6 and IL-21 induces the activation of signal transducer activator of transcription (STAT) 3 
whereas in humans IL-12, IL-21, IL-23 and TGF-β activate both STAT3 and STAT4, which 
then translocate to the nucleus to induce the activation of the master Tfh transcription factor B 
cell lymphoma (Bcl)-6 (Nurieva et al., 2008; Ma et al., 2009, 2012; Eto et al., 2011; Choi et 
al., 2013; Schmitt et al., 2014). Bcl6 is necessary for Tfh cell differentiation as it represses the 
expression of the master transcription factors of other CD4+ T cell subsets such as T-bet (Th1), 
GATA 3 (Th2), RORγt (Th17) and Foxp3 (Treg) (Johnston et al., 2009; Nurieva et al., 2009; 
Yu et al., 2009). Additionally, Bcl6 is able to repress and also be inhibited by the transcription 
factor B-lymphocyte-induced maturation protein-1 (Blimp1), therefore, as mutual repressors of 
each other they are critical in determining the type of effector cell a primed T cell will 
differentiate into (Johnston et al., 2009).  
 Tfh precursor cells (pre-Tfh) require cognate interactions with B cells to fully 
differentiate into GC Tfh cells. Bcl-6 and the transcription factor Ascl2 promote the expression 
of CXCR5 and downregulation of CCR7 that allows follicular migration of pre-Tfh cells 
towards the T-B border (Yu et al., 2009; Choi et al., 2011; Kageyama et al., 2012; Liu et al., 
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2014). The cognate interactions at the T-B border are essential for both GC formation and Tfh 
cell development. The maintenance and stabilization of these interactions is mediated by the 
signalling lymphocytic activation molecule (SLAM) family members CD84 and Ly108; whose 
intracellular signalling is mediated by the intracellular adaptor molecule SLAM-associated 
protein (SAP) (Crotty et al., 2003; Cannons et al., 2006; Kamperschroer et al., 2008). Pre-Tfh 
cells and B cells will then exchange signals through the ligation of CD40L on Tfh cells and 
CD40 on B cells as well as the ligation of ICOS/ICOSL and CD80/86 (Elgueta et al., 2009; 
Gigoux et al., 2009; Linterman et al., 2014). This results in sustained expression of Bcl-6 and 
thus, fully committed Tfh cells are able to enter the GC and play a central role in the selection 
and survival of GC B cells.  
 Once GC B cells have undergone SHM as centroblasts, exited the DZ as centrocytes 
and scanned the FDC network for antigen in the LZ, they undergo affinity-based selection 
through interactions with Tfh cells (Allen et al., 2007). Upon binding antigen on their newly 
mutated BCRs, centrocytes internalize and process these antigens for presentation on MHC-
Class II to Tfh cells in the LZ (Batista and Neuberger, 2000). Centrocytes with the highest 
affinity BCRs are able to present more peptide:MHC to Tfh cells than lower affinity B cells, 
therefore these high affinity B cells receive survival signals from Tfh cells by out-competing 
lower affinity centrocytes for T cell help (Meyer-Hermann, Maini and Iber, 2006; Allen et al., 
2007; Gabriel D Victora et al., 2010; Shulman et al., 2013; Gitlin, Shulman and Nussenzweig, 
2014; Gitlin et al., 2015).  In this manner, GC B cells are subject to Darwinian-like selection 
that results in an enriched population of high-affinity B cell clones (Tarlinton, 2008). Tfh cells 
provide survival signals to high-affinity B cells in the form of CD40/CD40L, ICOS/ICOL 
ligation and through the secretion of cytokines such as IL-21 and IL-4 (Bauquet et al., 2009; 
Linterman et al., 2010; Yusuf et al., 2010; Zotos et al., 2010). However, if a mutated BCR has 
become self-reactive, it will not be able to engage a Tfh cell in cognate interactions and the cell 
will not receive these survival signals leading it to apoptosis and clearance by tingible body 
macrophages in the GC (Gabriel D Victora et al., 2010). The positively selected B cells are 
then able to re-enter the DZ for additional rounds of SHM and proliferation, which further 
drives affinity maturation, and these cells are then able to differentiate into either long-lived 
antibody-secreting plasma cells or memory B cells (Gabriel D Victora et al., 2010; Victora and 





1.2.4 Regulation of GC responses by Tfr cells 
 
The stochastic nature of the SHM process within the GC response renders the generation 
of self-reactive B cell clones inevitable (Ray, Putterman and Diamond, 1996). Therefore, tight 
regulation of the GC response is necessary to prevent the survival of self-reactive GC B cells 
and the development of autoimmune reactions. It has long been established that Foxp3+ Treg 
cells are critical modulators of antibody and autoimmune responses (Ochs, Ziegler and 
Torgerson, 2005; Fujio et al., 2012; Wing and Sakaguchi, 2014; Dhaeze et al., 2015), however 
a specialised subset of Foxp3+ T cells in the GC has been recently identified; known as T 
follicular regulatory (Tfr) cells.  
Foxp3+ T cells were first observed within GCs of human tonsils (Lim, Hillsamer and 
Kim, 2004) and were then further characterised in mice by three independent groups who 
demonstrated that Foxp3+CD4+ T cells are capable of differentiating into Foxp3+ Tfr cells 
which migrate into and regulate the GC (Chung et al., 2011; Linterman et al., 2011; Wollenberg 
et al., 2011). Tfr cells phenotypically resemble Tfh cells by their expression of the Tfh lineage-
specific transcription factor Bcl6 as well as the cell surface markers CXCR5, PD-1, ICOS and 
SAP (Chung et al., 2011; Linterman et al., 2011). However, they do not express B cell-helper 
molecules such as IL-21, IL-4 and CD40L but instead express markers characteristic of Treg 
cells such as CTLA-4 (Chung et al., 2011; Linterman et al., 2011).  
 Whilst the differentiation requirements of Tfr cells are not as well characterised as they 
are for Tfh cells, it is known Tfr cells must undergo a Bcl-6 dependent differentiation process 
(Stebegg et al., 2018). Like in Tfh, Tfr differentiation begins with DC priming and co-
stimulatory signalling through CD28 and ICOS molecules (Linterman et al., 2011). Tfr 
precursors also require B cell encounters and the expression of SAP, which facilitates T:B cell 
interactions, as well as an elaborate network of several molecules such as stromal interaction 
molecule 1 (STIM1), STIM2, STAT3 and tumour associated factor 3 (TRAF3),  to become 
fully differentiated Tfr cells (Linterman et al., 2011; Feske, Skolnik and Prakriya, 2012; Chang 
et al., 2014; Vaeth et al., 2016; Wu et al., 2016). In contrast to Tfh, the initiation of CXCR5 
upregulation required for GC migration is not determined by Bcl-6 but by the expression of 
nuclear factor of activated T cells (NFAT) 2 (Vaeth et al., 2014). Upon CXCR5 expression, Tfr 
cells are able to migrate into the GC to exert their regulatory role.  
 During a GC response, the Tfh cell population peaks at days 7 to 11 whereas Tfr cells 
peak once a GC response has already been established at days 11 to 17 (Vanderleyden, 
Linterman and Smith, 2014). Thus, it is likely that Tfr cells regulate the function and 
maintenance of an established GC rather than its initiation. Tfr cell regulation and function have 
been studied both in vitro and in vivo, though the precise mechanisms require further study. In 
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vitro, Tfr cells have been shown to have comparable suppression capacity to Treg cells and are 
able to supress both T cell activation and proliferation as well as IgG production (Linterman et 
al., 2011; Sage et al., 2013). In vivo, specific reduction of Tfr cells leads to increased numbers 
of Tfh and GC B cells, which is accompanied by a decrease in antigen-specific GC B cells and 
lower titres of high affinity antibodies (Linterman et al., 2011). However, alternative in vivo 
models have also shown there is increased antibody secretion in the absence of Tfr cells (Chung 
et al., 2011; Wollenberg et al., 2011). It is therefore unclear whether Tfr cells limit antigen-
specific antibody production, yet they evidently play a critical role in limiting GC size. Tfr cells 
are able to supress GC responses by both direct and indirect mechanisms. At the immunological 
synapse, Tfr cells are able to physically interfere with Tfh and GC B cell interactions through 
the expression of CTLA-4, which directly blocks CD80/86 co-stimulation (P T Sage et al., 
2014; Wing et al., 2014). Tfr cells have also been reported to impair GC B cell metabolism by 
decreasing glucose uptake and usage (Sage et al., 2016). Moreover, they can induce the 
downregulation of GC B cell effector molecules necessary for GC B cell formation, antibody 
secretion and class switch recombination; Pou2af1, Xbp1 and Aicda respectively (Sage et al., 
2016). Tfr cells are also believed to supress the GC indirectly via the secretion of suppressive 
factors and cytokines such as granzyme B, TGF-b and IL-10 (Stebegg et al., 2018). Though, 
Tfr-derived IL-10 has been shown to promote GC responses in the context of acute LCMV 
infection (Laidlaw et al., 2017). Thus, while Tfr cells have emerged as a critical specialised 
regulatory CD4+ T cell subset required for the regulation and maintenance of the GC response, 
the precise mechanisms by which they exert their regulatory function remain to be fully 
elucidated. In addition, the maintenance of GC responses is also coordinated by an intricate 
network of stromal cells which provide structural integrity and set the stage for T cell and B 














1.2.5 GC organisation and maintenance are mediated by chemokine 
gradients from resident stroma 
 
Once the GC response is initiated, the stromal networks within the B cell follicle must 
undergo intense changes to restructure the follicle and maintain the GC response. Both the FDC 
and CRC networks expand and divide the GC into two distinct zones. The DZ is populated by 
the CRC network and contains the proliferating centroblasts, that undergo SHM (Gabriel D 
Victora et al., 2010; Rodda et al., 2015). The LZ is populated by FDCs and is the site where 
centrocytes undergo selection through interactions with FDCs and Tfh cells (Denton and 
Linterman, 2017). Therefore, the CRC and FDC networks are essential in maintaining the 
function and structure of the GC while orchestrating the interactions between the different 
immune cells of the GC.  
The network of CRCs was recently discovered due to their high expression of CXCL12 
in the DZ and they were found to have low network density as well as a net-like morphology 
(Bannard, Robert M Horton, et al., 2013; Rodda et al., 2015). These cells are distinct from 
FDCs and FRCs as they do not express the typical FDC/FRC markers which include CD35, 
ERTR7, FDC-M1/M2, FcgRII and VCAM1 (Rodda et al., 2015). Due to the lack of antigen-
capture mechanisms such as CD35 and FcgRII on the surface of CRCs, it is likely that CRCs 
meet another specialised requirement in the DZ niche. Thus, CXCL12 production is believed 
to be one of the essential functions of CRCs in the GC DZ (Denton and Linterman, 2017). 
Moreover, two-photon laser-scanning microscopy revealed GC B cells are able to crawl in and 
around CRC networks, which depend on CXCR4 signalling for their distribution (Rodda et al., 
2015). Therefore, CRCs likely provide support for GC B cells through structural maintenance 
of the DZ in addition to generating a CXCL12 gradient within the GC.  
In contrast to the CRCs, FDCs were discovered in the 1960s and are better 
characterized. During GC formation, the expansion of FDCs is mainly driven by proliferation 
of MRCs and their subsequent differentiation into FDCs (Jarjour et al., 2014). Throughout this 
process the FDCs also become activated through TLR4 (Victoratos et al., 2006; Garin et al., 
2010) and B-cell derived lymphotoxin (LT) α1β2 signalling (Myers et al., 2013), though the 
precise mechanisms remain unidentified. Once activated, FDCs begin to increase their 
expression of CXCL13 and BAFF, which support GC development, and maintenance of the LZ 
(Denton and Linterman, 2017). Studies in mice have shown that ablation of FDCs results in GC 
termination due to reduced survival and localization of GC B cells; therefore FDCs are 
absolutely necessary for the GC response (Wang et al., 2011). The activation of FDCs also 
triggers an increase in their expression of antigen-capture molecules such as CD35, CD21 and 
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FcgRII (Denton and Linterman, 2017). These molecules are critical for the long-term retention 
and display of antigen on the surface of the FDC network, which is thought to be one of the key 
functions of FDCs. Pro-longed antigen presentation on FDCs allows antigen-specific B cells to 
test their Ig receptors by capturing antigen from FDCs to subsequently internalize, process and 
present the antigen peptides to Tfh cells in order to receive critical survival signals (Suzuki et 
al., 2009; Gabriel D Victora et al., 2010). While studies have shown that presentation of ICs by 
FDCs promotes AID expression and class switching (Aydar et al., 2005), it has been debated 
whether FDC-mediated IC presentation is critical for optimal GC responses and affinity 
maturation (Haberman and Shlomchik, 2003; Kosco-Vilbois, 2003). However, the loss of 
CD35 in mice results in poor GC responses to T-dependent immunization, which suggests that 
IC-presentation is indeed a key aspect of FDC function (Donius et al., 2013). FDCs can also 
produce cytokines such as IL-6 (Kopf et al., 1998; Wu et al., 2009) and IL-15 (Dubois et al., 
2002; Park et al., 2014) that promote SHM and IgG production and support B cell proliferation, 
respectively. FDC production of Mfge8 (FDC-M1) aids in the clearance of apoptotic GC B 
cells as Mfge8 coats the B cells marking them for clearance by tingible-body macrophages 
(Kranich et al., 2008).   
Overall, the CRC and FDC networks form distinct niches critical for the structural 
support and maintenance of the GC. These two stromal cell subsets are also crucial for the 
localization of GC B cells within the GC and form a spatially segregated stage where T and B 
cells can undergo crucial interactions to promote the generation of high-affinity antibody-
secreting plasma cells and memory B cells.  
During the GC response, GC B cells shuttle between the DZ and LZ using a timed 
program (Bannard, Robert M Horton, et al., 2013). GC B cells can localize in the DZ through 
their expression of CXCR4 in response to CXCL12 where they proliferate and undergo SHM 
as centroblasts (Mesin, Ersching and Victora, 2016). However as they proliferate they 
downregulate CXCR4 and upregulate CXCR5, which together with the FDC-mediated 
CXCL13 gradient, enables them to move towards the LZ as centrocytes (Bannard, Robert M 
Horton, et al., 2013). Migration to the LZ is necessary for centrocytes to acquire antigen and 
present it to Tfh cells in order for high-affinity B cell clones to survive (Gabriel D Victora et 
al., 2010). Through undetermined signals received in the LZ, a subset of centrocytes is then 
able to re-express CXCR4 and migrate back to the DZ via CXCL12 where they can undergo 
further rounds of proliferation and SHM (Bannard, Robert M Horton, et al., 2013). This results 
in bidirectional B cell trafficking between the two zones that allows for multiple rounds of 
proliferation and selection to further refine the affinity of responding GC B cells (Gabriel D 
Victora et al., 2010; Bannard, Robert M Horton, et al., 2013).  Once GC B cells have exited the 
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GC as high-affinity antibody-secreting plasma cells, their secreted antibodies can enter the GC 
to bind antigen displayed on FDCs which limits the antigen availability to centrocytes of lower 
affinity (Zhang et al., 2013). This provides a feedback mechanism by which the GC response 
is refined, limited and ultimately terminated.  
Tfh cells are conventionally thought to localize to the LZ through their high-expression 
of CXCR5. For Tfh cells to be retained in the GC they must express not only S1PR2 as 
previously discussed but also SLAM-associated protein (SAP), which promotes antigen-
specific T-B adhesion (Kamperschroer et al., 2008; Qi et al., 2008). SAP deficient T cells are 
able to localize to the follicle through their expression of CXCR5 but once in the follicle they 
exhibit severe defects in GC recruitment and retention (Qi et al., 2008). Additionally, GC 
retention of Tfh cells can be mediated by expression of a class B Ephrin, EFNB1, which 
negatively controls Tfh cell retention and also promotes IL-21 production (Lu, Shih and Qi, 
2017). While these studies have investigated mechanisms by which Tfh cells are retained within 
the GC, the functional importance of their localization within the GC compartments remains 
largely unexplored. GC Tfh cells are able to co-express both CXCR4 and CXCR5 (Elsner, Ernst 
and Baumgarth, 2012). The expression of CXCR4 by Tfh cells has been shown to influence 
their localization between the LZ and DZ (Elsner, Ernst and Baumgarth, 2012). Moreover, in 
vitro studies with human immune cells isolated from tonsils have shown FDCs may play a role 
in modulating CXCR4 expression on T cells (Estes et al., 2004). Another study also showed 
Tfh cells which express IL-21 have high expression of CXCR4 and are able to localize closer 
to the DZ while those producing IL-4 localize further away from the DZ (Weinstein et al., 
2016). However, the functional significance of differential CXCR4 expression of Tfh cells and 
their localization within the GC remains unknown largely due to the importance of CXCR4 in 
thymic maturation of T cells (Janas and Turner, 2010). Thus, GC stromal cells may also play a 
role in directing the localization of Tfh cells, but this has not been well characterised to date.  
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1.3 Ageing and the germinal centre response 
1.3.1 The ageing immune system 
 
 Ageing can be defined as the time-dependent deterioration of physiological integrity in 
living organisms (López-Otín et al., 2013). The ageing process can be attributed to multiple 
molecular and cellular changes that lead to impaired physiological function and in turn increase 
susceptibility to death. The time-dependent accumulation of genetic damage, the shortening of 
chromosomal ends known as telomeres, epigenetic alterations and the loss of protein 
homeostasis are common denominators of ageing at the molecular level (López-Otín et al., 
2013). Additionally at the cellular level, there is impaired mitochondrial function, stem cell 
exhaustion, altered intracellular communication and senescence with age (López-Otín et al., 
2013).  
 Ageing is accompanied by a decline in immune function which manifests in all the 
compartments of the immune system in both mice and humans (Dorshkind, Montecino-
Rodriguez and Signer, 2009; Boraschi et al., 2013; Goronzy and Weyand, 2013). Within the 
innate immune system, there is reduced functionality of the epithelial barriers that make up the 
first-line of defence of the skin, lung and gastrointestinal tract resulting in augmented 
pathogenic challenge with age at mucosal sites (Gomez, Boehmer and Kovacs, 2005; 
Nomellini, Gomez and Kovacs, 2008). Moreover, the intensity and length of innate-mediated 
inflammatory responses is amplified with age due to elevated plasma levels of pro-
inflammatory cytokines and chemokines (Weiskopf, Weinberger and Grubeck-Loebenstein, 
2009). This renders elderly individuals susceptible to inflammation and tissue damage known 
clinically as ‘inflamm-aging’ (Franceschi et al., 2000). At the cellular level, the differentiation 
and maturation of innate cells such as neutrophils, macrophages, dendritic cells (DCs) and 
natural killer (NK) cells is unperturbed with age (Weiskopf, Weinberger and Grubeck-
Loebenstein, 2009; Carr et al., 2016). However, their functional capacity including phagocytic 
capacity, bactericidal activity and the capacity to stimulate antigen-specific T cells is 
compromised with age (Weiskopf, Weinberger and Grubeck-Loebenstein, 2009).  
Likewise, the adaptive immune system is associated with detrimental age-dependent 
changes. In humans, hematopoietic stem cells (HSCs), which constantly renew the cells of the 
immune system in the bone marrow, start to lose their renewal and proliferative capacity with 
age (Lansdorp et al., 1994). This does not appear to disturb erythroid and myeloid progenitors 
of innate cells yet lymphoid progenitors are significantly affected (Weiskopf, Weinberger and 
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Grubeck-Loebenstein, 2009). In the B cell compartment, fewer mature B cells exit the bone 
marrow due to a reduction in the generation of pro-B cells and their subsequent differentiation 
with age (Cancro, 2005).  Similarly, fewer naïve T cells exit the thymus which in mice is due 
involution of the thymus with age (Fagnoni et al., 2000). Thus, both the humoral response and 
T-cell mediated immunity undergo substantial changes with age.   
1.3.2 Ageing of the T cell compartment and T follicular helper cells  
 
The T cell compartment undergoes various age-related changes that significantly impact 
the development, differentiation and functional competence of these cells. The naïve T cell pool 
is significantly reduced in both mice and humans with age (De Paoli, Battistin and Santini, 
1988; Utsuyama et al., 1992; Lazuardi et al., 2005). In mice, this reduction is mainly attributed 
to the involution of the thymus. In humans,  the naïve T cell pool is maintained in adulthood by 
peripheral division of naïve cells, therefore the decreased proportion of naïve T cells is 
associated with antigen encounter and activation of T cells throughout life leading to a shift in 
numbers to antigen-experienced effector cells (den Braber et al., 2012; Su et al., 2013). This 
age-related reduction is accompanied by a decline in TCR diversity in naïve CD4+ T cells, 
particularly after the age of 70; limiting the number of new antigens that an elderly individual 
can mount a response to (Naylor et al., 2005). Naïve T cells from elderly human donors have 
significantly shorter telomeres, decreased IL-2 production that impairs clonal expansion, and 
impaired differentiation into effector cells compared to naïve T cells from younger donors 
(Spaulding, Guo and Effros, 1999; Kohler et al., 2005; Vallejo, 2005). 
As discussed in section 1.2.3, Tfh cell differentiation begins with the priming of a naïve 
CD4+ T cell by DCs. However, T cell priming is compromised with age in both mice and 
humans. Naïve T cells from aged mice are less able to interact with DCs to form an 
immunological synapse for priming than young T cells (Garcia and Miller, 2001). Moreover, 
TCR signalling is impaired due to a decrease in intracellular proteins recruited downstream of 
TCR signalling (Garcia and Miller, 2001). Similarly, the magnitude of co-stimulation through 
CD28 signalling is reduced with age due to less CD28 being expressed at the immunological 
synapse on aged T cells (Vallejo, 2005; Perkey, Miller and Garcia, 2012). In addition to these 
defects in T cell priming, a number of the signals and molecules needed for Tfh cell 
differentiation are impaired with age. ICOS-specific signalling is crucial for Tfh cell lineage 
commitment yet as a result of impaired CD28 co-stimulation with age there is a decrease in 
ICOS expression in peripheral blood CD4+ T cells in both older humans and mice compared 
with young CD4+ T cells (Perkey, Miller and Garcia, 2012; Yu et al., 2012). Thus, the decrease 
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in ICOS in old CD4+ T cells could significantly impact lineage commitment in old Tfh cells, 
however this remains to be experimentally demonstrated (Linterman, 2014). On the other hand, 
Tfh cell lineage commitment is also promoted via the cytokines IL-12/TGF-b (human) and IL-
6/IL-21 (mice), which are increased in the serum of both humans and mice with age 
(Bruunsgaard et al., 1999; Ciaramella et al., 2011; Stojic-Vukanic et al., 2013). In vitro 
experiments have shown that T cells from older individuals appear to be more responsive to IL-
12 and more readily differentiate into Tfh cells than young T cells (Agrawal et al., 2012). Sage 
and colleagues described an increase in Tfh cell numbers in aged mice and thus it would be 
tempting to speculate this increase could be due to an increase in Tfh-promoting cytokines 
(Sage et al., 2015). Yet, an increase in Tfh cell number with age could also be due to a rise in 
the proportion of memory phenotype Tfh cells (Peter T Sage et al., 2014). Additionally, IL-6 
and IL-12 are able to promote the differentiation of other CD4+ T cell subsets based on 
additional signals the naïve T cell may receive. Studies have described T cell differentiation of 
older donors as favoring the Th1 (humans) and Th17 (mice) pathways though it has not been 
demonstrated whether this occurs at the expense of Tfh cell differentiation in vivo (Sakata-
Kaneko et al., 2000; Ouyang et al., 2011). Thus, the precise mechanisms of the age-dependent 
effects on Tfh cell differentiation remain to be further elucidated.  
Together with the impact on Tfh cell differentiation it is important to consider the age-
dependent effects on Tfh function. Sage and colleagues described an increase in Tfh cell 
numbers in aged mice yet these Tfh cells were less able to stimulate an antigen-specific B cell 
response in vitro (Sage et al., 2015). Similarly in vivo, when Tfh cells from aged mice were 
adoptively transferred into young Cd28-/- mice they were less able to stimulate GC B cell 
differentiation, plasma cell formation and antigen-specific antibody production compared to 
Tfh cells from young mice (Sage et al., 2015). In addition, the decreased expression of co-
stimulatory molecules CD28 and CD40L on aged CD4+ T cells compromises their capacity to 
provide adequate survival signals that are crucial for B cell proliferation and antibody 
production (Eaton et al., 2004; Vallejo, 2005; Yu et al., 2012).  The decrease in CD40L is due 
to an increase in dual-specific phosphatase 4 (DUSP4) following immunization which 
compromises the B-cell helper capacity of aged CD4+ T cells and results in decreased antibody 
and an impaired GC response (Yu et al., 2012). Moreover, Eaton and colleagues demonstrated 
that the transfer of aged CD4+ T cells into young mice results in reduced antigen-specific GC 
B cells after immunization indicating that CD4+ T cell aging significantly contributes to poor 
GC responses (Eaton et al., 2004). Thus, given the critical role Tfh cells play in GC formation 
and maintenance, the age-dependent effects on Tfh cell function are likely to be closely linked 
and have critical consequences for the GC response.  
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1.3.3 Age-associated defects in B cells and germinal centre responses 
 
The ageing process gives rise to substantial changes in all aspects of the humoral 
immune response (Linterman, 2014). In the periphery, B cell numbers do not appear to decline 
with age due to an accumulation of memory B cells that are less susceptible to apoptosis at the 
expense of the replenishment of naïve B cells (Weksler and Szabo, 2000; Chong et al., 2005). 
Like in the T cell compartment, BCR diversity decreases with age in both humans and mice, 
which limits the number of antigens the GC B cell precursors can respond to (Weksler and 
Szabo, 2000; Gibson et al., 2009). Additionally, B cells from older mice and humans are less 
able to proliferate in response to T-dependent and T-independent signals as well as undergoing 
less class-switch recombination and secreting less IgG1 in response to CD40L and IL-4 than B 
cells from young mice in vitro (Whisler, Williams and Newhouse, 1991; Blaeser, McGlauchlen 
and Vogel, 2008)These age-dependent effects could significantly impact the capacity for B 
cells to mount an adequate immune response upon infection or immunisation.  
 As described above, the GC response is a crucial component of humoral immunity, 
however it deteriorates with age (Linterman, 2014). In mice, GCs are smaller in size and the 
number of antigen-specific B cells generated after immunization is decreased with age (Kosco 
et al., 1989; Szakal et al., 1990). This results in an age-dependent decrease in generation of 
long-lived high-affinity plasma cells, serum antibody levels of lower affinity for antigen and 
consequently decreased protection against infection (Lu and Cerny, 2002; Han et al., 2003). 
Similarly in humans, there is a reduction in antigen-specific antibody titres in older individuals 
compared to young after vaccination with a T-dependent antigen (Burns et al., 1993; Stiasny et 
al., 2012). However unlike in mice, the age-related effect on the size of the GC in humans is 
harder to interpret (Linterman, 2014). In human lymph nodes and spleen, the size of the GC is 
comparable between old and young donors, (Monica Banerjee et al., 2002; Lazuardi et al., 
2005) one limitation of this analysis is that human LNs tend to be relatively quiescent and only 
contain small GCs (Wallin et al., 2014). In human tonsils, which are secondary lymphoid 
organs that have a persistent GC response, the size of the GC is decreased from middle-age but 
this observation does not account for the infectious status of the donor or the antigen-specificity 
of the GCs (Kolar et al., 2006; Linterman, 2014). Thus, the age-dependent decline of the GC 
response has been best described in mice as it is difficult to study antigen-specific GC responses 
in humans (Linterman, 2014). In mice, there is also a decrease in SHM with age, which is 
crucial for the process of affinity maturation (Miller and Kelsoe, 1995; Yang, Stedra and Cerny, 
1996). This could be attributed to an age-dependent decrease in the expression of AID in B 
cells, which is critical for class-switching and SHM, however studies investigating SHM of 
peripheral B cells in humans have yielded conflicting results (Frasca et al., 2004, 2008). In the 
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context of an influenza vaccine, B cells from older donors had more mutations in their Ig genes 
prior to vaccination and did not appear to accumulate mutations after vaccination compared 
with young donors (Jiang et al., 2013). Yet, this could simply be an effect from longer exposure 
to influenza antigens throughout life (Yu et al., 2012), which can be controlled in mouse studies. 
Thus, the age-dependent effects on SHM remain elusive and poorly understood in humans.  
 The ageing defects in the B-cell compartment and the GC response are not solely B cell 
intrinsic but are also likely to arise from impaired interactions with other cells types of the 
immune system. Adoptive transfer experiments by Cerny and colleagues demonstrated that the 
age of CD4+ T cells and not aged B cells are the main contributors to the decrease in size of the 
GC though the age of both T and B cells contributes to the decrease in somatic hypermutation 
with age (Yang, Stedra and Cerny, 1996). Moreover, a separate study confirmed that the 
transfer of old CD4+ T cells into young T cell-deficient mice resulted in a smaller germinal 
centre response upon immunization as well as less antigen-specific B cells and a reduction in 
IgG1 compared to CD4+ T cells derived from young donors (Eaton et al., 2004). Whilst these 
studies suggest T-cell age greatly contributes to the demise of the GC response it does not 
account for all GC defects arising with age. In fact, the transfer of young transgenic CD4+ T 
cells into old wild type mice resulted in decreased T cell recruitment and priming as well as 
reduced formation of Tfh cells which in turn impaired the generation of GCs (Lefebvre et al., 
2012). This indicates that the age of the microenvironment is also a crucial factor in generating 
an adequate GC response with age (Lefebvre et al., 2012). Thus, many of the underlying 
mechanisms that contribute to the age-dependent demise of the GC response are yet to be 
elucidated and better understanding them will provide insights into improving vaccination 












1.3.4 Improving vaccine efficacy in the elderly 
 
 Present-day advances in sanitation and public health have accomplished an increase in 
life expectancy in populations of both the developed and developing world. It is predicted that 
by 2050, 22% of the global population will be over 60 years old, which creates a challenge for 
public health in enabling healthy aging of older individuals (WHO, 2011). The decline of the 
immune system with age is reflected in an increased susceptibility to infections that results in 
increased morbidity and mortality from infectious disease in the elderly (Dorshkind, 
Montecino-Rodriguez and Signer, 2009). Vaccination has been the most successful medical 
intervention in preventing infectious disease worldwide and would therefore be the optimal 
intervention to prevent infectious disease in older individuals (Kim et al., 2017). However 
vaccination efficacy is compromised with age (Govaert et al., 1994; Ortqvist et al., 1998). In 
the context of the annual influenza vaccine, older individuals are not able to generate protective 
immunity to the same degree as younger individuals (Govaert et al., 1994). Similarly, protection 
after vaccination with attenuated varicella zoster virus (VZV) declines from 70% in 50-59-year-
old individuals to 38% in adults 70 years and older (Tseng et al., 2011; Schmader et al., 2012; 
Langan et al., 2013). Strategies to overcome age-dependent defects in vaccination have so far 
focused on increasing vaccine doses and exploring the benefits of various adjuvants to target 
the activation of the innate immune system and improve the induction of T cell responses which 
have had some, though limited, success (Kim et al., 2017).  
Most vaccines rely on the generation of long-lived antibody-secreting plasma cells that 
can neutralize a pathogen before it establishes an infection (Linterman, 2014). However, older 
individuals have decreased titres of pathogen-neutralizing antibodies compared with younger 
individuals after vaccination (Burns et al., 1993; Stiasny et al., 2012). These vaccine specific 
antibodies are largely produced as a result of the GC response, which deteriorates with age 
(Linterman, 2014). Whilst some of the age-dependent changes in the GC response have been 
described (section 1.3.3) the underlying mechanisms of these cellular and molecular changes 
remain to be understood. In silico modelling, also referred to as mathematical modelling, is a 
powerful tool for quantitative and systemic analysis of hypotheses in addition to experimental 
data in immunology (Meyer-Hermann, Figge and Toellner, 2009). An in silico model of the 
GC has been established by Michael Meyer-Hermann at the Helmholtz Centre for Infection 
Research (HZI), Germany and it has been previously used to predict novel concepts in GC 
dynamics including mechanisms of B cell selection and affinity maturation (Meyer-Hermann, 
Maini and Iber, 2006; Meyer-Hermann et al., 2012). In this project, the in silico model of the 
GC will be used in combination with in vivo studies phenotyping the age-dependent changes in 
the GC in mice, to predict how the aged GC response can be improved upon vaccination, which 
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will then be validated experimentally. This project ultimately aims to better understand the 
underlying mechanisms of the age-dependent changes in the GC response, which would enable 







1.4 Project Aims 
 
This project aims to investigate how aging affects the germinal centre response using a 
combination of in vivo and in silico tools to gain insights into improving vaccination efficacy 
in older individuals. The specific aims are: 
 
1. Assess the cellular changes of the germinal centre response with age in vivo in mice 
2. Set up an in silico model of the aged germinal centre response using in vivo data to 
generate hypotheses on which are the main drivers of GC deterioration with age 






Materials and Methods 
 




The following mice strains were used: Wild type (WT) BALB/c and C57BL/6 mice, 
congenic B6.SJL (CD45.1), SWHEL, OT-II, and ERT2CreCxcr4fl/fl mice. Aged BALB/c and 
C57BL/6 mice were 90-95 and 95-108 weeks old, respectively, at the start of the experiments. 
All other adult mice were between 5 and 12 weeks old at the start of experiments. Details of 
each mouse strain are listed in Table 2.1 below. Mice were housed under specific pathogen-
free conditions at the Biological Support Unit (BSU), Babraham Research Campus. All 
experiments were performed according to the regulations of the UK Home Office Scientific 













Table 2.1 Mouse models used for experiments in this project 
Mouse Strain Description Source Key publications 














Congenic mice carrying the 







Transgenic mice that express 
the B cell receptor specific 
for hen egg lysozyme (HEL). 
Brink Laboratory  (Phan et al., 2003) 
OT-II 
Transgenic mice that express 
the T cell receptor specific 
for chicken ovalbumin 323-




(Barnden et al., 
1998) 
Cxcr4fl/fl 
Transgenic mice with loxP 
sites on either side of intron 2 
of the Cxcr4 gene. 
JAXâ mice (Nie et al., 2004) 
ERT2Cre 
Transgenic mice with 





(Ventura et al., 
2007) 
ERT2CreCxcr4fl/fl 
Transgenic mice in which 
ubiquitous deletion of Cxcr4 
can be achieved by 
tamoxifen administration. 




All antibodies used for ELISAs, ELISpots, confocal microscopy and flow cytometry are listed 
in Table 2.2-2.11 
 
Table 2.2 Antibodies used for ELISAs and ELISpots 
Antibody Clone Vendor 
Goat anti-mouse IgG1 (HRP) Polyclonal Abcam 
Goat anti-mouse IgM (HRP) Polyclonal Abcam 
 
 
Table 2.3 Antibodies used for confocal microscopy 
Species Reactivity Antigen Conjugation Clone Vendor 
Rat Anti-mouse IgD FITC 11-26c.2a BioLegend 
Rat Anti-mouse IgD A647 11-26c.2a BioLegend 
Hamster Anti-mouse CD3e APC 17A2 BioLegend 
Hamster Anti-mouse CD3e Purified 500A ThermoFisher 
Rabbit Anti-mouse Casp3 Purified C92-605 BD 
- - CD35 Biotin 8C12 BD 
Rabbit Anti-mouse Ki67 Purified Polyclonal Abcam 
Rat Anti-mouse Ki67 FITC SolA15 ThermoFisher 
Rat Anti-mouse Foxp3 AF488 FJK16S ThermoFisher 
 Anti-mouse CD45.2 A700 104 eBioscience 
Goat Anti-rabbit IgG AF568 Polyclonal ThermoFisher 














Table 2.4 Antibodies used for BALB/c kinetic flow cytometry  
Antigen Fluorochrome Clone Vendor 
B220 BV510 RA3-682 BioLegend 
Bcl-6 BV421 K112-91 Benton Dickson (BD) 
CD4 BV605 RM4-5 BioLegend 
CD38 PercP-Cy5.5 90 eBioscience 
CD86 APC GL-1 eBioscience 
CXCR4 PE L276F12 BioLegend 
CXCR5 BV785 L138D7 BioLegend 
DEVED-FMK (Casp3) FITC - eBioscience 
Ki67 AF780 SolA15 eBioscience 
PD-1 PE-Cy7 RMP1-30 BioLegend 
 
 
Table 2.5 Antibodies and fluorescently-labelled hapten used for NP+GC B cell 
sorting  
Antigen Fluorochrome Clone Vendor 
B220 BV510 RA3-682 BioLegend 
CD38 PB 90 eBioscience 
CD95 PE-Cy7 Jo2  BD 
GL7 FITC GL7 eBioscience 
GR1 APC RB6-8C5 eBioscience 
IgG1 BV605 A85-1 BD 
IgM  APC R6-60.2 BD 











Table 2.6 Antibodies used for C57BL/6 kinetic flow cytometry  
Antigen Fluorochrome Clone Vendor 
B220 BV510 RA3-682 BioLegend 
Bcl-6 PE-Cy7 K112-91 BD 
CD4 BV605 RM4-5 BioLegend 
CD44 Percp-Cy5.5 IM7 BioLegend 
CXCR5 BV421 L138D7 BioLegend 
Foxp3 APC FJK-16S eBioscience 
Ki67 FITC SolA15 eBioscience 
PD-1 APC Hy7 RMP1-30 BioLegend 
 
 
Table 2.7 Antibodies and dyes used for additional flow cytometry in BALB/c mice 
Antigen Fluorochrome Clone Vendor 
B220 BV785 RA3-6B2 BioLegend 
Bcl-6 PE-Cy7 K112-91 BD 
CD4 BV605 RM4-5 BioLegend 
CD44 Percp-Cy5.5 IM7 BioLegend 
CRTAM APC 11-5 BioLegend 
CXCR4 PE L276F12 BioLegend 
CXCR5 BV421 L138D7 BioLegend 
Foxp3 AF488 FJK-16s eBioscience 
ICOS BUV395 C398.4A BD 
Ki67 AF780 SolA15 eBioscience 
PD-1 APC eF780 J43 eBioscience 











Table 2.8 Antibodies used for flow cytometry in chemotaxis assays  
Antigen Fluorochrome Clone Vendor 
B220 BV510 RA3-682 BioLegend 
CD4 APC GK1.5 eBioscience 
CD44 Percp-Cy5.5 IM7 BioLegend 
CXCR4 PE L276F12 BioLegend 
CXCR5 BV421 L138D7 BioLegend 
Foxp3 AF488 FJK-16s eBioscience 
ICOS BUV395 C398.4A BD 
PD-1 PE-Cy7 RMP1-30 BioLegend 
 
 
Table 2.9 Antibodies and fluorescently-labelled HEL used for flow cytometry in 
SWHEL and OT-II adoptive transfers 
Antigen Fluorochrome Clone Vendor 
aCasp3 PE C92-605 BD 
B220 BV785 RA3-6B2 BioLegend 
CD4 BUV496 GK1.5 BD 
CD4* BV510 GK1.5 BioLegend 
CD38 Percp-Cy5.5 90 eBioscience 
CD45.1 PE-Cy7 A20 eBioscience 
CD45.2 A700 104 eBioscience 
CD95 BV510 Jo2 BD 
CXCR5 BV421 L138D7 BioLegend 
HEL A647 - Conjugated in house 
IgG1 BV605 A85-1 BD 
IgM BUV395 R6-60.2 BD 
PD-1 APC eF780 J43 eBioscience 
TCR Va2* Percp-Cy5.5 B20.1 eBioscience 






Table 2.10 Antibodies and dyes used for flow cytometry in Cxcr4fl/fl adoptive 
transfers  
Antigen Fluorochrome Clone Vendor 
B220 BV785 RA3-6B2 BioLegend 
Bcl6 A647 K112-91 BD 
Bcl6 PE-Cy7 K112-91 BD 
CD4 BV605 RM4-5 BioLegend 
CD45.1 A700 A20 BioLegend 
CD45.1 PE-Cy7 A20 eBioscience 
CD45.2 Percp-Cy5.5 104 eBioscience 
Cell Trace Violet eF450 - eBioscience 
CXCR5 APC L138D7 BioLegend 
CXCR5 BV421 L138D7 BioLegend 
CXCR4 PE L276F12 BioLegend 
CXCR4 Percp-eF710 2B11 eBioscience 
Foxp3 AF488 FJK-16s eBioscience 
ICOS BUV395 C398.4A BD 
IgG1 BV605 A85-1 BD 
IgM BUV395 R6-60.2 BD 
Ki67 A700 SolA15 eBioscience 
Ki67 FITC SolA15 eBioscience 














Table 2.11 Antibodies and dyes used for identifying transduced OT-II cells in 
adoptive transfers 
Antigen Fluorochrome Clone Vendor 
B220 BV785 RA3-6B2 BioLegend 
CD4 BV605 RM4-5 BioLegend 
CD38 Percp-Cy5.5 90 eBioscience 
CD45.1 PE-Cy7 A20 eBioscience 
CD45.2 A700 104 eBioscience 
CD95 BV510 Jo2 BD 
Cell Viability Dye Blue (450/50) - eBioscience 
CXCR4 PE L276F12 BioLegend 
CXCR4 Percp-eF710 2B11 eBioscience 
CXCR5 BV421 L138D7 BioLegend 
IgG1 BV605 A85-1 BD 
IgM BUV395 R6-60.2 BD 
NP PE - Biosearch Technologies 


















Table 2.12 Primers used for two-round nested PCR of VH186.2 
 
Primer name Sequence (5’- 3’) Vendor 
1st PCR round 
External 186.2 GCTGTATCATGCTCTTCTTG Sigma-Aldrich 
External Cg1 GGATGACTCATCCCAGGGTCACCATGGAGT Sigma-Aldrich 
2nd PCR round 
Internal 186.2 GGTGTCCACTCCCAGGTCCA Sigma-Aldrich 
Internal Cg1 CCAGGGGCCAGTGGATAGAC Sigma-Aldrich 
 
 
Table 2.13 Taqman probes used for reverse transcription qPCR  
 
Primer name Taqman Probe ID Vendor 
Cxcr4 Mm01996749_s1 ThermoFisher  
Hprt Mm03024075_m1 ThermoFisher 
 
 
Table 2.14 Primers used to confirm cloned expression and retroviral vectors 
 
Primer name Sequence (5’- 3’) Vendor 
pBABE-F CTTTATCCAGCCCTCAC Sigma Aldrich 
CXCR4-F GTCCAGTGTGGTGGAATTCAC Sigma Aldrich 










2.1.4 Expression and retroviral vectors 
 
 
Table 2.15 Vectors used to subclone and overexpress CXCR4 
 
Vector name Source 
pcDNA3-HA-Cxcr4 A gift from Karl Balabanian (France) 
pMSCV-IRES-GFP II (pMIG-II) Addgene  
pMSCV-Cxcr4-IRES-GFP II (pMIG-II) Subcloned in house 
 
 
2.1.5 Chemicals, peptides and recombinant proteins 
 
Table 2.16 List of peptides/recombinant proteins and respective source 
Peptides and recombinant proteins Source 
NP-KLH (Conjugation ratio: 29-33) Biosearch Technologies 
NP-1W1K Conjugated in house 
Lysozyme from hen egg white (HEL) Sigma-Aldrich 
Albumin from chicken egg white (OVA) Sigma-Aldrich 
HEL-OVA Conjugated in house 
4-OH Tamoxifen Sigma-Aldrich 
Recombinant mouse CXCL12 Peprotech 
Recombinant mouse IL-2 Peprotech 
Recombinant mouse IL-7 Peprotech 
Trans-IT Mirus 







2.1.6 Buffers, solutions and media  
 




ELISA/ELISpot wash buffer 0.05% Tween 20 (v/v) in PBS 
ELISA blocking buffer 2% BSA (w/v) in PBS  
Confocal wash buffer 0.5% Tween 20 (v/v) 
Confocal 
blocking/permeabilisation buffer 
2% (w/v) bovine serum albumin (BSA), 10% (v/v) 
normal goat serum (NGS), 2% (v/v) Triton X in PBS 
DMEM Obtained from GibcoBRL. 10% (v/v) Heat-inactivated 
fetal calf serum (HI-FCS), 1% (v/v) Penicillin-
Streptomycin-Glutamine (PSG) 
RPMI Obtained from GibcoBRL 10% (v/v) HI-FCS, 1% (v/v) 
PSG, 10mM HEPES, 0.1mM MEM non-essential 
amino acid solution, 1mM sodium pyruvate, 55µM β-
Mercaptoethanol 
OPTIMEM Obtained from GibcoBRL, ThermoFisher Scientific 
FACS Wash 2% FCS (v/v) in PBS 
Brilliant Stain Buffer Obtained from Becton Dickson (BD) 
Red blood cell lysis buffer Ammonium-Chloride-Potassium (ACK) buffer 150mM 
NH4Cl, 10mM KHCO3, 0.1mM NA2EDTA in H2O 
Reverse Transcription buffer 
(VH186.2 PCR) 
1mMdNTPs, 8mM DTT, 0.2U/ µL RNase inhibitor and 
100U SuperScript enzyme  
RT-lysis buffer 2 U/µL RNase inhibitor, 4mM DTT, 30ng/µL Random 













2.1.7 Software and bioinformatic tools  
 
 
Table 2.18 List of software and bioinformatic tools used for this project 
Software Details 
Adobe Illustrator Adobe Creative Cloud 2019 
Cell Profiler Cell Profiler ™ version 3.1.8 
FlowJo FlowJo LLC, version 10.1r5, Tree Star 
GraphPad  GraphPad Prism 7 
GLE Graphics Layout Engine, version 4.2 
ImageJ Fiji ImageJ, version 1.50e 




























For induction of GCs in inguinal lymph nodes (iLN), experimental mice were 
immunised subcutaneously on both flanks on the lower part of the body. The iLNs were 
dissected at the appropriate end point for each experiment and blood was collected by cardiac 
puncture to determine antigen-specific antibody production.  
 
2.2.1.1 NP-KLH and OVA  
BALB/c mice were immunised with 4-hydroxy-3-nitrophenylacetyl (NP) conjugated to 
the Keyhole Limpet Hemocyanin (KLH) protein (NP-KLH) (Biosearch Technologies). NP31-
KLH was prepared at 1mg/ml in sterile PBS and mixed at a 1:1 ratio in Aluminium Hydroxide 
(Alum, ThermoScientific, UK) by vortexing for 30 minutes. Mice were then immunised with 
100µL on each flank under inhaled isoflurane anaesthesia. The iLNs, bone marrow and blood 
were taken at days 0, 7, 14 and 21 after immunisation.  
For adoptive transfers, recipient mice were immunised with OVA prepared at 1mg/ml 
in sterile PBS and mixed at a 1:1 ratio in Alum by vortexing for 30 minutes. Each mouse was 
immunised 100µL on each flank under anaesthesia and as such each received 100ug of OVA. 
The iLNs and blood were taken at day 10 after immunisation. 
 
2.2.1.2 NP-1W1K 
C57BL/6 mice were immunised with 1W1K-biotinylated peptide (Cambridge Research 
Biochemicals, UK) conjugated to streptavidin coated with NP (loading=12). Streptavidin (SA) 
was linked to NP by Jonathan Clark at the Babraham Institute Chemistry Department. For the 
conjugation of SA-NP to the biotinylated 1W1K peptide, 0.3 mg of biotinylated peptide per 1 
mg of SA-NP were resuspended in 400µL of PBS and incubated at room temperature for an 
hour. Following incubation, conjugated NP-1W1K was purified using centriprep YM-10 
dialysis columns (EMD Millipore, UK) as per the manufacturer’s instructions. 1W1K-NP was 
then prepared at 0.2mg/ml in sterile PBS and mixed at a 1:1 ratio in Alum. C57BL/6 mice were 
immunised with 100µL on each flank under anaesthesia. The iLNs, bone marrow and blood 
were taken at days 0, 7, 10, 14 and 21 after immunization. 
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2.2.1.3 HEL-OVA 
For SWHEL B cell and OT-II T cell co-transfers, recipient mice were immunised with 
HEL protein conjugated to OVA. The HEL and OVA proteins were conjugated using the 
SoluLinnk Protein-Protein Conjugation Kit (TriLink BioTechnologies) according to the 
manufacturer’s instructions. HEL-OVA conjugate was prepared at 0.2mg/ml in sterile PBS and 
mixed at a 1:1 ratio in Alum. Each mouse was immunised with 100µL on each flank under 
anaesthesia and as such each received 20ug of HEL-OVA. The iLNs and blood were taken at 
day 10 after immunisation. 
2.2.2 Flow cytometry  
 
2.2.2.1 Cell suspension preparation 
Throughout this project, lymph nodes, spleen and bone marrow were dissected from 
experimental mice. Bone marrow cells for ELISpot were isolated by flushing sterile FACS 
wash (Table 2.17) through the bone using a 1ml syringe (Terumo, Philippines) under sterile 
conditions in a Bio2+ Envair tissue culture hood (Envair, UK).  Cell suspensions from LNs and 
spleens were prepared by mechanical disruption with a syringe plunger on 70µm nylon cell 
strainers (Falcon). Cells isolated from spleens and bone marrow were treated with RBC lysis 
buffer (Table 2.17) in order to lyse the red blood cells prior to surface staining. The cell 
suspensions were then washed and collected in FACS wash. Aliquots were taken to assess the 
number of viable cells using an automated CASY Cell Counter (Roche, Switzerland).   
 
2.2.2.2 Surface Staining 
For cell surface staining, 1-5x106 cells per inguinal LN were used. For experiments 
requiring B cell-specific staining, cell suspensions were treated with unlabelled anti-CD16/32 
(BioLegend) for 10 min at 4°C to block Fc receptors prior to surface staining. Cells were stained 
for 1hr at 4°C in 100µL of the appropriate antibody cocktail (Table 2.4-11) which was diluted 
in Brilliant Stain buffer (Table 2.17). For Caspase 3 inhibitor staining, cells were resuspended 
in 300µL of complete RPMI (Table 2.17) with 1µL of FITC-DEVED-FMK being added into 
each tube and stained for 1 hour at 37°C with 5% CO2. Once stained, cells were then washed 
twice with FACS wash and centrifuged at 1800rpm for 5 min. Cells which did not require 
intracellular staining were resuspended in 100µL of FACS wash, filtered with a 50 µm filter 
(Cell Trics, Sysmex, US) and kept in the dark at 4°C until acquisition.  
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2.2.2.3 Intracellular Staining 
 Subsequent to surface staining, cells were fixed and permeabilised for intracellular 
staining of Foxp3, Ki67 and Bcl6 using the eBioscience Foxp3 Transcription Factor 
Fixation/Permeabilisation Staining buffer set (ThermoFisher Scientific) according to the 
manufacturer’s instructions. Cells were fixed in 100µL of 1x Fixation/permeabilisation solution 
for 30 min at 4°C. Cells were then washed twice with 1x Permeabilisation buffer, centrifuged 
at 1800rpm for 5min and resuspended in 100µL of the appropriate intracellular antibody 
cocktail (Table 2.4-11) diluted in Permeabilisation buffer. Cells were stained in the dark for 1hr 
at 4°C. Once stained, cells were washed once in Permeabilisation buffer and once with FACS 
wash. Cells were then resuspended in 100µL of FACS wash, filtered with a 50 µm filter (Cell 
Trics, Sysmex, US) and kept in the dark at 4°C until acquisition. 
Likewise, for anti-active Caspase 3 intracellular staining, cells were fixed and 
permeabilised using the BD Cytofix/Cytoperm Kit (BD), according to the manufacturer’s 
instructions. Cells were fixed in 100µL of BD Cytofix/Cytoperm solution for 30 min at 4°C. 
The cells were then washed with 1x BD Perm/Wash, centrifuged at 1800rpm for 5min and 
resuspended in 100µL of anti-aCasp3 (Table 2.4-11) diluted in Permeabilisation buffer. Cells 
were stained in the dark for 1hr at 4°C. Once stained, cells were washed once in 
Permeabilisation buffer and once with FACS wash. Cells were then resuspended in 100µL of 




 Flow cytometry was performed using the BD LSR Fortessa with 5 lasers: 
488nm, 405nm, 561nm, 640nm, UV (BD). Prior to the acquisition of samples, fluorescence 
compensation was calculated using single colour UltraComp eBead controls (ThermoFisher 
Scientific, UK) with FACSdiva software. Analysis of flow cytometry data was done using 








2.2.3 Enzyme-Linked Immunosorbent Assays (ELISAs) 
 
2.2.3.1 IgG1 NP-specific ELISA 
ELISA plates (Nunc, ThermoFisher Scientific) were coated with NP20-BSA or NP7-
BSA in PBS at a concentration of 10µg/ml and 2.5µg/ml respectively and were incubated 
overnight at 4oC. Plates were then washed four times with ELISA wash buffer (Table 2.17) and 
blocked with 150µL/well of blocking buffer (Table 2.17) for 1hr at RT. The previous wash step 
was repeated after incubation with blocking buffer, serum and antibody. The serum was serially 
diluted (1:3) down the plate at a starting dilution of 1:200 in 1% BSA PBS solution and 
incubated for 2hrs at RT. Detection was done using an anti-mouse HRP-conjugated IgG1 
antibody (Table 2.2) diluted at 1:8000 in PBS. Plates were developed using 100µL 
Tetramethylbenzidine (TMB) substrate kit (BioLegend) and the reaction was stopped with 
50µL 0.5M H2SO4. Absorbance was read immediately with a PHERAstar FS plate reader 
(BMG Labtech) at 450nm.  
 
2.2.3.2 IgM NP-specific ELISA 
ELISA plates (Nunc, ThermoFisher Scientific) were coated with NP20-BSA in PBS at 
a concentration of 10µg/ml and were incubated overnight. Plates were then washed four times 
with ELISA wash buffer (Table 2.17) and blocked with 200µL/well of blocking buffer (Table 
2.17) for 1hr at RT. Wash step was repeated after incubation with blocking buffer, serum and 
antibody. The serum was serially diluted (1:3) down the plate at a starting dilution of 1:1800 in 
1% PBS solution and incubated for 2hrs at RT. Detection was done using an anti-mouse HRP-
conjugated IgG1 antibody (Table 2.2) diluted at 1:7000 in 0.1%BSA, 0.05% Tween20 PBS. 
Plates were developed using 100µL Tetramethylbenzidine (TMB) substrate kit (BioLegend) 
and the reaction was stopped with 50µL 0.5M H2SO4. Absorbance was read immediately with 
a PHERAstar FS plate reader (BMG Labtech) at 450nm.  
 
2.2.3.3 HEL-specific ELISA  
 ELISA plates (Nunc, ThermoFisher Scientific) were coated with HEL in PBS at 
a concentration of 10µg/ml and were incubated overnight. Plates were then washed four times 
with ELISA wash buffer (Table 2.17) and blocked with 200µL/well of blocking buffer (Table 
2.17) for 1hr at RT. Wash step was repeated after incubation with blocking buffer, serum and 
antibody. The serum was serially diluted (1:3) down the plate at a starting dilution of 1:1800 in 
1% PBS solution and incubated for 2hrs at RT. Detection was done using an anti-mouse HRP-
conjugated IgG1 antibody (Table 2.2) diluted at 1:7000 in 0.1%BSA, 0.05% Tween20 PBS. 
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Plates were developed using 100µL Tetramethylbenzidine (TMB) substrate kit (BioLegend, 
USA) and the reaction was stopped with 50µL 0.5M H2SO4. Absorbance was read immediately 
with a PHERAstar FS plate reader (BMG Labtech, UK) at 450nm.  
 
2.2.4 NP-specific ELISpot 
 
MultiScreen-HA mixed cellulose ester plates (Millipore, Watford, UK) were coated 
with NP23-BSA or NP2-BSA in PBS at a concentration 10µg/ml and 5µg/ml respectively and 
were incubated overnight at 4oC. Plates were then washed twice with PBS and blocked with 
50µL/well of complete DMEM medium for 1hr at RT. The bone marrow cell suspensions were 
serially diluted (1:2) down the plate and incubated at 37oC (5%CO2) overnight. Cells 
suspensions were flicked out and plates were rinsed five times with ELISpot wash buffer (Table 
2.17), three times with PBS and three times with dH2O. Detection was performed using an anti-
mouse HRP-conjugated IgG1 or IgM antibody (Table 2.2) diluted at 1:5000 in 0.1%BSA, 
0.05% Tween20 PBS. Plates were developed using the AEC staining kit (Sigma-Aldrich, 
Merck Germany) according to the manufacturer’s instructions. The number of antibody-
secreting cells (ASCs) was determined using a CTL ELISPOT reader and CTL ImmunoSpot 
Software (Cell Technologies, USA).  
 
2.2.5 VH186.2 PCR and Sequencing 
 
2.2.5.1 Single cell FACS sorting 
Cell suspensions were prepared from a single iLN as outlined in section 2.2.2.1. The 
cell suspensions were washed and collected in FACS wash. Cells for single-cell sorting were 
resuspended in 500µL of antibody mix diluted in FACS wash (Table 2.5) and incubated at 4°C 
for 1 hour. Cells were then washed with PBS and centrifuged at 1800rpm at 4°C for 5min. Cells 
were resuspended in PBS 0.5% FCS and kept in the dark at 4°C until single-cell sorting. 
B220+IgM-GR1-/NP+IgG1+ GC B cells were sorted into 96-well plates containing 10µL of RT-
lysis buffer (Table 2.17) using an Aria III Cell Sorter (BD, USA). Sorted plates were covered 




2.2.5.2 Reverse transcription  
 Plates containing sorted NP+IgG1+ GC B cells were taken from the -80°C freezer and 
placed directly in a thermocycler (PT-100™, MJ Research Inc., USA) pre-set with the program 
outlined in Table 2.2.1 below. After the initial heating step 1 at 65°C, the program was paused 
at 4 minutes and 30 seconds of the 10°C incubation step. Once paused, 15 µL of the reverse 
transcription buffer (Table 2.17) was added to each well. The program was then restarted at 
step 3 and left to run till completion. Prepared cDNA was stored at -20°C.  
 
Table 2.19 Reverse transcription thermocycling program 
Step Temperature (°C) Time (min) 
1 65 2 
2 10 5 
3 22 10 
4 37 30 
5 90 6 
 
 
2.2.5.3 VH186.2 PCR, sequencing and analysis 
 For amplification of VH186.2 region, nested PCR was performed using 2.5 µL of the 
cDNA prepared from a single cell in section 2.2.5.2. The PCR mix for the first round of 
amplification was prepared using 20 pmol of each of the external primers (Table 2.12) and the 
HotStar Taq DNA polymerase kit (QIAGEN, Denmark) according to the manufacturer’s 
instructions with a final volume of 30 µL/well in 96-well plates. Plates were then placed in a 
(BioRad, USA) thermocycler pre-set with the PCR1 program outlined in Table 2.20  The first 
PCR product was then diluted 30 times and 1 µL of the diluted product was used in the second 
PCR mix which was prepared with 20 pmol of each of the internal primers (Table 2.12) and the 
HotStar Taq DNA polymerase kit (QIAGEN, Denmark) according to the manufacturer’s 
instructions in 96-well plates. Plates were then placed in a (brand) thermocycler pre-set with 
the PCR2 program outlined in Table 2.20. Upon completion of the program, 5 µL of the second 
PCR product was ran on a 1% agarose gel to check for positive clones, which were 350bp in 
size. The remaining 25 µL of the PCR2 product was purified using ExoSAP-IT PCR product 
clean up reagent (ThermoFisher Scientific, USA) according to the manufacturer’s instructions. 
The purified samples were then sent for Sanger sequencing with the Cg1 primer (Table 2.12) to 
Source Bioscience, UK. The sequences were then analysed by automated alignment to the 
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VH186.2 sequence downloaded from NCBI IgBLAST. The number of point mutations in the 
CDR1 region of VH186.2 were quantified as well as the frequency of the affinity-inducing 
W33L mutation.  The automated alignment pipeline was designed by Christel Krueger from the 
Bioinformatics Facility.  
 
Table 2.20 Two round nested VH186.2 thermocycling programs 
 Step Temperature (°C) Time (min)  
PCR1 HotStar Taq Activation 95 15  
1 Denaturation 94 3  
2 Denaturation 94 45 sec 
Repeat steps 
2-4 39 times 
3 Annealing 50 1 
4 Extension 72 1 
5 Extension 72 10  
 Hold 4   
PCR2 HotStar Taq Activation 95 15  
1 Denaturation 94 3  
2 Denaturation 94 45 sec 
Repeat steps 
2-4 39 times 
3 Annealing 50 1 
4 Extension 72 1 
5 Extension 72 10  
















2.2.6 Immunofluorescence staining for confocal microscopy 
 
2.2.6.1 Preparation of frozen tissue  
 Inguinal lymph nodes were dissected and fixed for 5 hours at 4°C in Periodate-lysine-
paraformaldehyde (PLP) solution containing 1% (v/v) paraformaldehyde (PFA), 0.075M L-
Lysine, 0.37M Na3PO4 (pH 7.4) and 0.01M NaIO4. Following fixation, the tissues were 
dehydrated in 30% (w/v) sucrose at 4°C, overnight. The tissues were then washed twice with 
fresh 30% (w/v) sucrose with 15 min intervals in between washes and embedded in Optimum 
Cutting Temperature (OCT) medium (VWR, USA). Embedded tissues were stored at -80°C 
until the time of cryo-sectioning. The frozen tissues were sectioned into 10 µm serial sections 
with a Leica cryostat (Leica Biosystems, Germany) set at -20°C. Sections were stored at -20°C 
for short-term storage and -80°C for long-term storage.  
 
2.2.6.2 Immunofluorescence staining 
 Prior to staining, slides were air-dried for 30-60 min under a Bio2+ Envair tissue culture 
hood (Envair, UK).  Once dry, the sections were rehydrated by washing the slides three times 
for 5 min with confocal wash buffer (Table 2.17) in a coplin jar. To prevent non-specific binding 
of primary antigens, the sections were blocked and permeabilised with 100 µL of confocal 
blocking/permeabilisation buffer (Table 2.17) for 30 min at room temperature. The samples 
were then washed three times for 5 min with wash buffer in coplin jars. Endogenous biotin or 
biotin-binding proteins on the tissue sections were then blocked using the Streptavidin/Biotin 
Blocking kit (Vector Laboratories) according to the manufacturer’s instructions. Sections were 
then washed once with wash buffer and incubated for 2 hours at room temperature in the dark 
with 100 µL of the appropriate primary antibody mix (Table 2.3). Following the primary stain, 
sections were washed three times for 5 min with wash buffer to remove unbound antibodies. 
The sections were then incubated with 100 µL of the secondary antibody mix (Table 2.3) for 2 
hours at room temperature in the dark. After the secondary stain, samples were rinsed twice 
with wash buffer and twice with PBS. Excess PBS was carefully wiped off the slides and the 
sections were mounted in Hydromount Aqueous Mounting Medium (National Diagnostics, 
USA). A coverslip was added gently using forceps to prevent the generation of air bubbles. The 
slides were then dried overnight in the dark until analysis.  
 
2.2.6.3 Confocal microscopy and analysis 
 Tissue sections were visualised with a Zeiss 780 confocal microscope and images were 
acquired using the 20x and 40x objectives. A minimum of six sections were analysed per mouse 
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and each germinal centre (GC) within each lymph node was imaged. This resulted in a total of 
4-6 GCs per section. Image analysis was performed using Cell Profiler and Volocity (Table 
2.18). The GC area (µm2) was defined as IgD-Ki67+CD35+ and analysis was done using 
automated identification of GCs in Cell Profiler. The GC light zone are (LZ) was defined as the 
IgD-CD35+ follicular dendritic cell (FDC) network area (µm2) with an automated Cell Profiler 
analysis pipeline. The number of CD3+ T cells within each GC was quantified using an 
automated Cell Profiler analysis pipeline and normalised to the GC area. T follicular regulatory 
(Tfr) cells within the GC were defined as CD3+Foxp3+ and quantified manually using Volocity 
and normalised to GC area. T cell localisation within the GC was also analysed using an 
automated Cell Profiler pipeline. Immunofluorescence staining and blinded image analysis of 
repeat experiments was performed by Sigrid Fra-Bido of the Linterman Lab.  
 
2.2.7 In silico GC simulations 
 In silico simulations of the aged GC response were carried out at the Meyer-Hermann 
Lab in TU Braunschweig, Germany using an in silico model of the GC established by Dr. 
Michael Meyer-Hermann. The model known as hyphasma, is an agent-based model which 
accounts for the dynamic nature of the GC and it was first introduced in Dr Michael Meyer-
Hermann in 2005 (M. E. Meyer-Hermann & Maini, 2005). In hyphasma, each simulated cell 
represents an agent with properties such as direction of movement, position and antigen 
receptor (for B cells and T cells). The GC area is the system defined as a sphere and is 
represented as a grid. Each grid point is the size of a cell (5 µm) and has a defined concentration 
of each chemokine, CXCL12 and CXCL13. Each cell in the system carries a polarity defining 
the direction of its movement which is assumed to be random. However, a defined turning angle 
is allocated to the movement of cells taken from experimental measurements performed by 
Cyster and colleagues (Allen et al., 2007), which can be further influenced by its sensitvity to 
chemotaxis. The sensitivity to CXCL12 or CXCL13 is allocated by adding a small movement 
bias in the direction to the gradient of both chemokines (Figge et al., 2008). Thus, throughout 
a simulation, the movement of each cell within the GC space is influenced by its polarity and 
by its sensitivity to chemotaxis. For T cell movement, the preferential localisation of Tfh within 
the LZ is done by adding a preference to follow a direction termed as ‘north’ in the hyphasma 
model. It is worth noting that in the hyphasma model, stromal cells and FDCs do not move but 
they do secrete chemokines. 
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 During a simulation, the selection of B cells is influenced by a combination of processes, 
which include the abundance of antigen, the capacity of antigen uptake based on BCR affinity 
and the chance to encounter a Tfh cell. Selection begins with centrocytes searching for antigen 
on FDCs whilst having a high probability to die by apoptosis. The antigen collection phase is 
assumed to have a predetermined time-window during which each antigen interaction is directly 
proportional to BCR affinity in such a way that centrocytes with high-affinity BCR can 
internalise much larger amounts of antigen than low affinity clones. To limit the amount of 
antigen that can be collected, the model assumes that a centrocyte leaving an interaction with 
an FDC is not able to interact with the FDC again. Once the antigen collection-window is over, 
the centrocytes search for Tfh cells to receive a proliferation signal. The hyphasma model 
assumes that all Tfh present in the system are antigen-specific and can support the selection of 
B cells. However, Tfh cells will only provide help to the centrocyte with the highest amount of 
antigen (Duchez et al., 2011). Nonetheless, this model only simulates Tfh cells that can provide 
help to B cells which does not account for bystander Tfh cells and their effects. Throughout the 
simulation, the state of centroblasts and centrocytes is updated at each time point, leading to 
the decision of division, death, differentiation, or recycling following the selection processes. 
A typical simulation will generate results such as the evolution over time of B cell numbers, B 
cell affinity within the GC and affinity of GC output. Thus, the results from in silico simulations 
can be directly compared with GC dynamics observed in vivo. 
For this project, simulations were carried out using two versions of the hyphasma model. 
The first is known as the LEDA model which is initiated with 3 founder B cell clones that 
undergo 12 divisions during the initial expansion phase of the GC. The LEDA model also 
assumes that selected centrocytes capable of retaining enough antigen upon recycling and 
dividing are then allowed to become output cells which exit through the dark zone of the GC. 
This model of exit through the dark zone was demonstrated to be more advantageous in terms 
of GC output (M. Meyer-Hermann et al., 2012). The alternative model used is known as 
Bcinflow, for which cells are assumed to flux into the GC at a rate of 2 cells per hour over the 
course of 3 days each of them dividing 6 times. This alternative model was generated due to 
the number of GC founder cells being determined to be within the range of 100 B cell clones 
(Tas et al., 2016). The full list of parameters for the hyphasma models can be found in Methods 
in Molecular Biology 1623: Germinal Centers (Robert et al., 2017).   
To simulate the aged GC, parameters of interest were chosen from measurements taken 
from aged mice, and their values changed in order to recreate the aged GC phenotype in silico. 
Thus, these parameters were selected based on the changes observed in vivo during the initial 
phenotyping of the aged GC response in mice (e.g. increased T cell numbers and reduced FDC 
 55 
network size). The chosen parameters for both models and their original values are shown in 
Table 2.21. To determine the effect of each parameter and their biological relevance, sensitivity 
testing of the chosen parameters was carried out where multiple changes to a single parameter 
were performed (e.g T cell number ranging from 50-1200). Once the sensitivity was 
established, the biologically relevant changes which best fit in vivo observations, were chosen 
to simulate the aged GC response. Furthermore, single changes to multiple parameters were 
also simulated in order to best fit the aged phenotype. The change to each parameter value is 
outlined with its corresponding figure in Chapter 5. Each simulation was repeated at least 20 




Table 2.21 List of parameters used for in silico modelling of the aged GC response 
with Bcinflow and LEDA model 
Parameter name Value Description 
Tcnumber 250 Total number of initial T cells 
FDC number 200 Total number of FDCs 
Percentage of FDC network  50 Percentage of the FDC network 
volume within the total GC volume 
AntigenAmountPerFDC 3000 Presented Ag per FDC in units of 
threshold 
northweight 0.1 Tendency for Tc to stay in the LZ 



















2.2.8 Chemotaxis Assays 
 Chemotaxis assays were performed with lymphocytes isolated from inguinal, axillary 
and brachial LNs at day 14 after NP-KLH subcutaneous immunisation (Section 2.2.1.1). Cell 
suspensions were prepared as outlined in section 2.2.2.1 and washed twice in RPMI medium 
(Table 2.17). Aliquots of each sample were taken for cell counting with the automated CASY 
Cell Counter prior to migration assay. Cells were then resuspended at 1x107 cells/ml in 
migration medium and rested for 30 min at 37°C, 5% CO2. Chemokines were serially diluted 
in migration medium, CXCL12 at 300, 100, 30, 10 ng/ml (Table 2.16). Once diluted, 400 µL 
of each chemokine concentration was added to the bottom compartment of a 6.5mm Transwell 
plate with 5.0 µm pore polycarbonate membrane inserts (Corning, Sigma-Aldrich) and plates 
were incubated for 15 min at 37°C, 5% CO2. In addition, 400 µL of plain migration medium 
was added to the bottom compartment of a transwell to account for non-specific migration. A 
total of 1.5x106 cells/well were added to the top compartments of each 5.0 µm transwell. Cells 
(1.5x106) were also added to a well without a transwell insert containing 400 µL of plain 
migration medium to account for the precise input of cells added to each transwell insert. Cells 
were allowed to migrate for 2.5 hours at 37°C, 5% CO2. The cells which migrated to the bottom 
of each transwell were collected, stained (Table 2.8) and the entire samples acquired as 
described in sections 2.2.2.2-4. Migration was calculated as a percentage of input cells that 
migrated at each chemokine concentration once non-specific cell migration was subtracted.  
 
2.2.9 Quantitative RT-PCR 
 
2.2.9.1 RNA preparation  
 For quantitative RT-PCR of Cxcr4, RNA was isolated from at least 2x106 tamoxifen-
treated CreERT2Cxcr4fl/fl CD4+ OT-II T cells using the RNeasy Mini Kit (QIAGEN, Denmark) 
according to the manufacturer’s protocol. Final RNA concentrations in ng/µL and quality were 
measured on the NanoDrop ND-1000 (ThermoFisher Scientific, USA) spectrophotometer with 
an ideal 260/280 ratio of 1.8-2.1 and 260/230 ratio of ³ 2. Samples were stored at -20°C.  
 
2.2.9.2 qRT-PCR and analysis  
 Quantitative RT-PCR for analysis of Cxcr4 and chemokine transcripts was performed 
using the TaqMan RNA-To-CT 1-Step Kit (Applied Biosystems, ThermoFisher Scientific, 
USA) according to the manufacturer’s instructions. Reactions were performed in 96-well plates 
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(Nunc, ThermoFisher Scientific, USA) using the appropriate TaqMan Probes for the transcripts 
of interest (Table 2.13) with a final volume of 20 µl per reaction for which 10ng of RNA was 
used. The thermocycling program was performed as outlined in Table 2.22 below. Reactions 
were performed in triplicates and the average CT values were calculated for analysis. The 
relative expression of transcripts was calculated by normalising the CT values of the reactions 
to the house keeping gene Hprt with the following formula: 2(-DCt), where DCt=Ctgene of interest – 
Cthousekeeping gene. 
 
Table 2.22 Thermocycling program for qRT-PCR 
 Step Temperature (°C) Time (min)  
1 Reverse transcription 48 15  
2 
Activation of AmpliTaq 
Gold DNA Polymerase 
95 10  
3 Denature 95 15sec 
40 cycles 
4 Anneal/Extend 60 1 
 
2.2.10 Tamoxifen-induced deletion of Cxcr4 in OT-II cells 
 
2.2.10.1 In vivo tamoxifen-induced deletion of Cxcr4 in ERT2CreCxcr4fl/fl mice 
Tamoxifen administration for in vivo deletion of Cxcr4 was performed on 
ERT2CreCxcr4fl/fl OT-II and litter-mate control mice by oral gavage. Mice were weighed prior 
to oral gavage and each received a dose of 0.2mg of tamoxifen in peanut oil (Sigma-Aldrich) 
per gram of mouse. In total, 3 doses of tamoxifen were administered spaced 48 hours by animal-
handling technicians of the BSU Experimental Unit. The iLNs, spleen and msLNs were then 
taken 7 days after the last dose of tamoxifen, from which cell suspensions were prepared as 
described in section 2.2.2.1. Cells were stained with the appropriate antibody mix (Table 2.10) 
for flow cytometric analysis of CXCR4 deletion or for single cell sorting of naïve 
CD62L+CD44-CD4+B220- T cells for downstream RNA preparation and qPCR analysis as 
described in Section 2.2.9. 
  
 
2.2.10.2 In vitro tamoxifen-induced deletion of Cxcr4 in OT-II cells 
 Tamoxifen treatment for in vitro deletion of Cxcr4 was performed on lymphocytes 
isolated from dissected spleens and peripheral lymph nodes (excluding the mesenteric lymph 
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nodes) of ERT2CreCxcr4fl/fl OT-II and litter-mate control mice. Cell suspensions were prepared 
under sterile conditions under a Bio2+ Envair tissue culture hood as described in section 2.2.2.1 
using sterile FACS wash. Prior to tamoxifen treatment, cell suspensions were enriched for CD4+ 
T cells using the Magnisort Mouse CD4 T cell Enrichment kit (ThermoFisher Scientific) 
according to the manufacturer’s instructions. Aliquots were taken for counting on the automated 
CASY Cell Counter and cells were resuspended at a concentration of 2x106 cells/ml in pre-
warmed complete RPMI medium (Table 2.17) containing 200nM of 4-OH tamoxifen and 
2ng/ml recombinant murine IL-7 (Table 2.16). Cells were then seeded into 24-well plates 
(Nunc, ThermoFisher) at 2x106cells/well and incubated for 48 hours at 37°C, 5% CO2. 
Following incubation, cells were washed with pre-warmed complete RPMI medium. Aliquots 
were taken to check protein deletion by flow cytometry (as in Section 2.2.2.2) with the 
appropriate antibody mix (Table 2.11). The remaining cells were then used for adoptive 
transfers described in sections 2.2.14.2 and 2.2.14.3.  
 
2.2.11 CXCR4 retroviral vector expression in OT-II cells 
 
2.2.11.1 Retroviral plasmid cloning 
 To generate a retroviral vector for expression of Cxcr4, the sequence was sub-cloned 
from an existing pcDNA3.1-HA-Cxcr4 plasmid expression vector provided by the Karl 
Balabanian (ISERM, France), into the retroviral vector pMSCV-IRES-GFP II (pMIG-II) (Table 
2.15). Both the destination pMIG-II vector and the donor pcDNA3.1-HA-Cxcr4 vector were 
cut using restriction enzymes EcoR1 and Xho1 (New England Biolabs, USA) according to the 
manufacturer’s instructions.  The restriction digest products were then separated on a 1% 
agarose gel and the desired bands were excised based on size, the backbone was ~6 kb and the 
Cxcr4 insert ~1 kb. The excised DNA was then purified using the QIAquick Gel Extraction Kit 
(QIAGEN, Denmark) according to the manufacturer’s protocol. The purified vector backbone 
and insert products were then ligated with T4 DNA Ligase (New England Biolabs, USA) 
according to the recommended manufacturer’s protocol with a 1:3 vector to insert ratio. A 
ligation reaction with only the vector backbone was also done side by side as a negative control. 
Ligation products were then transformed into OneShot Top 10 Chemically Competent E.coli 
cells (ThermoFisher Scientific, USA) according to the manufacturer’s instructions. 
Transformed E.coli cells were then plated onto ampicillin+ agar plates to screen for colonies 
containing a ligated vector. Positive colonies were then partially picked using a pipette tip and 
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dipped into 10 µl of PBS which was used for PCR screening of pMIG-II vector clones 
containing the Cxcr4 insert. PCR products were run on a 1% agarose gel and the DNA of 
positive clones was prepared with the QIAGEN Plasmid Maxi Kit by picking the appropriate 
leftover colonies from the ampicillin+ agar plates, according to the manufacturer’s protocol. 
Retroviral vectors were resuspended at a concentration of 1mg/ml in TE buffer and aliquots 
were sent for Sanger sequencing with the CXCR4-F primer (Table 2.14) to Source Bioscience, 
UK for verification of the generated pMIG-II-Cxcr4-GFP retroviral vector.  
 
2.2.11.2 PLAT-E cell preparation and retrovirus production  
For retrovirus production, the Platinum-E (PLAT-E) Retroviral Packaging Cell Line 
(Cell Biolabs, USA) was used. PLAT-E cells were maintained in complete DMEM (Table 2.17) 
culture medium in 175cm2 culture flasks (Nunc, ThermoFisher Scientific) and were passaged 
at 70% confluency. For virus production, 0.75x106 cells/well in 2 ml were seeded into 6-well 
plates (Nunc, ThermoFisher Scientific) and were left to reach 70% confluency at 37°C, 5% CO2 
prior to transfection. Retroviral transfection was carried out using the Trans-IT transfection 
reagent (Table 2.16). For each well the following mixture was prepared and incubated at room 
temperature for 25 min: 250 µL of OPTIMEM, 7.5 µg Trans-IT, 1.5 µg of retroviral pMIG-II-
Cxcr4-GFP or empty vector, and 0.5 µg of packaging pCL-ECO vector. The mixture containing 
the retroviral vector was then added dropwise to the appropriate wells containing the PLAT-E 
cells and cells were incubated at 37°C, 5% CO2 overnight. Following overnight incubation, the 
cell culture media was replaced with 2ml of complete RPMI medium (Table 2.17) per well and 
cells were incubated at 32°C, 5% CO2 for 24 hrs. The following day, retroviral supernatants 
were harvested and either frozen on dry ice (stored at -80°C) or used fresh for T cell 
transduction. Fresh culture media was then added to the PLAT-E cells, 2 ml of complete RPMI, 
and harvested the following day after incubation at 32°C, 5% CO2. To check transfection 
efficiency, PLAT-E cells were fixed with BD Cytofix Fixation Buffer (BD, USA) and GFP+ 
cells were assessed by flow cytometry.  
 
2.2.11.3 In vitro activation of Primary CD4+ OT-II cells  
 Lymphocytes isolated from peripheral skin-draining LNs and spleens of OT-II donor 
mice were used for transduction of primary CD4+ OT-II T cells. Cell suspensions were prepared 
as outlined in section 2.2.2.1 under sterile conditions under a Bio2+ Envair tissue culture hood. 
Cell suspensions were then enriched for CD4+ T cells using the Magnisort Mouse CD4 T cell 
Enrichment kit (ThermoFisher Scientific, USA) according to the manufacturer’s instructions. 
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For activation, 24-well plates (Nunc, ThermoFisher Scientific, USA) were coated with 8 µg/ml 
of anti-CD3 and anti-CD28 antibodies diluted in PBS. Plates were incubated for at least 1 hr at 
37°C, 5% CO2 after which they were washed twice with PBS to remove uncoated anti-CD3/28 
antibodies. Isolated CD4+ T cells were resuspended in pre-warmed complete DMEM medium 
containing 2 ng/ml IL-7 at a concentration of 2x106 cells/ml. Cells were then seeded onto the 
coated plates at a concentration of 2x106 cells/well and incubated at 37°C, 5% CO2  for 24 hrs 
before proceeding to transduction. 
 
2.2.11.4 Transduction  
 Following stimulation, primary CD4+ OT-II T cells were transduced by spinoculation. 
Retroviral supernatants were prepared in pre-warmed RPMI medium containing 10 ng/ml of 
recombinant IL-2 and 10ng/ml of polybrene. Old media was aspirated from the plates 
containing CD4+ T cells and 1ml of retroviral supernatant was seeded onto each well. Plates 
were centrifuged at 1500g for 1 hr at 32°C after which they were incubated at 37°C overnight. 
The following morning, the media was replaced with fresh RPMI containing 10ng/ml IL-2 and 
cells were incubated at 37°C, 5% CO2 for 3 days prior to adoptive transfer. The day before 
adoptive transfer, the media was replaced with fresh RPMI containing 10ng/ml IL-2 and 2ng/ml 
IL-7.  
 
2.2.12 Adoptive Transfers 
 
2.2.12.1 SWHEL B cell and OT-II T cell co-transfer  
 To perform transgenic B and T cell co-transfers, the spleens and peripheral skin-
draining LNs were dissected from young or aged SWHEL and young OT-II donor mice. Cell 
suspensions were prepared under sterile conditions in a Bio2+ Envair tissue culture hood as 
described in section 2.2.2.1 using sterile FACS wash. Cells were then counted using the 
automated CASY Cell Counter. Aliquots of each sample were taken and stained for flow 
cytometric analysis to determine the proportion of HEL-binding B220+ B cells and TCR Va2+ 
CD4+ T cells as outlined in section 2.2.2.2. Once the proportion of antigen-specific cells was 
determined, a mixture of lymphocytes from young or aged SWHEL and young OT-II mice was 
prepared in sterile FACS wash containing 1x106 HEL-binding B cells and 1x106 Va2+ CD4+ 
OT-II T cells per recipient mouse. The mixture of lymphocytes was then injected intravenously 
into wild type C57BL/6 recipient mice, each mouse received 100 µL of cells. Recipient mice 
were then immunised subcutaneously with a total of 20 µg of HEL-OVA prepared in Alum 
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(Section 2.2.1.3). Injections and immunisations were done by animal-handling technicians of 
the BSU Experimental Unit. At day 10 post-immunisation, the inguinal LNs and blood were 
taken from the recipient mice. Cell suspensions from the dissected LNs, were prepared as 
outlined in section 2.2.2.1 and the cells were stained with the appropriate antibody mix (Table 
2.1.9) for flow cytometric analysis of CD45.1+CD45.2+HEL+ GC B cell populations. Sera was 
isolated by centrifugation of blood samples at 13 000 rpm for 13 min and stored at -20°C.  
 
2.2.12.2 ERT2Cre/+Cxcr4fl/fl CTV+ OT-II T cell transfer  
Adoptive transfers of ERT2Cre/+Cxcr4fl/fl CTV+ OT-II CD4+ T cells were done with 
lymphocytes isolated from ERT2Cre/+Cxcr4fl/fl OT-II mice following 4-OH tamoxifen treatment 
(Section 2.2.10.2). After 4-OH tamoxifen treatment, cells were washed in sterile PBS and 
stained with CellTraceÔ Violet Cell Proliferation Kit (ThermoFisher Scientific, USA) 
according to the manufacturer’s instructions under sterile conditions in a Bio2+ Envair tissue 
culture hood.  Cells were then counted using the automated CASY Cell Counter. Aliquots of 
each sample were taken and stained for flow cytometric analysis (Section 2.2.2.2, Table 2.10) 
to determine the proportion of TCR Va2+ CD4+ T cells. Once the proportion of OVA-specific 
cells was determined the cells were resuspended in sterile FACS wash at a concentration of 
5x106 Va2+ CD4+ OT-II T cells/ml. The ERT2Cre/+Cxcr4fl/f CD4+ OT-II cells were then injected 
intravenously into congenic B6.SJL mice, each mouse received 100 µL of cells (i.e. 5x104 Va2+ 
CD4+ OT-II T cells/recipient). Recipient mice were then immunised subcutaneously with a total 
of 100 µg of OVA prepared in Alum (Section 2.2.1.1). At day 10 post-immunisation, the 
inguinal LNs were taken from the recipient mice. Cell suspensions were prepared from a single 
iLN as outlined in section 2.2.2.2 and cells were stained with the appropriate antibody mix 
(Table 2.10) for flow cytometric analysis of CTV+CD45.2+ Tfh cell differentiation.  
 
2.2.12.3 Cxcr4-deleted OT-II T cell transfer 
Adoptive transfers of Cxcr4-deleted OT-II CD4+ T cells were done with lymphocytes 
isolated from ERT2CreCxcr4fl/fl OT-II mice following 4-OH tamoxifen treatment (Section 
2.2.10.2) or with lymphocytes isolated from the spleens and peripheral skin-draining LNs of 
Cd4Cre/+Cxcr4fl/f mice. Cell suspensions were prepared under sterile conditions in a Bio2+ 
Envair tissue culture hood as described in section 2.2.2.1 using sterile FACS wash. Cells were 
then counted using the automated CASY Cell Counter. Aliquots of each sample were taken and 
stained for flow cytometric analysis (Section 2.2.2.2, Table 2.1.10) to determine the proportion 
of TCR Va2+ CD4+ T cells. Once the proportion of OVA-specific cells was determined the 
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cells were resuspended in sterile FACS wash at a concentration of 5x105 Va2+ CD4+ OT-II T 
cells/ml.  The Cxcr4-deleted CD4+ OT-II cells were then injected intravenously into congenic 
B6.SJL recipient mice, each mouse received 100 µL of cells (i.e. 5x104 Va2+ CD4+ OT-II T 
cells/recipient). Recipient mice were then immunised subcutaneously with a total of 100 µg of 
OVA prepared in Alum (Section 2.2.1.1). Injections and immunisations were done by animal-
handling technicians of the BSU Experimental Unit. At day 10 post-immunisation, the inguinal 
LNs and blood were taken from the recipient mice. Cell suspensions were prepared from a 
single iLN as outlined in section 2.2.2.1 and the remaining iLN was frozen for sectioning as 
outlined in section 2.2.6.1. Cells for flow cytometry were stained with the appropriate antibody 
mix (Table 2.10) for flow cytometric analysis of CD45.2+ Tfh and GC B cell populations. Sera 
was isolated by centrifugation of blood samples at 13 000 rpm for 13 min and stored at -20°C. 
 
2.2.12.4 Transduced OT-II T cell transfer  
Following transduction of OT-II CD4+ T cells with pMIG-II-Cxcr4-GFP virus 
generated in PLAT-E cells (Section 2.2.11.2), GFP+ TCR Va2+ CD4+ T cells were sorted and 
injected intravenously into wild type C57BL/6 recipient mice. Each mouse received 5x104 
GFP+ Va2+ CD4+ OT-II T cells in 100 µL of sterile FACS wash. Cells were left to equilibrate 
in host for 24 hours, after which the recipients were immunised subcutaneously with a total of 
100 µg of OVA or NP-OVA prepared in Alum per mouse. Injections and immunisations were 
done by animal-handling technicians of the BSU Experimental Unit. At day 10 post-
immunisation, the inguinal LNs and blood were taken from the recipient mice. Cell suspensions 
were prepared from a single iLN as outlined in section 2.2.2.1 and the remaining iLN was frozen 
for sectioning as outlined in section 2.2.6.1. Cells for flow cytometry were stained with the 
appropriate antibody mix (Table 2.11) for flow cytometric analysis of GFP+ CXCR4+ Tfh and 
GC B cell populations. Sera was isolated by centrifugation of blood samples at 13 000 rpm for 
13 min and stored at -20°C. 
 
2.2.13 Statistical Tests 
 All statistical tests were performed using GraphPad Prism v6 and v7 software. All data 
points were analysed including outliers unless there were technical errors, or the mice were 
significantly ill (i.e. lymphoma), in which case they were excluded from analysis. Sample sizes 
were determined based on the availability of age or sex-matched experimental mice and litter-
mate controls. The data was assumed to follow a non-gaussian distribution based on the small 
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sample sizes used (n£ 10) for each experiment. Therefore, analyses were done using non-
parametric tests. For unpaired comparisons, Mann-Whitney U tests were carried out and a 
threshold of p< 0.05 was used to establish statistical significance. Grouped analyses were 
performed by a 2-way ANOVA with Sidak’s multiple comparisons, and the multiplicity 
adjusted p values for the multiple comparison tests are noted on the figures with a threshold of 
p< 0.05 for statistical significance. All experiments were done at least twice, and data are 
















































Phenotypic assessment of the aged GC response in vivo in 
mice 
3.1 Preamble 
The ageing process negatively impacts several physiological pathways through complex 
underlying molecular and cellular changes which steadily increase an organism’s susceptibility 
to death. Ageing affects all compartments of the immune system leading to reduced immune 
function and increased vulnerability to infectious agents. Here I investigate the effects of ageing 
on the germinal centre (GC), a specialized microenvironment within secondary lymphoid 
organs that generates long-lived antibody secreting plasma cells and memory B cells that 
provide protective immunity after vaccination. The age-related changes of the GC response 
have been studied for several years in both mice and humans, yet the precise mechanisms 
driving the age-dependent demise of the GC remain poorly understood.  
In 1989, Kosco and colleagues examined GC function in aged mice and described a 
delay in the formation of antibody secreting cells at an early phase of GC formation (Kosco et 
al., 1989). This study was one of the first to reveal age-dependent defects in the output of the 
GC, however it heavily relied on an in vitro system to monitor antibody production of isolated 
GC B cells (Kosco et al., 1989). A year later, Szakal and colleagues described a reduction in 
GC size and LN volume in aged mice by examining histochemically stained LN sections, yet 
formal quantification of GC B cell populations and defects in GC output were not addressed 
(Szakal et al., 1990). In the following years, several groups rigorously examined the effects of 
ageing on GC B cell function at the early and late stages of the GC response and described age-
related defects in GC B cell proliferation, somatic hypermutation (SHM), antibody output along 
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with decreased antibody-secreting plasma cells in the bone marrow (Miller and Kelsoe, 1995; 
Lu and Cerny, 2002; Han et al., 2003; Blaeser, McGlauchlen and Vogel, 2008). However, many 
of these studies relied on in vitro systems to determine defects in GC B cell proliferation, SHM 
and antibody output; and have therefore neglected the influences of B cell extrinsic factors 
which would be present in vivo. In contrast, two separate groups used adoptive transfer 
approaches to demonstrate that the age of CD4+ T cells greatly influences the size of the GC 
response, SHM and antibody-output in vivo (Yang, Stedra and Cerny, 1996; Eaton et al., 2004). 
Sage and colleagues showed there was an increase in T follicular helper (Tfh) cells, in the 
spleens of immunised aged mice, which had a lower capacity for B cell help in vitro (Sage et 
al., 2015). However, Lefebvre and colleagues adoptively transferred young CD4+ T cells into 
aged mice and found that the age of the microenvironment also influences GC formation 
(Lefebvre et al., 2012). Thus, through the use of different approaches, many groups have 
described the breakdown of several elements of the GC response with age. Yet despite of what 
has been shown, the underlying mechanisms and main contributors of the GC deterioration with 
age remain elusive.   
 In this project I aimed to take a holistic approach and simultaneously assess the changes 
of several GC elements by performing a kinetic study of the aged GC response in vivo in mice. 
For this, experiments were conducted using both BALB/c and C57BL/6 mice to ensure the 
changes observed were influenced by age irrespective of the genetic background of the mouse. 
Using this kinetic approach, we phenotyped the initiation, peak and termination stages of the 
aged GC response. Upon immunisation with the hapten 4-hydroxy-3-nitrophenyl (NP) acetyl 
conjugated to protein, changes in the magnitude of the aged GC were assessed by quantifying 
the populations of antigen-specific GC B cells and Tfh cells by flow cytometry. Changes in the 
quality of the aged GC output at each stage of the response were assessed by measuring NP-
specific antibody titres, NP-specific antibody secreting cells and SHM of NP+ GC B cells. 
Lastly, to explore the changes in the GC microenvironment with age we performed 
immunofluorescence staining of LN sections that allowed us to visualise changes in GC size 
and stroma structure by confocal microscopy. This chapter describes the findings from our 




3.2 Kinetic studies reveal the GC response is delayed and 
diminished with age 
3.2.1 The GC response is decreased in old BALB/c mice  
 
To assess differences in GC kinetics, 8-12 week-old adult and 90-95 week-old aged 
BALB/c mice were subcutaneously immunized with the hapten 4-hydroxy-3-nitrophenylacetyl 
(NP) conjugated to the Keyhole Limpet Hemocyanin (KLH) protein after which the draining 
inguinal lymph nodes (dLN) were collected prior to, and at days 7, 14 and 21-post immunization 
(outlined in Figure 3.1 A). Using this approach, the proportion and total cell numbers of critical 
adaptive immune cell subsets of the GC response were examined by flow cytometry (gating 
strategy outlined in Figure 3.1 B). 
Aged mice showed a significant reduction in both frequency and absolute number of 
CD4+ T cells after immunisation. Younger adult mice had consistently higher frequencies of 
CD4+ T cells throughout days 7, 14 and 21 after immunization with a peak in absolute CD4+ T 
cell numbers at day 14 which was not observed in the aged response (Figure 3.2 A-B). 
Similarly, young mice had a greater total number of B220+ B cells at the peak of the immune 
response 14 days after immunization than aged mice, though aged mice had a higher frequency 
of B220+ B cells early in the response at day 7 (Figure 3.2 A & C). These results indicated that 
lymphocytes in aged mice were not able to undergo expansion or be recruited to the same 
magnitude as in the young mice supporting previous findings of diminished immune responses 
with age.  
Age-related changes were also observed in the frequency and absolute number of GC B 
cells (Bcl6+CD38-B220+CD4-). Absolute GC B cell numbers were significantly higher in young 
adult mice at the peak of the GC response at day 14-post immunization (p.i) (Figure 3.3 A-B). 
This observation was reflected in the frequency of aged GC B cells which remained relatively 
constant and did not reach a peak at day 14 p.i as is seen in the young mice (Figure 3.3 A-B), 
indicating this change was not simply due to higher numbers of total B-lymphocytes (B220+) 
in young mice. In contrast, there were no significant changes in the frequency of centroblasts 
(CXCR4+CD86-Bcl6+CD38-B220+CD4-) and centrocytes (CD86+CXCR4-Bcl6+CD38-
B220+CD4-) as determined by flow cytometry between young and aged mice though, in terms 
of absolute numbers, young mice still had higher levels of both cell types at day 14 p.i (Figure 
3.4 A-C) due to the higher overall number of GC B cells in young mice. Thus, the overall size 
of the GC was affects by ageing but the ratio of light zone to dark zone B cells was unaffected.  
Aged mice had a significantly higher frequency of Tfh cells (PD1+CXCR5+CD4+Casp3-
), at day 7 and 14 p.i than the young mice which peak at day 14 p.i (Figure 3.5 A-B). However, 
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due to the decreased number of CD4+ T cells in old LNs, the absolute number of aged Tfh cells 
remained lower at the peak of the GC response compared to the young (Figure 3.5 A-B).   
Together, these results show that the magnitude of the GC response is decreased in aged 
mice with respect to a decrease in absolute numbers of GC B cells and Tfh cells. Though 








Figure 3.1 Experimental outline and gating strategy for BALB/c kinetic study 
 
A. Experimental approach for the BALB/c kinetic study with time-points prior to, and at days 
7, 14 and 21 after subcutaneous immunisation with NP-KLH in alum B. Gating strategy for the 
identification of helper T cells (CD4+B220-), B cells (B220+CD4-), GC B cells (Bcl6+CD38-
B220+CD4-), centrocytes (CXCR4+CD86-Bcl6+CD38-), centroblasts (CD86+CXCR4-
Bcl6+CD38-) and Tfh (PD1+CXCR5+CD4+Casp3-) cells. This experiment was done with help 






Figure 3.2 Kinetics of CD4+ T helper cells and B220+ B cells 
 
A. Representative flow cytometry plots identifying CD4+ helper T cells and B220+ B cells in 
young and aged BALB/c mice at days 0, 7, 14 and 21 post-immunisation. Numbers adjacent to 
gates indicate percentage of CD4+ T helper cells and B220+ B cells B. Quantification of the 
frequency (left) and total number (right) of CD4+ T helper cells C. Quantification of the 
frequency (left) and total number (right) of B220+ B cells in young and aged BALB/c mice. In 
each experiment there were 6-8 mice per age group, and the data presented are representative 
of two independent experiments. Each symbol represents the mean ± SD. P values indicated on 









































Figure 3.3 GC B cell kinetics are diminished in old BALB/c mice 
 
A. Representative flow cytometry plots identifying GC B cells (Bcl6+CD38-B220+CD4-) in 
young and aged BALB/c mice at days 0, 7, 14 and 21 post-immunisation. Numbers adjacent to 
gates indicate percentage of GC B cells B. Quantification of the frequency (left) and total 
number (right) of GC B cells (Bcl6+CD38-B220+CD4-) in young and aged BALB/c mice. In 
each experiment there were 6-8 mice per age group, and the data presented are representative 
of two independent experiments. Each symbol represents the mean ± SD and the p values 







Figure 3.4 Kinetics of centrocytes and centroblasts in BALB/c mice 
 
A. Representative flow cytometry plots identifying centroblasts (CXCR4+CD86-Bcl6+CD38-
B220+CD4-) and centrocytes (CD86+CXCR4-Bcl6+CD38-B220+CD4-) in young and aged 
BALB/c mice at days 0, 7, 14 and 21 post-immunisation. Numbers adjacent to gates indicate 
percentage of centrocytes and centroblasts B. Quantification of the frequency (left) and total 
number (right) of centroblasts in young and aged BALB/c mice C. Quantification of the 
frequency (left) and total numbers (right) of centrocytes in young and aged BALB/c mice. In 
each experiment there were 6-8 mice per age group, and the data presented are representative 
of two independent experiments. Each symbol represents the mean ± SD and the p values 































Figure 3.5 The frequency of Tfh cells is increased in old BALB/c mice 
 
A. Representative flow cytometry plots identifying Tfh cells (PD1+CXCR5+CD4+Casp3-B220-
) in young and aged BALB/c mice at days 0, 7, 14 and 21 post-immunisation. Numbers adjacent 
to gates indicate percentage of Tfh cells B. Quantification of the frequency (top) and total 
number (bottom) of Tfh cells in young and aged BALB/c mice. In each experiment there were 
6-8 mice per age group, and the data presented are representative of two independent 
experiments. Each symbol represents the mean ± SD and the p values indicated on graphs were 






3.2.2 The antigen-specific GC response is delayed in old C57BL/6 mice 
 
The experiments done with BALB/c mice indicated that the global GC response is 
impaired with age, however, I wanted to determine if the antigen-specific response was also 
affected by ageing. Additionally, in this mouse strain we were not able to identify T cells that 
are specific for the immunising antigen due to a lack of good quality MHC class II tetramers 
specific for BALB/c mice. To study the antigen-specific GC response, 8-12 week old young 
adult and 90-108 week-old aged 90-108 week-old C57BL/6 mice were immunized with the 
1W1K peptide conjugated to the NP hapten after which the draining lymph nodes (dLN) were 
collected at days 0, 7, 10, 14 and 21-post immunization (Figure 3.6 A). Like with the BALB/c 
kinetic study, the proportion and total cell numbers of critical cell types of the GC response 
were assessed by flow cytometry (gating strategy outlined in Figure 3.6 B). This  approach had 
the added advantage of being able to track antigen-specific Tfh cells by flow cytometry using 
a tetramer, MHC Class II-IAb, with the 1W1K peptide bound in its peptide binding groove. 
In agreement with the results of the BALB/c kinetic study, the absolute number of GC 
B cells (Bcl6+Ki67+B220+CD4-) in aged C57BL/6 mice was significantly decreased at the peak 
of the GC response, which in this study, was at day 10 post immunization (p.i) (Figure 3.7 A-
B). Similarly, the frequency of aged GC B cells was significantly lower at day 10 p.i compared 
to the young mice (Figure 3.7 B left panel). Interestingly, the peak of the aged GC B cells 
appears at day 14 and did not reach the same magnitude as in the young mice. This suggests 
that there is not only a decrease in the expansion of aged GC B cells but also a delay. These 
observations were corroborated in a separate stain by which GC B cells were identified as 
GL7+CD38-B220+CD4- cells (Figure 3.8 A-B). The absolute number and frequency of 
GL7+CD38- GC B cells in aged mice was significantly decreased at day 10 p.i (Figure 3.8 A-
B), yet at day 14 aged the frequency of GL7+CD38- GC B cells reached a clear peak (Figure 
3.8 B left panel), confirming a delay in the expansion of GC B cells with age. Despite the 
frequency of GC B cells reaching a peak at day 14 in aged mice, the absolute number of GC B 
cells at this time was far lower than seen in young mice at the peak response, indicating that 
over the 21-day period in which the GC response was assessed, the absolute size of the GC was 
greatly reduced in aged mice. 
Significant age-related changes were observed in the frequency and absolute number of 
antigen-specific GC B cells (IgG1+NP+GL7+CD38-) (Figure 3.9 A-B). The frequency of 
antigen-specific GC B cells in young mice was significantly higher than in old mice as early as 
day 7 p.i and at day 10 (Figure 3.9 B left panel). Yet, the frequency of aged antigen-specific 
GC B cells appeared to steadily increase and reach a peak comparable to that of the young 
response at day 21 p.i, yet when comparing absolute numbers, these cells are barely above the 
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baseline. This indicates that there is an overall decrease in the magnitude of the response and a 
delay in the production of antigen-specific GC B cells in the aged mice.  
Similar to the BALB/c study, aged C57BL/6 mice had a significantly higher frequency 
of Tfh cells (PD1+CXCR5+CD4+Foxp3-) than the young mice (Figure 3.10 A-B). At days 7, 10 
and 14 p.i the frequency of aged Tfh cells was consistently higher than the young Tfh cells 
which peaked at day 10 p.i (Figure 3.10 B left panel). In terms of absolute Tfh cell numbers, 
the young mice had a significantly higher peak at day 10 p.i than the old mice, which instead 
peaked at day 21 though not reaching the same magnitude as the young response. Thus, there 
also appears to be a delay in the production of total numbers of Tfh cells in the aged GC 
response.  
Furthermore, significant age-related changes were also observed in antigen-specific Tfh 
cells (1W1K-IAb+PD1+CXCR5+CD4+Foxp3-) (Figure 3.11 A-B). The frequency of antigen-
specific Tfh cells in young mice was comparable to that of aged mice early on in the GC 
response at day 7 and 10 p.i peaking at day 10. In aged mice the antigen-specific Tfh cells reach 
a peak that remains consistent at days 10, 14 and 21 p.i (Figure 3.11 B left panel). However, 
the absolute number of aged antigen-specific Tfh cells was significantly reduced at day 10 p.i. 
compared to antigen-specific Tfh cells from young mice, and peak much later at day 21 p.i 
(Figure 3.11 B right panel). Therefore, much like in antigen-specific GC B cells, there appears 
to also be a delay in the production of antigen-specific Tfh cells in the aged GC.  
In contrast, there were no significant age-related changes in the frequency of T follicular 
regulatory (Tfr) cells (PD1+CXCR5+Foxp3+CD4+) (Figure 3.12 A-B). The frequency of both 
young and aged Tfr cells peaked at day 10 p.i with no significant differences between the two 
peaks (Figure 3.11 B left panel). The absolute number of young Tfr cells was higher at day 10 
p.i in young mice than in the aged mice yet this is not unexpected given that young mice have 
more CD4+ T cells and a more robust GC in terms of total cell numbers. To validate this 
observation, young and aged BALB/c mice were immunised with NP-KLH and the Tfr cell 
population at the peak of the GC response (day 14 p.i) was examined by flow cytometry and 
confocal microscopy (Figure 3.13 A-E). I found that both the frequency and absolute number 
of Tfr cells (PD1+CXCR5+Foxp3+CD4+) were significantly increased in aged BALB/c mice 
(Figure 3.13 A-B). However, quantification of Tfr cell numbers within the GC by confocal 
microscopy revealed negligible differences between young and aged BALB/c mice (Figure 3.13 
C-E) indicating that the observed increase in Tfr cell numbers by flow cytometry is likely due 
to an increase in Tfr cells outside the GC, in the follicular mantle area. Therefore, due to 
contradicting results between the two mouse strains, the effects of ageing on the Tfr 
compartment remain unclear.   
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Together, the results of the C57BL/6 kinetic study confirm the decrease in magnitude 
of the GC response with age as observed in the aged BALB/c mice. These results demonstrate 
that the reduction of the aged GC response is also accompanied by a delay in the production of 





































Figure 3.6 Experimental outline and gating strategies for C57BL/6 kinetic study 
 
A. Experimental approach for the C57BL/6 kinetic study with time-points at days 0, 7, 10, 14 
and 21 after subcutaneous immunisation with 1W1K-NP B. Gating strategy for the 
identification of GC B cells (GL7+CD38-B220+IgM-GR1-) and single cell sorting of antigen-
specific IgG1+NP+ GC B cells C. Gating strategy for the identification of Tfh cells 
(PD1+CXCR5+CD4+Foxp3-), tetramer-specific Tfh cells (Tet+PD1+CXCR5+CD4+Foxp3-)  and 
Tfr cells (PD1+CXCR5+CD4+Foxp3+). The flow cytometry in this experiment was performed 










































Figure 3.7 Ki67+Bcl6+ GC B cell production is delayed and diminished in old 
C57BL/6 mice 
 
A. Representative flow cytometry plots identifying GC B cells (Bcl6+Ki67+B220+CD4-) in 
young and old C57BL/6 mice at days 0, 7, 10, 14 and 21 post-immunisation. Numbers adjacent 
to gates indicate percentage of GC B cells B. Quantification of the frequency (left) and total 
numbers (right) of GC B cells in young and aged C57BL/6 mice. In each experiment there were 
6-8 mice per age group, and the data presented are representative of two independent 
experiments. Each symbol represents the mean ± SD and the p values indicated on graphs were 






Figure 3.8 GL7+CD38- GC B cell production is delayed and diminished in old 
C57BL/6 mice 
 
A. Representative flow cytometry plots identifying GC B cells (GL7+CD38-B220+IgM-GR1-) 
in young and old C57BL/6 mice at days 7, 10, 14 and 21 post-immunisation. Numbers adjacent 
to gates indicate percentage of GC B cells B. Quantification of the frequency (left) and total 
number (right) of GC B cells in young and aged C57BL/6 mice. In each experiment there were 
6-8 mice per age group, and the data presented are representative of two independent 
experiments. Each symbol represents the mean ± SD and the p values indicated on graphs were 






Figure 3.9 Antigen-specific IgG1+GC B cell kinetics are delayed and diminished 
in old mice 
  
A. Representative flow cytometry plots identifying antigen-specific GC B cells (IgG1+NP+ 
GL7+CD38-B220+IgM-GR1-) in young and aged C57BL6 mice at days 7, 10, 14 and 21 post-
immunisation. Numbers adjacent to gates indicate percentage of IgG1+NP+ antigen-specific GC 
B cells B. Quantification of the frequency (left) and total numbers (right) of IgG1+NP+ antigen-
specific GC B cells in young and aged C57BL/6 mice. In each experiment there were 6-8 mice 
per age group, and the data presented are representative of two independent experiments. Each 
symbol represents the mean ± SD and the p values indicated on graphs were generated by 






Figure 3.10 The frequency of Tfh cells is increased in old C57BL/6 mice 
 
A. Representative flow cytometry plots identifying Tfh cells (PD1+CXCR5+CD4+Foxp3-) in 
young and aged C57BL/6 mice at days 0, 7, 10, 14 and 21 post-immunisation. Numbers 
adjacent to gates indicate percentage of Tfh cells B. Quantification of the frequency (left) and 
total numbers (right) of Tfh cells in young and aged C57BL/6 mice. In each experiment there 
were 6-8 mice per age group, and the data presented are representative of two independent 
experiments. Each symbol represents the mean ± SD and the p values indicated on graphs were 








Figure 3.11 Antigen-specific Tfh cell kinetics are delayed and diminished in old 
mice 
  
A. Representative flow cytometry plots identifying antigen (tetramer)-specific Tfh cells 
(1W1K-IAb+PD1+CXCR5+CD4+Foxp3-B220-) in young and aged C57BL6 mice at days 0, 7, 
10, 14 and 21 post-immunisation. Numbers adjacent to gates indicate percentage of tetramer-
specific Tfh cells B. Quantification of the frequency (left) and total numbers (right) of antigen-
specific Tfh cells in young and aged C57BL/6 mice. In each experiment there were 6-8 mice 
per age group, and the data presented are representative of two independent experiments. Each 
symbol represents the mean ± SD and the p values indicated on graphs were generated by 





Figure 3.12 Kinetics of Tfr cells in C57BL/6 mice 
 
A. Representative flow cytometry plots identifying Tfr cells (PD1+CXCR5+CD4+Foxp3+) in 
young and aged C57BL/6 mice at days 0, 7, 10, 14 and 21 post-immunisation. Numbers 
adjacent to gates indicate percentage of Tfr cells B. Quantification of the frequency (left) and 
total numbers (right) of Tfr cells in young and aged C57BL/6 mice. In each experiment there 
were 6-8 mice per age group, and the data presented are representative of two independent 
experiments. Each symbol represents the mean ± SD and the p values indicated on graphs were 









Figure 3.13 The frequency and total number of Tfr cells is increased at the peak of 
the GC response in BALB/c mice 
 
A. Representative flow cytometry plots identifying Tfr cells (PD1+CXCR5+CD4+Foxp3+) in 
young and aged BALB/c mice at day 14 post-immunisation with NP-KLH in alum. Numbers 
adjacent to gates indicate percentage of Tfr cells B. Quantification of the frequency (left) and 
total numbers (right) of Tfr cells in young and aged BALB/c mice. In each experiment there 
were 8-10 mice per age group, and the data presented are representative of two independent 
experiments. Each symbol represents a mouse and the p values indicated on graphs were 
generated by performing an unpaired Mann Whitney U test C. Representative confocal images 
of GCs at 20x magnification within inguinal LNs taken from young and aged BALB/c mice at 
day 14 post-immunisation. LN sections were stained for IgD, CD35, CD3 and Foxp3. GCs were 
identified as IgD- regions containing CD35+ FDCs and Tfr cells were defined as CD3+Foxp3+ 
cells which are marked by white stars on images D. Quantification of the total number of 
CD3+Foxp3+ Tfr cells within the GC area and E. per mm2 of GC area. Quantification of Tfr 
cells was performed manually on Volocity. Additional representative confocal images used for 
this analysis can be found in Appendix 9.1. In each experiment there were 8-10 mice per age 
group, and the data presented are representative of two independent experiments. Each symbol 
represents a GC and the p values indicated on graphs were generated by performing an unpaired 

























3.3 The quality of the GC is compromised with age  
3.3.1 The frequency of affinity inducing mutations and somatic hyper 
mutation of GC B cells is reduced with age 
 
 Phenotyping the GC response in aged mice by flow cytometry clearly indicated a 
reduction in GC magnitude, yet I wanted to understand if the quality of the response is also 
affected with advancing age as has previously been reported (Miller and Kelsoe, 1995). To 
investigate the quality of the GC response in aged mice, NP+IgG1+GL-7+CD38- GC B cells 
from the C57BL/6 kinetic studies were sorted for single cell sequencing of the V186.2 heavy 
chain Ig gene. Immunization with the NP hapten facilitates the tracking of NP-binding GC B 
cells, of which approximately 90% bear the V186.2 heavy chain Ig gene. Within the 
complimentary determining region 1 (CDR1) of VH186.2, the substitution of a tryptophane (W) 
by a leucine (L) at position 33 has been associated with ten times greater binding affinity for 
NP. Thus, by identifying the frequency of the W33L mutation, via sequencing of the VH186.2 
gene, I assessed changes in affinity maturation of GC B cells.  
 The sequencing analysis of VH186.2 in NP+IgG1+ GC B cells taken at day 21 p.i 
revealed an age-related reduction in the frequency of the high affinity-inducing W33L mutation. 
The W33L mutation was more than twice as frequent in GC B cells from young mice than those 
isolated from aged mice suggesting a reduction of affinity maturation with age (Figure 3.14 A). 
Additionally, this approach was used to assess the changes in the rate of somatic hyper mutation 
(SHM) by determining the number of non-synonymous mutations within the VH186.2 gene. 
This revealed a significant decrease in the total number of mutations with the VH186.2 Ig gene 
of aged mice suggesting a possible defect in SHM (Figure 3.14 B)  
These results indicate that the processes by which centroblasts acquire affinity for 
antigen or by which high affinity centrocytes acquire T cell help within the GC may be impaired 















Figure 3.14 The frequency of the affinity enhancing mutation W33L and SHM is 
decreased in NP+IgG1+ GC B cells from aged mice 
 
A. Circle charts indicating the frequency of the affinity-inducing mutation W33L in the CDR1 
region of VH186.2 sequenced from single cell sorted NP+IgG1+ GC B cells of young and aged 
C57BL/6 mice at day 21 post-immunisation with 1W1K-NP. The number in the centre of the 
circle chart indicates the number of cells sequenced per age group B. Quantification of the 
number of single base pair mutations in the CDR1 region of VH186.2 in both young and aged 
C57BL/6 mice at day 21 post-immunisation. In each experiment there were 8-10 mice per age 
group, and the data presented are representative of two independent experiments. Each symbol 
represents a single VH186.2 sequence derived from a single NP+IgG1+ GC B cell. The p value 




3.3.2 NP-specific IgG1 antibody titres and affinity maturation decrease with 
age 
   
To further assess the quality of the GC output, serum was collected from the mice in 
both the BALB/c and C57BL/6 kinetic studies. Immunization with the NP hapten in this 
approach also allowed us to assess the differences in NP-specific serum-antibody titre and 
affinity maturation by enzyme-linked immunosorbent assays (ELISAs). These assays were 
done by coating the plates with the protein BSA conjugated to different loading of NP 
molecules. The use of a high loading of NP molecules (NP20), results in an indication of the 
relative antibody titre that is specific for NP whereas the use of a low loading of NP (NP7), 
indicates which antibodies are of high affinity and are able to bind the hapten when it is limited.  
 Using this method, I observed the NP20-specific IgG1 titres in aged mice were 
significantly decreased at days 14 and 21 p.i in BALB/c mice (Figure 3.15 A left panel) and at 
days 10, 14 and 21 p.i in C57BL/6 mice (Figure 3.15 A right panel). In both strains, the NP-20 
specific antibody titre of aged mice starts to increase at day 21 p.i yet failed to reach the same 
levels as in the young.  Similarly, the titres of high affinity (NP7-specific) IgG1 antibodies were 
significantly reduced in aged mice of both strains (Figure 3.15 B).  In the BALB/c mice (Figure 
3.15 B left panel) the titre of high affinity IgG1 is significantly different between young and 
aged mice as early as day 7 p.i, subsequently peaking at day 14 and remaining significantly 
higher at day 21. In the C57BL/6 mice (Figure 3.15 B right panel), the titre of high affinity 
IgG1 in young mice becomes significantly higher at day 10 p.i and continues to increase and 
remains significantly higher at days 14 and 21.  
 Affinity maturation of IgG1 antibody was determined by the ratio of high affinity titre 
(NP7) to total NP-specific titre (NP20). With this approach, I observed significant age-related 
changes in affinity maturation in both strains of mice. In BALB/c mice, affinity maturation was 
significantly diminished in aged mice at days 7 and 14 p.i (Figure 3.15 C left panel). Affinity 
maturation in aged BALB/c mice starts to increase at day 14 p.i and becomes comparable to 
the young at day 21 p.i suggesting a delay in the aged mice. Likewise, in C57BL/6 mice (Figure 
3.15 C right panel), affinity maturation in aged mice was significantly decreased at day 10 p.i 
as it only starts to increase at day 14 and remains significantly lower at day 21 p.i, a delay which 
is consistent with the delay observed in the NP+IgG1+ GC B cell kinetics.  
 Serum levels of antigen-specific (NP20) IgM were also measured with minimal 
differences between young and aged mice of both strains being observed. In BALB/c mice 
(Figure 3.16 A), there was no significant age-related difference in the production of IgM. 
Similarly, in C57BL/6 mice (Figure 3.16 B), levels of antigen-specific IgM are comparable 
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between young and aged mice at most time points except at day 21 p.i during which young 
mice are producing significantly higher amounts of IgM.  
These results indicate that the serum levels of antigen-specific IgG1, including high 
affinity IgG1, are significantly compromised with age, consistent with the V186.2 heavy chain 
Ig gene sequencing data. Therefore, both the output and the quality of the GC response appear 



































Figure 3.15 Decrease in NP-specific IgG1 antibody titre and affinity maturation 
with age  
 
A.  Antibody titres of NP20-specific IgG1 in young and old BALB/c (left) and C57BL/6 (right) 
mice B. Antibody titres of NP7-specific high affinity IgG1 in the serum taken from young and 
aged BALB/c (left) and C57BL/6 (right) mice C. Affinity maturation determined by the ratio 
NP7/NP20-specific IgG1 titre of young and aged BALB/c (left) and C57BL/6 (right) mice. 
Antibody titres shown have been normalised to a negative control (unimmunised mice) and are 
displayed as arbitrary units (AU). In each experiment there were 6-8 mice per age group, and 
the data presented are representative of two independent experiments. Each symbol represents 
the mean ± SD and the p values indicated on graphs were generated by performing a two-way 



























Figure 3.16 Minimal differences in NP-specific IgM antibody titre with age  
 
A.  Antibody titres of NP20-specific IgM in young and aged BALB/c and B. C57BL/6 mice. 
The antibody titres shown have been normalised to a negative control (unimmunised mice) and 
are displayed as arbitrary units (AU). In each experiment there were 6-8 mice per age group, 
and the data presented are representative of two independent experiments. Each symbol 
represents the mean ± SD and the p values indicated on graphs were generated by performing 
a two-way ANOVA with Sidak’s multiple comparisons test. 
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3.3.3 The frequency of NP-specific IgG1 antibody-secreting cells declines 
with age 
 
As antibody production can occur from plasma cells of non-germinal centre origin, I 
wanted to directly assess whether GC output changes with age. To this end, I used an additional 
approach to assess GC output by performing enzyme-linked immune spot (ELISpot) assays to 
measure age-related differences in NP-specific antibody-secreting cells (ASCs) of the bone 
marrow at day 21 post immunization (p.i). Bone marrow plasma cells have a GC origin, and 
therefore reflect GC output. Like the ELISA method, these assays were done by coating the 
plates with the protein BSA conjugated to a high (NP23) and low (NP2) loading of NP 
molecules to assess affinity.  
In both BALB/c and C57BL/6 mice, there was a significant decrease in NP23-specific 
IgG1 ASCs with age (Figure 3.17 A-B). Likewise, high affinity (NP2)-IgG1 ASCs were 
significantly reduced in aged mice of both strains (Figure 3.17 C-D). Affinity maturation was 
measured, as previously described, by the ratio of high affinity cells (NP2) to total NP-specific 
cells (NP23). In BALB/c mice (Figure 3.17 E), affinity maturation was significantly affected 
by age whereas a similar trend was observed in C57BL/6 mice, though it was not statistically 
significant (p=0.0584) (Figure 3.17 F).  
There was a significant increase of NP23-specific IgM ASCs with age in BALB/c mice 
with a similar trend being observed in C57BL/6 (p=0.0931) (Figure 3.18 A-B). However, when 
these assays were repeated using bone marrow from unimmunized mice (Day 0), we saw that 
aged mice of both strains had markedly higher frequencies of NP23-specific IgM ASCs 
suggesting that the observed difference at day 21 p.i was likely to be heavily influenced by non-
specific binding of aged IgM ASCs (Figure 3.18 C-D), suggesting that there is an increase in 
polyreactive IgM secreting plasma cells with ageing.  
In agreement with the ELISA findings, these assays showed a significant decrease in 
both affinity maturation and frequency of antigen-specific, including those of high affinity, 
IgG1-secreting cells with age. Therefore, these results provide further support for the notion of 
















Figure 3.17 Decrease in frequency of NP-specific IgG1 antibody-secreting cells 
(ASCs) with age 
  
A. Representative ELISpot well images (left) and frequency (right) of bone marrow NP-23 
specific IgG1 ASCs in BALB/c mice 21 days after immunisation B. Representative ELISpot 
well images (left) and frequency (right) of bone marrow NP-23 specific IgG1 ASCs in C57BL/6 
mice 21 days after immunisation  C. Representative ELISpot well images (left) and frequency 
(right) of bone marrow NP-2 specific IgG1 ASCs in BALB/c mice, 21 days after immunisation 
D. Representative ELISpot well images (left) and frequency (right) of bone marrow NP-2 
specific IgG1 ASCs in C57Bl/6 mice, 21 days after immunisation E. Affinity maturation 
determined by the ratio of NP2/NP23-specific ASCs from young and aged BALB/c mice F. 
Affinity maturation determined by the ratio of NP2/NP23-specific ASCs from young and aged 
C57BL/6 mice. In each experiment there were 6-8 mice per age group, and the data presented 
are representative of two independent experiments. Each symbol represents an individual 
mouse and the p values indicated on graphs were generated by performing an unpaired Mann 


































Figure 3.18 The frequency of NP-specific IgM-secreting cells (ASCs) is increased 
with age  
 
A. Representative ELISpot well images (left) and the frequency (right) of bone marrow NP-23 
specific IgM ASCs in BALB/c mice 21 days after immunisation B.  Representative ELISpot 
well images (left) and the frequency (right) of bone marrow NP-23 specific IgM ASCs in 
C57BL/6 mice 21 days after immunisation C. Representative ELISpot well images (left) and 
the frequency (right) of bone marrow NP-23 specific IgM ASCs in unimmunised BALB/c mice 
D. Representative ELISpot well images (left) and the frequency (right) of bone marrow NP-23 
specific IgM ASCs in unimmunised C57BL/6 mice. In each experiment there were 6-8 mice 
per age group, and the data presented are representative of two independent experiments. Each 
symbol represents an individual mouse and the p values indicated on graphs were generated by 
performing an unpaired Mann Whitney U test. 
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3.4 Ageing perturbs the GC structure   
3.4.1 Ageing alters lymph node structure   
 
Flow cytometric analysis clearly demonstrated an impairment in the GC response of 
aged mice. However, spatial information is lost using flow cytometry, which is particularly 
relevant for the three-dimensional GC that has distinct specialised compartments. To 
complement my flow cytometry data, I used fluorescent staining of tissue sections to assess 
how the GC structure is affected by age. Inguinal lymph nodes (iLNs) from young and aged 
BALB/c mice immunized subcutaneously with NP-KLH were taken at the peak of the GC 
response, day 14 p.i, to evaluate the age-related changes in LN and GC structure. For each 
mouse, six sections from the centre of the iLN were stained and each GC identified was 
analysed. LN sections were stained with IgD-FITC, CD3-APC, CD35-BV421 and Ki67-A568 
in order to visualize the T cell zone, the B cell follicle and number of GCs within the LNs by 
confocal microscopy (Figure 3.19 A). 
Quantification of the overall LN area showed that LNs taken from young mice were 
significantly larger than those of aged mice (Figure 3.19 A-B). Moreover, the number of IgD-
CD35+Ki67+ GCs structures per LN at the peak of the immune response appears to decrease 
with age, though this was not statistically significant (p=0.0584) (Figure 3.19 C). Similarly, 
quantification of the CD3+ T cell zone area revealed a significant decrease with age (Figure 
3.19 D). The T cell zone area from young mice was twice the size of the T cell zone in aged 
LNs (Figure 3.19 D). This decrease was not simply due to a decrease in overall LN size with 
age, as the percentage of the T cell zone area of the LN was also quantified and was significantly 
reduced in LNs from aged mice (Figure 3.19 E). This reduction in T cell zone area was 
reminiscent of the quantification performed by flow cytometry where we observed a lower 
proportion of CD4+ T cells in cells isolated from the iLNs of aged mice. 
These results indicate that LN structure is significantly altered with age.  Additionally, 
these observed decreases in LN size, T cell zone area and GC number corroborate the age-
related decrease in absolute numbers of adaptive immune cell subsets and the magnitude of the 
GC response observed in the BALB/c kinetic studies. Thus, these results further confirm a 











Figure 3.19 Decrease in draining lymph node size and the T cell zone with age  
 
A. Representative confocal images of inguinal lymph nodes at 20x magnification taken at day 
14 post-immunisation from young and aged BALB/c mice. LN sections were stained for IgD 
(green), CD35 (white), CD3 (magenta) and Ki67 (blue). The T cell zone was identified as the 
CD3+IgD- area of the LN and GCs were identified as IgD-Ki67+ regions within the IgD+ B cell 
follicles B. Quantification of the total LN area in mm2 C. Quantification of the number of GCs 
per LN in young and aged mice D. Quantification of the T cell zone area in mm2 and E. per 
mm2 of LN area of young and aged mice. Quantification was performed using ImageJ software. 
In each experiment there were 6-10 mice per age group, and the data presented are 
representative of two independent experiments. Each symbol represents an inguinal LN per 
individual mouse and the p values indicated on graphs were generated by performing an 



























3.4.2 Ageing disrupts the anatomy and compartmentalization of the GC  
 
 To assess the changes in structural integrity of the GC with age, GCs from the 
aforementioned iLN sections were identified as IgD-CD35+Ki67+ microanatomical structures 
within the B cell follicle of the LN (Figure 3.20 A-B). Staining for CD35+ follicular dendritic 
cells (FDCs) and Ki67+ GC B cells allowed us to visualize changes in the LZ and DZ regions 
of the GC, respectively.  
Quantification of the total GC area revealed there was a significant reduction in GC size 
in the LNs of aged mice (Figure 3.20 A-C). In addition, given the observed accumulation of 
Tfh cells in aged BALB/c mice by flow cytometry, the total number of CD3+ T cells within the 
GC were quantified. The total number of T cells within the GCs of aged mice appeared to be 
increased compared to the T cell number in young GCs (p=0.0614) (Figure 3.20 D). When 
normalized for GC size, the number of CD3+ T cells was significantly increased within the GCs 
of aged mice compared to those of young (Figure 3.20 E). Therefore, the immunofluorescence 
staining of CD3+ T cells in the GC confirmed there is indeed an accumulation of T cells in the 
aged GC. 
Within the GC area, the CD35+ FDC network appeared to be compressed towards the 
edge of the GC in LNs from aged mice compared to those of young mice (Figure 3.21 A-C). 
Quantification showed there was a significant reduction in the total FDC area in GCs from aged 
mice (Figure 3.21 B) alongside a significant reduction in the percentage of the GC area 
occupied by the FDC network (Figure 3.21 C) indicating that the observed reduction in the LZ 
area was not simply due to reduced GC size with age. In contrast, quantification of the DZ area 
defined as the CD35-Ki67+ region within the GC, revealed the DZ is significantly expanded in 
the GCs of age mice (Figure 3.21 D) and occupies a greater percentage of that total GC area in 
aged GCs compared to those of young mice (Figure 3.21 E). Therefore, even though it 
previously seemed there was no significant age-related differences in the LZ and DZ phenotype 
of GC B cells by flow cytometry staining of centroblasts and centrocytes, these results indicate 
the stromal FDC network which represents the LZ region of the GC undergo significant changes 
with age. In addition to structural changes in GC stroma, the localisation of T cells within GC, 
which are known to preferentially localise within the LZ region, was also significantly changed 
with age. The total number of T cells within the LZ area was significantly reduced in aged mice 
compared to the young mice (Figure 3.22 A-B). However, the number of T cells normalised to 
the FDC area was not significantly changed with age (Figure 3.22 C) indicating the reduced 
number of T cells in the LZ may be due to a smaller LZ area in aged GCs. On the other hand, 
the total number of T cells in the DZ is significantly increased in aged GCs compared to young 
(Figure 3.22 D) alongside a significant increase when normalised to the DZ area (Figure 3.22 
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E). This indicated that there is aberrant T cell localisation in aged GCs that may not simply be 
due to an increased DZ area.  
 Sections from these iLNs were also stained for Caspase-3 in order to evaluate age-
related changes in the number of Caspase-3+ apoptotic GC B cells (Figure 3.23 A-B). I found 
the number of Caspase-3+ GC B cells was significantly increased in the GCs of aged mice, in 
terms of both absolute numbers and when normalized for GC size (Figure 3.23 C-D). Thus, this 
observation suggests there is increased GC B cell apoptosis with age.  
 Together, these results indicate that alongside decreased GC size with age, there are 
significant changes in the key cell subsets that play a role in the GC response. The age-related 
decrease in the FDC network indicated a loss of compartmentalization within the GC and 
likewise the unusual localisation and increase in T cell numbers alongside an increased presence 
of apoptotic GC B cells indicate a loss of GC homeostasis. Thus, the anatomy of this specialised 






























Figure 3.20 GC size is decreased with age and the number of T cells is increased in 
the GCs of aged BALB/c mice 
 
A. Representative confocal images of GCs within inguinal lymph nodes, at 20x magnification, 
taken at day 14 post-immunisation from young and aged BALB/c mice. LN sections were 
stained for IgD (green), CD35 (white), CD3 (magenta) and Ki67 (blue). GCs were identified as 
IgD-Ki67+ regions within the IgD+ B cell follicles and GC T cells were identified as CD3+ cells 
within the IgD-Ki67+ region B. Representative Cell Profiler images generated from the pipeline 
used for quantification of GC size and T cell numbers within the GC C. Quantification of GC 
size in mm2 D. Quantification of T cell numbers per GC and per mm2 of GC area in young and 
aged mice. Quantification was performed using Cell Profiler software. Additional 
representative confocal images used for this analysis can be found in Appendix 9.2. In each 
experiment there were 6-10 mice per age group, and the data presented are representative of 
two independent experiments. Each symbol represents a GC and the p values indicated on 



























Figure 3.21 The LZ area is decreased whilst the DZ is increased in GCs of aged 
BALB/c mice 
 
A. Representative confocal and Cell Profiler images of the GC LZ and DZ regions, at 20x 
magnification, taken at day 14 post-immunisation from young and aged BALB/c mice. GCs 
were identified as IgD-Ki67+ regions within the IgD+ B cell follicles, the LZ was defined as the 
region occupied by CD35+ FDCs and the DZ was defined as the Ki67+CD35- region within the 
GC B. Quantification of the LZ area in mm2 and C. as a percentage of GC area D. Quantification 
of the DZ area in mm2 and E. as a percentage of GC area. Quantification was performed using 
Cell Profiler software. In each experiment there were 6-10 mice per age group, and the data 
presented are representative of two independent experiments. Each symbol represents a GC and 










































Figure 3.22 The number of T cells is increased in the DZ region of GCs from aged 
BALB/c mice 
 
A. Representative confocal and Cell Profiler images of CD3+ T cells within the GC, taken at 
20x magnification at day 14 post-immunisation from young and aged BALB/c mice. GCs were 
identified as IgD-Ki67+ regions within the IgD+ B cell follicles, and T cells were identified as 
CD3+ by Cell Profiler software B. Quantification of T cell numbers within the LZ area and C. 
per mm2 of LZ area D. Quantification of T cell numbers within the DZ area and E. per mm2 of 
DZ area. In each experiment there were 6-10 mice per age group, and the data presented are 
representative of two independent experiments. Each symbol represents a GC and the p values 









































Figure 3.23 An increased presence of apoptotic Caspase 3+ GC B cells in the GCs 
of aged BALB/c mice 
 
A. Representative confocal images of GCs within inguinal lymph nodes, at 20x magnification, 
taken at day 14 post-immunisation from young and aged BALB/c mice. LN sections were 
stained for IgD (green), CD35 (white), CD3 (magenta) and active Caspase (red). GCs were 
identified as IgD- regions containing CD35+ FDCs within the IgD+ B cell follicles and apoptotic 
GC B cells were identified as Caspase3+ cells within the GC region B. Representative Cell 
Profiler images generated from the pipeline used for quantification of GC size and Caspase 3+ 
cell numbers within the GC C. Quantification of Caspase 3+ cell numbers within the GC and 
D. per mm2 of GC area. Additional representative confocal images used for this analysis can be 
found in Appendix 9.3. In each experiment there were 6-10 mice per age group, and the data 
presented are representative of two independent experiments. Each symbol represents a GC and 






























3.5 Discussion   
 
The findings reported describe our assessment of the age-dependent changes in the 
germinal center (GC) in vivo in mice. The data presented here demonstrates there is an age-
dependent decrease in the magnitude of the GC response, a delay in the production of antigen-
specific cells accompanied by deterioration in the quality of the GC output and structural 
defects within the GC after immunization. 
Ageing is accompanied by a reduction in naïve CD4+ T and B-lymphocytes in the 
periphery (Lazuardi et al., 2005). Here, I showed that the lymph nodes from aged mice were 
smaller than those of young mice, which had a significant impact in the absolute numbers of 
CD4+ T and B-lymphocytes in aged mice. The reduction in lymphocytes was particularly 
striking at the peak of the immune response, which suggested that aged lymphocytes are not 
able to undergo clonal expansion to the same extent as young cells upon immunization. As 
previously reported, we observed a decrease in GC B cells with age in both strains of mice 
indicating that the aged GC response is not as robust as it can be in young mice and as a 
consequence the titers of antigen-specific IgG1 antibodies along with the number of IgG1-
secreting cells were also reduced (Lu and Cerny, 2002). Interestingly, the percentage of 
centroblasts and centrocytes did not differ between young and aged mice suggesting that even 
though there are less GC B cells their ratio and migration between the dark zone (DZ) and the 
light zone (LZ) are not affected with age. However, examining the proportion of these cells did 
not account for the structural integrity of the DZ and LZ within the aged GC as confocal 
microscopy revealed the LZ area was significantly diminished with age.  
Sage and colleagues demonstrated there was an increase in the percentage of Tfh and 
Tfr cells in aged mice and proposed that the diminished GC response with age could be due to 
increased suppression by Tfr cells and impaired Tfh cell function (Sage et al., 2015). Here we 
confirmed, there was an increase in the percentage of Tfh cells in both strains of mice, though 
not in absolute numbers. Whilst this accumulation in Tfh cells with age could be partially due 
to an increase in memory Tfh cells (Peter T Sage et al., 2014), this expansion was not observed 
in unimmunized mice making an imbalance of memory Tfh cells a less likely explanation for 
my findings. Thus it is crucial to understand the functionality and antigen-specificity of these 
aged Tfh cells. In addition, I observed contradicting results when examining the percentage of 
Tfr cells in aged C57BL/6 and BALB/c mice. Whilst the frequency of Tfr cells was comparable 
between young and age C57BL/6 mice, both the frequency and absolute number of Tfr cells 
was significantly increased in aged BALB/c mice. Therefore, it is difficult to draw conclusions 
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on the contribution of Tfr cells to the age-dependent decline of the GC as the changes observed 
may be strain-dependent and thus we cannot assume that the diminished aged GC response is 
solely due to increased Tfr cell suppression. Together, these defects indicate the magnitude of 
the GC after immunization is reduced with age however, under non-antigen-specific conditions, 
these defects do not exclude cells of a memory phenotype that are known to be present in higher 
proportions in aged mice. 
The C57BL/6 kinetic study had the added advantage of tracking the antigen-specific 
GC response. Studies have shown there is a reduction in the number of antigen-specific GC B 
cells with age that form upon immunization (Kosco et al., 1989; Szakal et al., 1990). Likewise, 
I observed a reduction in total numbers of IgG1+NP+ GC B cells, yet in addition we saw there 
was a delay in the proportion of antigen-specific GC B cells being produced in aged mice 
compared to young mice. In fact, the percentage of aged antigen-specific GC B cells peaked 11 
days after the peak in the young GC response indicating that not only is the magnitude of the 
response decreased with age but that expansion of GC B cells specifically mounting a response 
to immunization occurs much later in aged mice. Sage and colleagues demonstrated that though 
there is an accumulation of Tfh cells with age, these cells were unable to adequately stimulate 
antigen-specific B cells in vitro (Sage et al., 2015). In contrast, here we were able to examine 
antigen-specific Tfh cells using a tetramer (1W1K-IAb) specific for the 1W1K peptide that the 
mice were immunized with. Similar to the antigen-specific response in GC B cells, I saw that 
there was a decrease in the percentage of aged antigen-specific Tfh cells in the early stage of 
the GC response (day 7). This delay in the formation of antigen-specific Tfh cells with age 
indicates there could be an age-dependent defect in the initial steps of Tfh cell formation such 
as the priming of the T cell by a dendritic cell (DC) or in the cognate interactions with B cells 
at the T: B border required for Tfh cell linage commitment in response to immunization. 
However, as the GC response progressed the percentage of antigen-specific Tfh cells in aged 
mice was not much higher than in young mice as it was under non-antigen-specific conditions. 
This suggests that although there is an accumulation of Tfh cells in the aged GC upon 
immunization, only a small proportion are antigen-specific upon expansion which indicates the 
possibility for bystander activation leading to non-antigen-specific expansion of cells in the 
GCs of aged mice. Together, this data shows that alongside a reduction in magnitude there is a 
delay in the formation of antigen-specific cells in the aged GC response. This suggests there 
could be significant defects in the steps prior to or during the initiation of the GC that may be 
critical for its age-dependent deterioration.  
In addition to cellular phenotyping, immunization with the NP hapten allowed us to 
assess the quality of GC B cells, antigen-specific antibody-secreting cells and antibodies being 
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produced in aged mice. Studies have reported SHM to be reduced with age in mice (Miller and 
Kelsoe, 1995; Yang, Stedra and Cerny, 1996), which we also demonstrated was significantly 
reduced in aged GC B cells. This may be due to an age-dependent decrease in the expression 
of activation induced cytidine deaminase (AID) in B cells, which is critical for class-switching 
and SHM (Frasca et al., 2004, 2008). Thus, the SHM process by which GC B cells are able to 
acquire higher affinity for antigen is likely impaired with age, which in turn could have 
deleterious consequences on the affinity of the GC output. Indeed, the frequency of high affinity 
inducing mutations was decreased in aged GC B cells thus, the pool of high affinity centrocytes 
available for selection in the aged GC could be diminished and lead to a lower quality of GC 
output. However, Cerny and colleagues demonstrated that the transfer of young CD4+ T cells 
to Ighb Scid mice was better able to generate high affinity VH186.2 GC B cell clones than CD4+ 
T cells from aged donors after immunisation with NP (Yang, Stedra and Cerny, 1996). 
Therefore, the observed loss of high affinity inducing mutations in aged GC B cell clones may 
not necessarily be a B cell intrinsic effect but could also be due to aberrant Tfh cell selection 
during which low affinity GC B cells are permitted to survive and recycle back into the DZ for 
further rounds of mutation and proliferation.    
We have also shown aged mice produced significantly less NP-specific IgG1 
throughout the GC response than young mice, which was in agreement with previous findings 
that report lower titers of NP (25)-specific antibody titers in aged mice (Han et al., 2003). It has 
been reported that there is a shift in antibody isotypes from IgG to IgM with age (Johnson and 
Cambier, 2004), and indeed there were more IgM-secreting cells present in the bone marrow 
of aged mice though no age-dependent differences in the levels of NP-specific IgM in the serum 
were observed here. Furthermore, in this study young mice produced significantly higher 
amounts of high-affinity NP (7)-specific IgG1 and high-affinity IgG1 secreting cells than old 
mice indicating that both the quantity and quality of the GC output are compromised with age. 
We were also able to determine affinity maturation via this method by calculating what 
proportion of NP-specific IgG1 was of high affinity from the total NP (20)-specific titer. 
Affinity maturation was significantly compromised in aged mice throughout the GC response 
and it only appeared to increase at later time points compared with young mice, which could be 
due to the observed delay in the production of antigen-specific GC B cells. The observed age-
dependent defect in affinity maturation within the GC and its output indicates that the steps 
during affinity-based GC B cell selection could be significantly compromised with age.  
The GC is a specialised microenvironment, which is organized in such a way that each 
compartment provides an optimal stage for the various processes critical for a successful 
response (Allen et al., 2004, 2007). Thus, we used confocal microscopy to assess the changes 
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in GC structure in fine detail. Visualization of the LN revealed the observed reduction in the 
magnitude of the GC response might be attributed to a reduced number of GCs in the LN as 
well as a reduction in GC size with age. Within the GC, the LZ is the critical stage in which 
affinity-based selection takes place.  After undergoing somatic hypermutation (SHM) in the 
DZ, GC B cells test the ability of their newly mutated B cell receptor (BCR) to bind antigen 
that is presented on FDCs in the LZ (Miller et al., 2002). However, I showed that with age the 
size of the FDC network is significantly reduced and thus it is possible this aberrant change 
could lead to a reduced amount of antigen presented, or to impaired interactions between 
centrocytes and FDCs. Following contact with FDCs, high–affinity centroblasts compete for 
survival signals from Tfh cells, however we observed an age-dependent accumulation of Tfh 
cells by flow cytometry as well as an accumulation of CD3+ T cells by confocal microscopy. 
This could alter the competitive environment required for GC B cell selection as it has been 
previously shown that a limiting number of Tfh cells are required for optimal GC B cell output 
(Meyer-Hermann, Maini and Iber, 2006; Gitlin, Shulman and Nussenzweig, 2014). However, 
we also observed mislocalisation of Tfh cells towards the DZ region of aged GCs which could 
negatively impact GC B cell selection by decreasing the probability of centrocytes acquiring 
Tfh-derived survival signals through T: B cell interactions that are believed to occur in the LZ 
(Allen, Okada and Cyster, 2007; Gabriel D Victora et al., 2010). Additionally, we observed a 
striking increase in the number of apoptotic GC B cells with age. This could be the result of a 
reduction in survival signals arising from an impaired interaction with a decreased FDC 
network or defective Tfh cells. Alternatively, it has been shown that the FDC network is critical 
in the clearance of apoptotic bodies from the GC by secreting Mfge8 which coats apoptotic 
cells and marks them for opsonisation by tangible body macrophages (Kranich et al., 2008); 
such a mechanism could be impaired with age due to the reduction of the FDC network. 
Therefore, the aberrant changes observed in the GC structure could compromise the success of 
affinity-based selection and lead to the survival of low-affinity GC B cells and increases in GC 
B cell apoptosis.  
The GC is a dynamic microenvironment that relies on successful interactions between 
various cell types for initiation, maintenance and the quality of its output (Mesin, Ersching and 
Victora, 2016).  Our initial assessment of the cellular changes that arise with ageing has 
demonstrated that there is a significant reduction in the magnitude of the GC response and a 
delay in the production of antigen-specific cells which could be attributed to defects in T cell 
priming and cognate T: B cell interactions. Moreover, we have demonstrated a significant 
decrease in affinity maturation, which could arise as a result of aberrant GC B cell selection 
due to various age-dependent changes in the compartmentalization and anatomy of the GC. In 
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conclusion, the data presented thus far indicate there are various age-dependent defects that 
could be affecting different stages of the GC response.  
 This chapter describes the findings from our initial phenotypic assessment of the cellular 
changes of the GC response with age in vivo in mice. We have found there is a significant age-
related reduction in the magnitude of the GC response alongside a delay in the production of 
antigen-specific cells. Moreover, we confirmed there is a significant decline in affinity 
maturation with age as well as a disruption to the specialised structure of the GC. These 
observations indicate there are age-dependent defects that likely affect the initiation, 
maintenance and affinity-based selection stages of the GC response, which could be 
contributing to its deterioration with age. Therefore, this in vivo data provides a foundation for 
the generation of hypotheses to be tested in silico and in vivo to gain further insights into the 































B cell intrinsic effects of ageing on the GC response in vivo 
4.1 Preamble 
 
The initial kinetic studies, performed to phenotype the aged GC response in vivo, clearly 
demonstrated there are several defects in the GC response of aged mice. I observed a decrease 
in the proportion and total number of GC B cells in aged mice after immunisation, reflecting a 
reduction in the magnitude of the response with age. Similarly, the GC output and affinity 
maturation are compromised with age through a decrease in antigen-specific serum antibody 
titres, IgG1 switched antibody-secreting cells in the bone marrow, reduced rate of somatic 
hypermutation and frequency of affinity-inducing mutations in aged GC B cells. In addition, 
there is an increased presence of Tfh cells and apoptotic B cells in the GCs of aged mice, which 
are smaller and structurally different to young GCs due to a reduction in the FDC network 
compartment. Overall, I identified age-dependent defects in the key GC cell types which are 
required to collaborate effectively for the success of the GC response. Therefore, in order to 
understand the precise mechanisms driving GC deterioration with age, it is essential to consider 
and assess the age-related intrinsic effects of the main cell types that interact with each other 
during GC responses. To address this, Cerny and colleagues performed co-transfers of different 
combinations of young and old T and B cells into young mice which suggested that T cells are 
the main contributors to the demise of the GC with age (Yang, Stedra and Cerny, 1996), yet 
several groups have described B cell intrinsic changes with age, in both humans and mice, that 
could alter the outcome of the GC response upon immunisation.  
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 In 1991, Newhouse and colleagues described a proliferation defect in peripheral blood 
B cells of elderly human donors upon B cell receptor and CD40 stimulation in vitro (Whisler, 
Williams and Newhouse, 1991). This was later confirmed with B cells from aged mice which 
had a diminished proliferative capacity when stimulated in vitro with both T-dependent and T-
independent signals, suggesting there are B cell intrinsic changes in intracellular signalling with 
age (Blaeser, McGlauchlen and Vogel, 2008). In addition, in vitro studies performed by 
Blomberg and colleagues using naïve and memory B cells isolated from elderly human donors 
and aged mice revealed there are B cell intrinsic effects in isotype class switching and secretion 
of IgG1 upon stimulation with anti-CD40 antibodies and recombinant IL-4 (Frasca et al., 2004, 
2008). They demonstrated that this defect correlates with a reduced expression of activation-
induced cytidine deaminase (AID), an enzyme that is critical for isotype class switching and 
somatic hypermutation (Masamichi Muramatsu et al., 2000), which in turn was attributed to a 
decreased expression of its positive regulator, transcription factor E47 in aged B cells (Frasca 
et al., 2004, 2008). This defect in AID expression may also explain the reported reduction of 
somatic hypermutation in aged mice (Miller and Kelsoe, 1995). However, analysis of IgVH 
gene hypermutation in GC B cells isolated from elderly human donors demonstrated that there 
are no age-associated defects in somatic hypermutation (M Banerjee et al., 2002). Whilst these 
studies provide evidence for age-associated B cell intrinsic defects in cell proliferation and 
isotype class switching, many of these were performed using in vitro systems. Thus, definitive 
evidence for B-cell intrinsic effects on the ageing GC response have not yet been formally 
demonstrated in vivo.  
In the initial phenotyping of the aged GC response, I observed defects in GC B cell 
expansion, isotype class switching, somatic hypermutation and apoptosis; all of which are 
processes that may be driven by age-associated B cell intrinsic effects. Yet the outcome of these 
processes could also be influenced by interactions with other key GC cell types such as Tfh 
cells and FDCs. Thus, we next aimed to examine the B cell intrinsic contribution to the decline 
of the ageing GC response in vivo in mice. To do this in an antigen-specific manner, I used the 
SWHEL experimental system developed by Brink and colleagues in 2003, for which a gene-
targeting approach was used to generate mice resulting in ~10-20% of B cells that carry 
specificity for hen egg lysozyme (HEL)(Phan et al., 2003). A key feature of this system is that 
because the transgenes are knocked in to the endogenous locus the transgenic SWHEL B cells 
are able to class switch to all classes of immunoglobulin and undergo somatic hypermutation. 
Furthermore, the study of collaborative B cell-T cell responses is made possible by adoptively 
co-transferring SWHEL B cells alongside ovalbumin-specific OT-II cells into wild type mice 
followed by immunisation with HEL conjugated to ovalbumin (HEL-OVA). Here I used this 
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approach to co-transfer young or old SWHEL B cells from a young or aged mouse, along with 
OT-II cells from a young mouse into young recipient mice in which I assessed the differences 
in HEL-specific GC B cell and OT-II Tfh cell differentiation, isotype class switching, GC B 
cell apoptosis and HEL-specific antibody output upon immunisation. This chapter describes the 
results from these SWHEL B cell and OT-II T cell co-transfers used to examine the B cell 
intrinsic effects of ageing on the GC response in vivo in mice. 
 
4.2 Adoptive transfer of aged SWHEL B cells into young mice reveals 
negligible effects of B cell age on the GC response 
4.2.1 B cell age does not affect the magnitude of the HEL-specific GC 
response 
 
To investigate the B cell intrinsic effects of ageing on the GC response, we set up an 
adoptive transfer model whereby HEL-binding B cells isolated from either 2-month old or 22-
month old SWHEL mice were co-transferred alongside OVA-specific CD4+ T cells from young 
OT-II mice into young C57BL/6 mice. For this, total cells were isolated from the skin-draining 
LNs and spleens of SWHEL and OT-II donor mice for which the proportion of HEL-binding B 
cells and TCR-Va2+ T cells was calculated by flow cytometry to control for the number of 
antigen-binding cells amongst the total cells being transferred. The recipient mice were then 
subcutaneously immunised with HEL conjugated to OVA (HEL-OVA) after which the draining 
inguinal lymph nodes (dLNs) were collected at the peak of the GC response, day 10 post 
immunisation (outlined in Figure 4.1 A). With this approach, I was able to assess the proportion 
and total cell number of HEL-specific GC B cell subsets that were generated in the context of 
a young microenvironment, as well as the differentiation of the transferred OT-II CD4+ T cells 
into Tfh cells, by flow cytometry (gating strategy outlined in Figure 4.1 B).  
Using CD45 congenic markers, I first assessed the success of the adoptive transfer by 
identifying the transferred CD45.1+CD45.2+ SWHEL cells and CD45.1+ OT-II cell populations 
in the dLNs of recipient mice that received either young (group A) or aged (group B) B cells 
(Figure 4.2 A). The transferred CD45.1+CD45.2+ SWHEL cell population could be identified in 
the dLNs of both recipient groups, yet these cells were present in significantly higher 
proportions and numbers in the recipients which received young SWHEL cells (Figure 4.2 B). 
Transferred CD45.1+ OT-II cells were identified in both groups with no significant difference 
in the proportion or absolute cell number between both groups of recipient mice (Figure 4.2 C). 
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Despite there being a greater proportion of CD45.1+CD45.2+ SWHEL cells present in the dLNs 
of group A recipients, there was no significant difference in both the proportion and total cell 
number of HEL-binding B cells (HEL+B220+ CD45.1+CD45.2+) between the two groups 
(Figure 4.3 A-B). These results indicated there was no bias between the number of young or 
aged HEL-binding B cells and young OT-II cells that were transferred into the two groups of 
recipient mice, thus I proceeded to examine the GC response.  
Young recipients which received SWHEL B cells from aged mice were able to generate 
comparable HEL-specific GC B cell populations (CD45.1+CD45.2+) to those that received 
SWHEL B cells from young mice (Figure 4.4 A). There was no significant difference in the 
proportion and total cell number of HEL+CD95+CD38- GC B cells generated upon HEL-OVA 
immunisation between the two recipient groups (Figure 4.4 B) suggesting that B cells from 
aged mice are equally capable of differentiating into GC B cells as those from young mice. 
Additionally, to assess the B cell intrinsic effects on the observed increased GC B cell apoptosis 
in aged mice, cells were stained with anti-active caspase 3. The proportion and absolute cell 
number of active caspase 3 (aCasp3) +HEL+GC B cells (CD45.1+CD45.2+) was not significantly 
different between the two recipient groups, however these cells were rare and present in very 
small numbers (Figure 4.5 A-B). Anti-aCasp3 staining was verified by identifying aCasp3+ 
cells gated on the more abundant CD95+CD38-CD45.2+ GC B cell populations from the host 
mice (Figure 4.5 C).  This aCasp3+ population was not significantly different in proportion and 
total number between the two groups (Figure 4.5 D).  Together, these results indicate that B 
cell age does not contribute to the observed decrease in GC magnitude of aged mice and it is 
























Figure 4.1 Experimental outline and gating strategy for SWHEL B cell and OT-II T 
cell adoptive co-transfer 
 
A. Experimental setup for the SWHEL B cell and OT-II T cell co-transfers for which inguinal 
lymph nodes and blood from the young C57BL/6 recipient mice were taken 10 days after 
immunisation with HEL-OVA in alum B. Gating strategy for the identification of 
CD45.2+CD45.1+ transferred SWHEL cells, HEL+ B cells (B220+CD45.2+CD45.1+), HEL+ GC 
B cells (CD95+CD38-B220+CD45.2+CD45.1+), HEL+IgG1+ GC B cells, HEL+ IgM+ GC B 
cells, active caspase 3+HEL+ GC B cells, CD45.1+CD45.2- transferred OT-II cells and OT-II 
Tfh cells (PD1+CXCR5+CD45.1+CD45.2-). Numbers adjacent to gate indicate percentage of 






Figure 4.2 Transferred SWHEL and OT-II cells in LNs of young C57BL/6 recipient 
mice 
 
A. Representative flow cytometry plots identifying CD45.2+CD45.1+ transferred SWHEL cells 
and CD45.1+CD45.2- transferred OT-II cells in inguinal LNs of young C57BL/6 recipient mice 
at day 10 post-immunisation with HEL-OVA. Numbers adjacent to gates indicate percentage 
of each cell population for the representative sample B. Quantification of the frequency (left) 
and total number (right) of transferred CD45.2+CD45.1+ cells from SWHEL mice C. 
Quantification of the frequency (left) and total number (right) of transferred CD45.1+ CD45.2- 
cells from OT-II mice. In each experiment there were 3-6 mice per recipient group, and the data 
presented are representative of three independent experiments. Each symbol represents a mouse 
and bar height indicates the mean. The p values indicated on graphs were generated by 










Figure 4.3 The proportion and total number of HEL-specific B cells is comparable 
between recipients of young and aged SWHEL B cells 
 
A. Representative flow cytometry plots identifying HEL-specific B220+ B cells gated on 
CD45.1+CD45.2+ cells in inguinal LNs of young C57BL/6 recipient mice at day 10 post-
immunisation with HEL-OVA. Numbers adjacent to gates indicate percentage of each cell 
population for the representative sample B. Quantification of the frequency (left) and total 
number (right) of HEL-specific B220+ B cells (CD45.1+CD45.2+B220+). In each experiment 
there were 3-6 mice per recipient group, and the data presented are representative of three 
independent experiments. Each symbol represents a mouse and the mean is indicated by the bar 
graph height. The p values indicated on graphs were generated by performing an unpaired Mann 






Figure 4.4 The frequency and absolute number of HEL-specific GC B cells is 
comparable between recipients of young and aged SWHEL B cells 
 
A. Representative flow cytometry plots identifying HEL-specific CD95+ CD38- GC B cells 
gated on HEL+B220+CD45.1+CD45.2+ cells in inguinal LNs of young C57BL/6 recipient mice 
at day 10 post-immunisation with HEL-OVA. Numbers adjacent to gates indicate percentage 
of each cell population B. Quantification of the frequency (left) and total number (right) of 
HEL-specific CD95+ CD38- GC B cells (HEL+B220+CD45.1+CD45.2+). In each experiment 
there were 3-6 mice per recipient group, and the data presented are representative of three 
independent experiments. Each symbol represents a mouse and the mean is indicated by the bar 
graph height. The p values indicated on graphs were generated by performing an unpaired Mann 







Figure 4.5 Apoptotic GC B cells in young C57BL/6 recipient mice 
 
A. Representative flow cytometry plots identifying active-caspase 3+ HEL-specific GC B cells 
gated on CD95+CD38-HEL+B220+CD45.1+CD45.2+ cells in inguinal LNs of young C57BL/6 
recipient mice at day 10 post-immunisation with HEL-OVA. Numbers adjacent to gates 
indicate percentage of each cell population B. Quantification of the frequency (left) and total 
number (right) of active-caspase 3+ HEL-specific GC B cells (CD95+CD38-
HEL+B220+CD45.1+CD45.2+) C. Representative flow cytometry plots identifying active-
caspase 3+ host GC B cells gated on CD95+CD38-B220+CD4-CD45.2+CD45.1- cells in inguinal 
LNs of young C57BL/6 recipient mice at day 10 post-immunisation with HEL-OVA D. 
Quantification of the frequency (left) and total number (right) of active-caspase 3+ GC B cells 
(CD95+CD38-B220+CD4-CD45.2+CD45.1-). Numbers adjacent to gates indicate percentage of 
each cell population. In each experiment there were 3-6 mice per recipient group, and the data 
presented are representative of three independent experiments. Each symbol represents a mouse 
and the mean is indicated by the bar graph height. The p values indicated on graphs were 


















4.2.2 B cell age has minimal effects on isotype class switching and antibody 
output 
 
An additional benefit of using the SWHEL adoptive transfer system is the ability to track 
HEL-specific GC B cells which have undergone isotype class switching by flow cytometry. 
SWHEL B cells which were transferred from aged mice were able to undergo isotype class 
switching equally to SWHEL B cells transferred from young donors (Figure 4.6 A). There was 
no significant difference in the proportion and absolute number of IgG1+HEL+GC B cells 
between the two recipient groups (Figure 4.6 A-B). Furthermore, there was a significantly 
higher proportion of IgM+HEL+GC B cells in mice which received SWHEL B cells from aged 
mice, though this difference was not significant in absolute numbers (Figure 4.6 C), and the 
frequency of IgM+ B cells is low within the SWHEL GC B cells. These results suggest that the 
process of isotype class switching is not significantly affected by B cell age.  
To assess the antigen-specific antibody output of the GC response in our SWHEL 
adoptive transfer system, I performed HEL-specific ELISAs using serum isolated from 
recipient mice. There were no significant differences in HEL-specific IgG1 and IgM serum 
antibody titres between the two groups (Figure 4.7 A-B). This indicated that the antibody output 
of the GC response in mice that received aged SWHEL B cells is equivalent to that of young 
SWHEL B cell recipients.  Thus, both the intrinsic ability of B cells to undergo isotype class 



















Figure 4.6 The frequency and total number class switched IgG1 and IgM HEL-
specific GC B cells is equivalent between recipients of young and aged SWHEL B 
cells 
 
A. Representative flow cytometry plots identifying IgG1+ and IgM+ HEL-specific GC B cells 
gated on CD95+CD38-HEL+B220+CD45.1+CD45.2+ cells in inguinal LNs of young C57BL/6 
recipient mice at day 10 post-immunisation with HEL-OVA. Numbers adjacent to gates 
indicate percentage of each cell population B. Quantification of the frequency (left) and total 
number (right) of IgG1+HEL-specific GC B cells (CD95+CD38-HEL+B220+CD45.1+CD45.2+) 
C. Quantification of the frequency (left) and total number (right) of IgM+ HEL-specific GC B 
cells (CD95+CD38-B220+CD4-CD45.2+CD45.1-). Numbers adjacent to gates indicate 
percentage of each cell population. In each experiment there were 3-6 mice per recipient group, 
and the data presented are representative of three independent experiments. Each symbol 
represents a mouse and the mean is indicated by the bar graph height. The p values indicated 
































Figure 4.7 HEL-specific serum antibody output in young C57BL/6 recipient mice 
 
A.  Antibody titres of HEL-specific IgG1 and B. IgM in the serum of young recipient C57BL/6 
mice at day 10 post-immunisation with HEL-OVA. The antibody titres shown have been 
normalised to a negative control (unimmunised mice) and are displayed as arbitrary units (AU). 
In each experiment there were 3-6 mice per age group, and the data presented are representative 
of two independent experiments. Each symbol represents a mouse and the mean is indicated by 
the bar graph height. The p values indicated on graphs were generated by performing an 











4.2.3 Tfh cell differentiation is unperturbed by cognate interactions with 
aged SWHEL B cells 
 
In addition to assessing HEL-specific GC formation, the co-transfer of OVA-specific 
OT-II+CD4+ T cells alongside SWHEL B cells allowed us to investigate the effects of B cell age 
on Tfh cell differentiation, which is initiated through collaborative T cell-B cell interactions 
upon HEL-OVA immunisation. OT-II+ T cells which were transferred alongside SWHEL B cells 
from aged mice were able to differentiate into PD-1+CXCR5+ Tfh cells in the same manner as 
those transferred alongside SWHEL B cells from young mice (Figure 4.8 A). There were no 
significant differences in both the proportion and absolute cell number of the PD-1+CXCR5+ 
Tfh cell populations gated on the transferred CD4+CD45.1+CD45.2- OT-II cells (Figure 4.8 B-
C). These results therefore indicated that B cells from aged mice are capable of undergoing 
























Figure 4.8 The frequency and total number of Tfh cells derived from transferred 
OT-II cells is comparable between recipients of young and aged SWHEL B cells 
 
A. Representative flow cytometry plots identifying OT-II derived PD1+CXCR5+ Tfh cells gated 
on CD4+CD45.1+CD45.2- cells in inguinal LNs of young C57BL/6 recipient mice at day 10 
post-immunisation with HEL-OVA. Numbers adjacent to gates indicate percentage of each cell 
population B. Quantification of the frequency (left) and total number (right) of OT-II derived 
PD1+CXCR5+ Tfh cells (CD4+CD45.1+CD45.2-). In each experiment there were 3-6 mice per 
recipient group, and the data presented are representative of three independent experiments. 
Each symbol represents a mouse and the mean is indicated by the bar graph height. The p values 




Vaccination of elderly individuals and aged mice results in diminished antibody 
responses and thus they fail to generate protective immunity in contrast to younger individuals 
(Linterman, 2014). To better understand this defect, several groups have investigated the B cell 
intrinsic changes of ageing and have revealed age-dependent defects in B cell proliferation, 
class switch recombination and antibody secretion (Whisler, Williams and Newhouse, 1991; 
Frasca et al., 2004, 2008). In light of this, I hypothesised that the GC deterioration observed in 
our initial phenotyping of the aged GC, could be driven by age-dependent B cell intrinsic 
effects. The data presented in this chapter describes our assessment of the B cell intrinsic effects 
of ageing on the GC response in vivo in mice using a SWHEL B cell and OT-II T cell adoptive 
co-transfer system. The findings clearly indicated that B cells from aged mice are equally able 
to differentiate into GC B cells and generate GC responses equally to B cells from young mice 
when transferred into young wild type mice.  
SWHEL B cells transferred from aged mice were able to differentiate into GC B cells at 
an equal capacity to SWHEL B cells from young mice suggesting that the ability of B cells to be 
activated and expand is intact in ageing. This finding is in line with a previous report that B 
cells from aged donors express similar levels of CD40 and upregulate the activation markers 
CD80 and CD86 as cells from young donors upon stimulation with T-dependent signals in vitro 
(Blaeser, McGlauchlen and Vogel, 2008). However, other studies have reported that B cells 
from elderly human donors and aged mice are less able to proliferate upon stimulation in vitro 
with anti-IgM, T cell dependent signals such as CD40 and IL-4 as well as T cell independent 
stimulation with LPS (Whisler, Williams and Newhouse, 1991; Blaeser, McGlauchlen and 
Vogel, 2008). In contrast, my findings imply that B cells from aged mice are capable of 
proliferating in vivo during GC responses upon immunisation as there were similar proportions 
and total number of antigen-specific GC B cells generated in mice that received young and aged 
SWHEL B cells. This discrepancy between my findings and previous reports could be due to the 
use of different experimental systems. The age-dependent defect in proliferation of purified B 
cells was reported using in vitro systems which cannot fully account for cellular interactions 
and B cell extrinsic cues, such as T cell and FDC derived cytokines, that can influence the 
outcome of B cell proliferation in an in vivo system. While in vitro stimulation of B cells using 
CD40 and IL-4 aims to mirror T cell derived cues critical for the cognate T-B cell interaction 
that occur in vivo, IL-21 secreted by Tfh cells is also a critical signal which regulates GC B cell 
differentiation and proliferation (Linterman et al., 2010; Zotos et al., 2010). Additionally, FDC 
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derived IL-15 has also been reported to promote GC B cell proliferation, a signal which is not 
accounted for in the in vitro measuring B cell proliferation of aged cells (Park et al., 2014). 
Therefore, in the presence of a young microenvironment where T cell and stromal cell cues 
remain unperturbed by age, B cells from aged mice are able to differentiate and expand to 
generate GC responses to the same capacity as B cells from young mice. Similar to clonal 
expansion and proliferation, GC B cells undergo high rates of apoptosis to eliminate self-
reactive B cell clones arising from detrimental SHM events, thus this process of GC B cell 
death is tightly regulated for optimal GC responses (Mayer et al., 2017; Stewart et al., 2018). 
  Due to the increased presence of apoptotic GC B cells in GCs of aged BALB/c mice in 
the previous chapter, I investigated B cell intrinsic apoptosis by staining for anti-active caspase 
3 and found there was no difference in apoptosis of HEL-specific GC B cells derived from 
either aged or young mice. However, caspase 3+ GC B cells derived from SWHEL cells were 
present in very low numbers which could influence the accuracy of a quantitative comparison 
between young and aged cells. Despite low cell numbers, apoptotic antigen-specific GC B cells 
derived from aged SWHEL mice did not appear to be enriched in young hosts, a feature which I 
observed in aged BALB/c mice, indicating that GC B cells from aged mice are unlikely to be 
more intrinsically susceptible to cell death than B cells from young mice. Therefore, the 
increased presence of apoptotic GC B cells we observed in aged BALB/c mice (Chapter 3.4.2) 
is likely due to B cell extrinsic factors in the ageing microenvironment. One such factor could 
be an increased competition for antigen due to the reduced FDC network area I observed in 
aged GCs (Chapter 3.4.2). This reduction in the FDC area could reduce the amount of local 
antigen presented, and increase GC B cell apoptosis due to an inability to test their Ig receptor 
on cognate antigen (Kosco, Szakal and Tew, 1988; Qin et al., 1998). The reduced FDC network 
in aged mice could also explain a B cell extrinsic increase in apoptotic GC B cells through 
reduced secretion of Mfge8 (FDC-M1) from FDCs. FDC-derived Mfge8 is a critical factor for 
the engulfment of apoptotic GC B cells by tangible body macrophages (Kranich et al., 2008), 
and therefore the increased presence of apoptotic GC B cells could result from impaired 
clearance of these cells. Alternatively, if tangible body macrophage function was impaired in 
ageing, the rate of clearance of apoptotic GC B cells would also be delayed. GC B cells can 
also undergo apoptosis during selection by Tfh cells, which provide centrocytes with critical 
survival signals through CD80-CD28 stimulation and the production of IL-4 and IL-21 (de 
Vinuesa et al., 2000; Sharpe et al., 2012). Tfh helper function has been reported to be 
compromised with age (Sage et al., 2015), thus a lack of T cell help in the aged GC may also 
lead to an increased presence of apoptotic GC B cells. Consequently, our findings show that in 
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the presence of a young microenvironment and young T cells, GC B cells generated from aged 
SWHEL cells do not appear to undergo higher rates of apoptosis than young GC B cells.  
 Another critical process which occurs upon B cell activation is class switch 
recombination (CSR) of the immunoglobulin (Ig) receptor on activated B cells. CSR is a crucial 
step for the generation of Ig class switched antibody secreting plasma cells that are essential for 
the development of protective immunity after vaccination and for secreting antibodies that will 
neutralise pathogens upon infection (Stavnezer and Schrader, 2014). However, previous reports 
suggest that this process is impaired with age in a B cell intrinsic manner. Upon stimulation 
with the T-dependent signals, anti-CD40 and IL-4 in vitro, B cells from aged mice and elderly 
human donors were found to be less capable of producing class switched antibodies than young 
B cells (Frasca et al., 2004, 2008). Interestingly, in this system, the co-transfer of aged SWHEL 
B cells into young mice did not reveal a defect in CSR upon immunisation. Though there was 
a slight increase in the proportion of antigen-specific IgM + GC B cells derived from aged 
donors, I saw no difference in the number of antigen specific class switched IgG+ GC B cells 
between recipients that received B cells from young or aged mice. This observation was also 
reflected in the serum where there was no difference in antigen-specific IgG1 antibody titres 
between mice that received young or aged B cells, though IgG1 antibody production is likely 
to also be influenced by endogenous antibody-secreting cells from the recipient mice. Together, 
these results indicate that the ability of B cells from aged mice to undergo activation and CSR 
to IgG is intact. 
It is possible that the differences between our findings and those which have been 
previously reported, arise from the differences between using in vitro and in vivo systems. An 
in vitro B cell culture provided with only T cell-dependent signals would not account for 
microenvironmental cues present in vivo such as FDC derived IL-6 which has been shown to 
promote CSR and SHM (Wu et al., 2009). It would therefore be interesting to see if in vitro 
cultures with B cells from aged mice would yield the same results upon stimulation with T cell-
dependent signals as well as IL-6 stimulation. However, the CSR defect in aged B cells has 
previously been attributed to a decreased expression of activation-induced cytidine deaminase 
(AID), the enzyme critical for SHM and CSR, and its positive transcriptional regulator E47 in 
B cells from older mice and humans (Frasca et al., 2004, 2008). In this study we did not assess 
AID or E47 expression in HEL-specific GC B cells derived from aged SWHEL mice in vivo. 
Moreover, a defect in AID expression could also contribute to poor SHM in aged mice, though 
SHM defects have not been observed in humans GCs (Miller and Kelsoe, 1995; Monica 
Banerjee et al., 2002). Thus, further experiments would need to be performed to better 
understand the role of AID in B cell intrinsic ageing, such as measuring AID expression and 
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sequencing of the VH10 Ig gene, which carries the specificity for HEL to assess possible 
changes in the frequency of SHM when young or aged SWHEL B cells are present in a young 
microenvironment. Additionally, we were unable to assess affinity maturation using the 
presented SWHEL system, as SWHEL B cells already have very high affinity for the HEL antigen 
prior to the GC response (Phan et al., 2003). Therefore, to assess affinity maturation, 
immunisation would need to be done using recombinant 3xHEL protein which reduces initial 
BCR antigen affinity in SWHEL B cells. Nevertheless, the data shown here indicates that in a 
young microenvironment, aged GC B cells are equally able to undergo CSR and may have 
similar antibody output compared to cells from young mice.  
The adoptive co-transfer of SWHEL and OT-II cells had the additional advantage of 
indirectly assessing the impact of cognate interactions between aged B cells and young OT-II 
cells on Tfh cell differentiation upon immunisation with HEL-OVA. Cognate T-B cell 
encounters at the T-B order facilitate interactions, which are crucial not only for the initiation 
of the GC response but also for differentiation of activated CD4+ T cells into GC Tfh cells 
(Crotty, 2014). Initial phenotyping of the aged GC response in aged BALB/c and C57BL/6 
mice revealed a delay in the production of antigen-specific Tfh cells and an accumulation of 
total Tfh cells in aged mice, therefore I hypothesised that this may be influenced by aberrant 
cognate T-B cell interactions during early GC events. However, OT-II T cells which were co-
transferred with aged SWHEL B cells were able to undergo Tfh cell differentiation equally to 
those transferred alongside young B cells suggesting that cognate T-B cell interactions such as 
ICOSL-ICOS and SAP-dependent interactions are unlikely to be affected by B cell age. 
However, these adoptive transfers were done into wild type mice capable of generating their 
own endogenous HEL+ GC B cells and thus cognate interactions with these cells can also 
influence Tfh cell differentiation of the transferred OT-II cells. Nevertheless, as I observed no 
obvious differences in Tfh cell differentiation of the transferred OT-II cells the Tfh cell defects 
observed in aged mice could be driven by aberrant DC priming, stromal cells or T cell intrinsic 
defects.  
The use of the adoptive SWHEL transfers facilitates the isolation and examination of the 
B cell intrinsic effects of ageing, yet there are certain limitations to this system. During the 
ageing process the diversity of the B cell repertoire in both mice and humans decreases which 
in turn limits the number of antigens that GC B cell precursors can respond to during immune 
challenge (LeMaoult et al., 1997; Weksler and Szabo, 2000; Gibson et al., 2009). Therefore, 
an adoptive transfer system in which a set number of antigen specific young or aged B cells are 
transferred into young mice that are then challenged with their cognate antigen is unable to 
model changes to the BCR repertoire in aged animals. Additionally, in these experiments, the 
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GC response was only assessed at day 10 after immunisation which could exclude possible B 
cell intrinsic defects in the events occurring early in the response, such as B cell priming and 
cognate T-B cell interactions, as well as in later stages to assess long-lived immunity. 
Assessment of the B cell response soon after immunisation would also be critical when 
characterising the B cell intrinsic effects of AID in ageing, as Vinuesa and colleagues have 
shown that most CSR events and AID expression occurs prior to the establishment of the GC 
indicating that early time points would need to be assessed (data unpublished). However, I was 
limited in the number of aged SWHEL animals and the number HEL-binding B cells that could 
be isolated from these mice. Therefore, I strategically chose to examine the GC response at day 
10 as I had previously established this timepoint as the peak of the response in C57BL/6 mice 
and had observed several significant age-related defects at this stage of the GC that we tested 
in the SWHEL adoptive transfer model and found to not be influenced by B cell intrinsic defects.   
Together, the data presented in this chapter did not reveal any evidence of B cell 
intrinsic defects on the ageing GC response, suggesting that B cells may remain functionally 
intact with age. Therefore, we postulate that the age-associated defects of the GC response are 
likely to be driven by B cell extrinsic factors such as the defects observed in Tfh cells and the 


































In silico modelling of the aged GC response 
5.1 Preamble 
 
The GC response of aged mice is severely diminished upon vaccination, as 
demonstrated in my initial kinetic experiments. This age-associated deterioration was 
characterised by several defects which included fewer GC B cells, reduced antibody output and 
affinity maturation, as well as structural defects such as a diminished FDC network and an 
increased presence of Tfh cells in aged GCs which preferentially localised to the dark zone. 
Interestingly, an assessment of the B cell intrinsic contributions to the aged GC phenotype by 
adoptively transferring B cells from aged mice into young mice, revealed that B cells remain 
functionally intact with age as they are fully able to differentiate and expand into GC B cells 
which undergo isotype class switching and generate a similar antibody output as B cells from 
younger adult mice. These findings suggest that the deterioration of the aged GC is likely driven 
by B cell extrinsic factors. Yet given the highly dynamic and interactive nature of the GC 
response, a vast number of B cell extrinsic mechanisms remained as possible drivers of the aged 
GC phenotype. To discriminate which cellular factor(s) could be causing the deterioration of 
the GC, I used an in silico model of the GC, developed by Dr Michael Meyer-Hermann, to 
simulate the aged phenotype observed in mice.  
In silico modelling, also referred to as mathematical modelling, is a powerful tool that 
has been used to predict novel concepts in immunology. The earliest models of the GC response 
and affinity maturation were based on Ordinary Differential Equations (Shlomchik et al., 1988; 
Kepler and Perelson, 1993; Kesmir and De Boer, 1999; Meyer-Hermann, Deutsch and Or-Guil, 
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2001). In these models the mechanisms of GC B cell proliferation, death and selection are 
incorporated into differential equations to describe the evolution of centroblast and centrocyte 
numbers together with the remaining antigen in the GC over time. At the time, MacLennan and 
colleagues had proposed that GC founder cells pass as a single wave through the centroblast 
and centrocyte stage after which they directly exit the GC centre, known as the one-pass GC 
theory (Kepler and Perelson, 1993). However, the large number of mutations observed in the 
V-region genes of GC B cells alluded to a selection step being present between rounds of 
mutations to prevent the survival of clones carrying detrimental mutations, thus putting the one-
pass theory into question. To clarify this concern, two independent groups used differential 
equation models of the GC to assess whether GC dynamics including proliferation, selection 
and affinity maturation could be reconciled with a model in which a B cell passes through the 
GC only once (Kepler and Perelson, 1993; Oprea, Nimwegen and Perelson, 2000; Meyer-
Hermann, Deutsch and Or-Guil, 2001). This revealed that the observed efficiency of affinity 
maturation could not be explained without including recirculation of centrocytes from the GC 
light zone (LZ) to the dark zone (DZ) to undergo further division.  Thus, the use of these 
mathematical models supported the theory of cell recycling within the GC several years before 
it was formally demonstrated in vivo by Victora and colleagues, who used two-photon 
microscopy to track photoactivated B cells through the GC (Gabriel D. Victora et al., 2010). 
While differential equations can be a suitable tool for the simulation of global GC kinetics, 
these models simulate affinity at the population level, as single cells cannot be distinguished 
and can therefore only provide a limited understanding of affinity maturation in the GC.  
In recent years, agent-based mathematical models have emerged as successful tools for 
the simulation of the GC response at the single cell level. In these models, a single cell 
represents an agent which is updated at each time point of a simulation according to a set of 
physiological rules, also referred to as parameters. Agent-based models can be used to simulate 
the GC in several ways, non-spatial agent-based models do not consider the spatial organisation 
of cells within the GC and simulate the proliferation and survival of cells based on the average 
affinity of other cells within the GC often excluding a Tfh cell component (Wang et al., 2015; 
Amitai et al., 2017; Reshetova et al., 2017).  An alternative agent-based GC model was 
established by Dr Michael Meyer-Hermann to explicitly simulate the position of cells within a 
three-dimensional GC, known as hyphasma (Meyer-Hermann, Maini and Iber, 2006). In this 
model, the physiological rules by which each agent is updated during the course of a simulation 
include cell cycle duration, an individual affinity for each cell, a change in affinity representing 
SHM and differentiation from centroblast into centrocytes, plasma cells or memory cells. Here, 
the probability of survival depends on the affinity of the cell, its ability to bind antigens on 
 145 
FDCs and competition for Tfh cell encounters. This model was used to assess several GC B 
cell selection hypotheses at a time when it was believed that B cell competition for antigen on 
FDCs was the limiting factor for B cell selection (Meyer-Hermann, Maini and Iber, 2006). This 
assessment predicted that it is in fact competition for T cell help that is the most efficient 
mechanism of B cell selection for affinity maturation. In vivo validation of this prediction 
occurred several years later, when Nussenzweig and colleagues found that cell division, SHM 
and DZ recycling is directly proportional to the amount of antigen captured and presented to 
Tfh cells (Gabriel D. Victora et al., 2010; Gitlin, Shulman and Nussenzweig, 2014). Moreover, 
in hyphasma the motility of cells is directly derived from two-photon microscopy data which 
allows modelling of cell movement between the DZ and LZ by the production of chemokines 
from GC stromal cells whereby constant, yet random cell movement is biased by CXCL12 and 
CXCL13 gradients. In this manner, hyphasma has been used to quantify the rate of recycling 
between the LZ and DZ as well as predicting that cells exit the GC via the DZ (Meyer-Hermann 
et al., 2012). Thus, this agent-based model of the GC response has greatly contributed to our 
current understanding of cell movement and affinity-based selection of B cells in the GC.  
Our in vivo data clearly demonstrated defects in GC B cell expansion, antibody output, 
affinity maturation and GC structure in aged mice upon vaccination. However, I have shown 
that the age-associated demise of the GC is unlikely to be influenced by B cell intrinsic 
mechanisms. Given the dynamic nature of the GC, the processes of GC B cell expansion, class 
switch recombination and affinity maturation are heavily influenced by interactions with 
several key GC cell types such as Tfh cells and GC stroma. Indeed, I observed aberrant age-
related changes in both of these compartments, as Tfh cells appeared to be over-represented in 
the GCs of aged mice while the FDC networks were significantly diminished. Therefore, I next 
aimed to assess the impact that the age-related changes in these cellular factors have on global 
GC kinetics and affinity maturation. To perform this task, I used the agent-based model known 
as hyphasma in which the physiological rules of the model can be manipulated to identify which 
physiological change best simulates the aged GC response. In this chapter, I describe the results 
from simulating the aged GC in silico, using data from in vivo experiments alongside the three-
dimensional agent-based model hyphasma to generate new theories on which cellular factor(s) 








To better understand which cellular factor(s) could be causing the deterioration of the 
GC in aged mice, I used the Hyphasma GC model to replicate the aged GC phenotype in silico. 
For this purpose, the following hypotheses were generated from current knowledge of GC 
dynamics and the in vivo data describing the GC in aged mice: 
i. Tfh cell accumulation within the aged GC reduces affinity-based competition 
between centrocytes for Tfh-derived survival signals resulting in the loss of 
affinity maturation 
ii. The diminished FDC network in aged GCs leads to fewer interactions of 
centrocytes with antigen-presenting FDCs compromising GC B cell expansion 
and affinity maturation 
iii. Aberrant Tfh cell localisation within the GC dark zone impedes T cell help and 
selection of centrocytes leading to reduced GC B cell expansion and affinity 
maturation 
This chapter describes the results of the in silico simulations performed with hyphasma 
to test the above hypotheses and to generate new theories on the main cellular contributors to 













5.3 In silico assessment of T cell and FDC intrinsic defects within 
the aged GC 
5.3.1 Increasing the number of T cells in the GC in silico increases GC size 
yet is detrimental to affinity of the GC output 
 
 Quantification of the Tfh cell population in the GCs of aged mice by flow cytometry 
and confocal microscopy revealed that there is an accumulation of these cells in the GC with 
age. Regulation of Tfh cell numbers in the GC is essential due to their critical role in mediating 
the survival of high affinity B cell clones upon infection or vaccination (Vinuesa et al., 2016). 
This is evident in several disease models where aberrant increases in Tfh cell numbers lead to 
poor quality antibody responses and autoimmunity (Vinuesa et al., 2016). To understand the 
effect that the observed increase in Tfh cell numbers has on the aged GC response, we 
performed in silico simulations using two versions of the agent-based hyphasma model, LEDA 
and Bcinflow (Meyer-Hermann et al., 2012; Tas et al., 2016). In the LEDA model, a GC is 
initiated with 3 founder B cell clones that divide 12 times during the GC expansion phase 
whereas in Bcinflow, B cells flux into the GC at a rate of 2 cells per hour over 3 days during 
which they undergo division (described in Chapter 2, Section 2.2.8). In both versions of 
hyphasma, T cells are kept at a constant number of 250 cells throughout the duration of the GC 
response. This physiological parameter was perturbed by increasing the number of T cells to 
800 and 1200 to assess whether this increase would mimic the outcomes of the aged GC 
response (Figure 5.1 A). Using this approach, I examined the impact of increasing T cells 
numbers on the number of total GC B cells generated, the number of output cells, the mean 
affinity within the GC and affinity of output cells which were calculated for each simulation. 
Due to the stochastic nature of hyphasma, each simulation was repeated 25 times and statistical 
analysis was performed at the peak, day 7, and the end point, day 21, of the in silico GC 
response. 
   Increasing the T cell number within the GC in both in silico models resulted in an 
increased expansion of total GC B cells (Figure 5.1 B). The total number of GC B cells was 
significantly increased at day 7 after GC formation in silico (Figure 5.1 C). This increase was 
reflected in the total number of output cells generated, which were significantly increased at 
day 21 after GC formation (Figure 5.1 D-E). On the other hand, increasing the number of T 
cells in the GC caused a significant decrease in the mean affinity of GC B cells in simulations 
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performed with the LEDA model, with only a slight decrease observed using the Bcinflow 
model (p=0.0698, p=0.0879) (Figure 5.1 F-G). This difference in GC B cell affinity between 
both models indicated that there is stringent regulation of affinity within the Bcinflow model 
whereas affinity of GC B cells in the LEDA model appears to be more sensitive to changes in 
its physiological parameters. Thus, all subsequent simulations were performed using both 
versions of hyphasma to ensure the detection of affinity maturation defects upon perturbation 
of the models. Nevertheless, the affinity of the GC output cells was significantly decreased in 
both hyphasma models (Figure 5.1 H-I), indicating that an increased presence of T cells in the 
GC disturbs the affinity maturation process. Together these results imply that an increase in GC 
Tfh cell numbers alone does not fully recapitulate the aged GC phenotype in silico, though it 
may contribute to the observed defects in affinity maturation with age. Therefore, the 
deterioration of the aged GC is not solely driven by an increase presence of Tfh cells but may 














Figure 5.1 Increasing T cell numbers in the Bcinflow and LEDA GC models leads 
to larger GC responses and loss of affinity maturation  
 
A. Legend table outlining the parameter changes for each simulation B. Total number of B cells 
generated throughout the GC reaction and C. at day 7 after GC formation simulated with the 
Bcinflow model (left) and LEDA model (right) D. Total number of produced output cells 
throughout the GC reaction and E. at day 21 after GC formation F. Mean affinity of GC B cells 
during the GC reaction and G.  at day 7 after GC formation H. Mean affinity of output cells 
during the GC reaction and I. at day 21 after GC formation. The full lines in the kinetic plots 
represent the mean of 25 simulations and shaded areas represent the standard deviation. For 
graphs, bar height represents the mean and error bars represent standard deviation. The p-values 
indicated on graphs were generated by performing a Kruskal-Wallis test with Dunn’s multiple 
































5.3.2 Diminished antigen presentation by FDCs in silico reduces the size of 
the GC and the affinity of the output cells 
  
FDCs are resident stromal cells of secondary lymphoid organs which play a critical role 
in shaping and regulating the GC microenvironment (Stebegg et al., 2018). During GC 
responses, the FDC network expands and forms the GC LZ where centrocytes can test the 
binding abilities of their newly mutated receptors on the antigen complexes presented on FDCs 
(Kranich and Krautler, 2016). Quantification of the FDC network by confocal microscopy 
revealed a significant reduction of the FDC area in the GCs of aged mice (Chapter 3). This 
observation led me to postulate that a reduction in the FDC network could lead to reduced 
amounts of antigen being presented to centrocytes in the GCs of aged mice, which could have 
detrimental effects on GC B cell expansion and selection. The LEDA model had previously 
shown that a decrease in antigen presentation to centrocytes results in poor affinity maturation 
of GC output cells which is a feature we observed in the aged GC response in vivo (Meyer-
Hermann, Maini and Iber, 2006). To investigate whether a reduction in antigen presentation 
could recapitulate other aspects of the aged GC phenotype we performed in silico simulations 
using the Bcinflow and LEDA models for which the unit of antigen being presented on FDCs 
is set to 3000 during the in silico GC response. This parameter was decreased to 1000 and 750 
units of antigen presentation, as previously done in M. E. Meyer-Hermann et al., 2006, and the 
effect on GC B cell expansion, output and affinity was assessed (Figure 5.2 A).  
Reducing the amount of antigen presented on FDCs during the in silico GC reaction 
resulted in a reduced expansion of total GC B cells (Figure 5.2 B), which was statistically 
significant at the peak of the response, day 7 (Figure 5.2 C). Similarly, the total number of 
output cells were significantly diminished upon completion of the GC reaction, at day 21 
(Figure 5.2 D-E). Interestingly, the reduction in antigen presentation did not appear to affect 
the affinity of GC B cells within the GC reaction, at the peak of the response, in both hyphasma 
models (Figure 5.2 F-G). Yet the affinity of the output cells in these simulations was 
significantly reduced compared to simulations with intact amounts of antigen (Figure 5.2 H-I), 
indicating that affinity maturation could be impaired by reduced antigen presentation to 
centrocytes. These results show that impaired function of FDCs recapitulate the defects in GC 
B cell expansion, GC output and affinity maturation of GC output cells observed in the GC 
response of aged mice. Therefore, in spite of negligible differences in affinity of GC B cells 
with decreased antigen presentation, these simulations indicate that aberrant FDC function 







Figure 5.2 Reducing the amount of antigen presentation by FDCs in the Bcinflow 
and LEDA GC models results in reduced GC magnitude and impaired affinity of 
output cells 
 
A. Legend table outlining the parameter changes for each simulation B. Total number of B cells 
generated throughout the GC reaction and C. at day 7 after GC formation simulated with the 
Bcinflow model (left) and LEDA model (right) D. Total number of produced output cells 
throughout the GC reaction and E. at day 21 after GC formation F. Mean affinity of GC B cells 
during the GC reaction and G.  at day 7 after GC formation H. Mean affinity of output cells 
during the GC reaction and I. at day 21 after GC formation. The full lines in the kinetic plots 
represent the mean of 25 simulations and shaded areas represent the standard deviation. For 
graphs, bar height represents the mean and error bars represent standard deviation. The p-values 
indicated on graphs were generated by performing a Kruskal-Wallis test with Dunn’s multiple 























5.3.3 Reducing the FDC network in silico lowers the magnitude and affinity 
of the GC response  
 
 Whilst decreasing the amount of antigen presented to centrocytes in silico resulted in 
GC outcomes reminiscent of the aged GC phenotype, I had not formally assessed defects in the 
amounts of antigen presented on FDCs in vivo in aged mice. Therefore, I next aimed to 
investigate the influence of reducing the FDC network area in silico, as observed in the aged 
GC in vivo, without altering antigen presentation. To do this, both Bcinflow and LEDA models 
were perturbed by reducing the percentage area of FDCs that occupies the total area of the GC 
from 50 to 30 percent, as I observed a similar reduction in vivo (Figure 5.3 A). Additionally, to 
preserve the FDC network density, the number of FDCs was also reduced from 200 to 100 cells 
in both hyphasma models and the effects on GC B cell expansion, output and affinity were 
quantified. To ensure these changes were representative of the structural FDC defects observed 
in vivo, the positioning of the FDC network in the three-dimensional space of the GC in silico 
was assessed for each simulation. This revealed that reducing the percentage of the FDC area 
and the cell number resulted in a reduced number of FDCs positioned along the LZ z-axis 
compared to the unperturbed FDC network, indicating that these changes did indeed shrink the 
size of the LZ FDCs as observed in vivo in aged mice (Figure 5.3 B).  
 The reduction in FDC network size within the GC in silico, resulted in a significant 
reduction of total GC B cells in both hyphasma models at day 7 (Figure 5.3 C-D). Likewise, 
the number of total output cells at the end of the GC response at day 21 was significantly 
diminished when simulating a reduced FDC network compared to intact FDCs (Figure 5.3 E-
F). The affinity of GC B cells during the GC response at day 7 was also significantly diminished 
in both hyphasma models upon reduction of the FDC network (Figure 5.3 G-H). The affinity 
of GC output cells at day 21 was also slightly yet significantly reduced compared to simulations 
performed with unperturbed FDCs in both models (Figure 5.3 I-J), suggesting that affinity 
maturation is impaired under these conditions. Together these results show that reducing the 
FDC network in silico can recapitulate the defects in GC expansion, output and affinity 
maturation observed in the aged GC response irrespective of a change in antigen presentation. 
This indicates that structural changes in the FDC network within the GCs could be responsible 










Figure 5.3 Reducing the size of the FDC network in the Bcinflow and LEDA GC 
models reduces GC B cell expansion, output and affinity 
 
A. Legend table outlining the parameter changes for each simulation B. Spatial representation 
of FDC number and positioning along the Z-axis C. Total number of B cells generated 
throughout the GC reaction and D. at day 7 after GC formation simulated with the Bcinflow 
model (left) and LEDA model (right) E. Total number of produced output cells throughout the 
GC reaction and F. at day 21 after GC G. Mean affinity of GC B cells during the GC reaction 
and H.  at day 7 after GC formation I. Mean affinity of output cells during the GC reaction and 
J. at day 21 after GC formation. The full lines in the kinetic plots represent the mean of 25 
simulations and shaded areas represent the standard deviation. For graphs, bar height represents 
the mean and error bars represent standard deviation. The p-values indicated on graphs were 
generated by performing a Kruskal-Wallis test with Dunn’s multiple comparison correction, 































5.3.4 Increasing T cell polarity towards the dark zone in silico reduces the 
magnitude of the GC response 
 
 In addition to a reduction in the FDC network in the aged GC, quantification of GC DZ 
and LZ areas by confocal microscopy revealed there was a significant enrichment of Tfh cells 
in the DZ of GCs from aged mice. From this observation, I postulated that aberrant Tfh 
localisation could interfere with the affinity-based selection process that occurs in the LZ, 
during which Tfh cells provide key survival signals to centrocytes with high affinity for antigen, 
thereby resulting in impaired GC B cell expansion and affinity maturation. To test this 
hypothesis in silico, the movement of T cells was biased towards the DZ in simulations 
performed with the Bcinflow and LEDA GC models.  In both hyphasma models, T cell 
movement is determined by a random walk which is biased towards the LZ by a chemotaxis 
weight of 0.1 (described in Meyer-Hermann 2012). To eliminate the tendency of T cell 
movement towards the LZ, the value of the chemotaxis weight was altered to zero for which 
the direction of T cell movement would be determined purely by a random walk. Furthermore, 
T cell movement was biased away from the LZ towards the DZ by reducing the chemotaxis 
weight to negative 0.1 and negative 0.5 (Figure 5.4 A). To ensure these changes altered Tfh cell 
localisation in silico, the position of T cells along the LZ and DZ z-axis was compared to T 
cells with unaltered tendency towards the LZ. This showed that even when the LZ tendency of 
T cells was eliminated by changing the chemotaxis weight to zero, T cells still localised within 
the LZ (Figure 5.4 B), indicating that negative chemotaxis weight values are more likely to 
represent the mislocalisation observed in vivo. Thus, this change had no effect on GC B cell 
expansion, output and affinity on the GC response in silico (Figure 5.4 C-J). It was only by 
directly biasing T cell movement away from the LZ with a negative chemotaxis weight that we 
observed increased T cell localisation towards the DZ and found that changing the weight value 
to negative 0.5 completely polarised T cells to the DZ (Figure 5.4 B). 
 Increased T cell movement towards the DZ in silico resulted in a significantly reduced 
expansion of total GC B cells, at day 7 after GC formation, which was exacerbated the further 
the T cells localised to the DZ (Figure 5.4 C-D). Similarly, the total number of produced output 
cells at day 21 was significantly decreased when T cells were polarised towards the DZ (Figure 
5.4 E-F). However, polarising the T cells towards the DZ had no effect on the affinity of GC B 
cells during the GC reaction in silico (Figure 5.4 G-H), as well as the affinity of produced output 
cells (Figure 5.4 I-J). In fact, complete polarisation to the DZ appeared to increase the affinity 
of output cells at day 21 (Figure 5.4 J), possibly due an increase in selection pressure due to a 
limiting number of T cells in the LZ of the in silico response. These results indicate that the 
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effects of aberrant Tfh cell localisation alone does not replicate the aged GC phenotype but 






Figure 5.4 Aberrant T cell localisation towards the GC dark zone in the Bcinflow 
and LEDA GC models leads to diminished GC B cell expansion and number of 
output cells 
 
A. Legend table outlining the parameter changes for each simulation B. Spatial representation 
of T cell positioning along the Z-axis indicating LZ or DZ localisation C. Total number of B 
cells generated throughout the GC reaction and D. at day 7 after GC formation simulated with 
the Bcinflow model (left) and LEDA model (right) E. Total number of produced output cells 
throughout the GC reaction and F. at day 21 after GC formation G. Mean affinity of GC B cells 
during the GC reaction and H.  at day 7 after GC formation I. Mean affinity of output cells 
during the GC reaction and J. at day 21 after GC formation. The full lines in the kinetic plots 
represent the mean of 25 simulations and shaded areas represent the standard deviation. For 
graphs, bar height represents the mean and error bars represent standard deviation. The p-values 
indicated on graphs were generated by performing a Kruskal-Wallis test with Dunn’s multiple 


















5.4 In silico simulations reveal a combination of multiple 
parameters are likely to contribute to the ageing GC phenotype 
5.4.1 Increased T cell numbers and reduced FDC network in silico decrease 
GC size and affinity but do not decrease the GC output 
 
 The simulations performed to investigate the influence of the aberrant changes in Tfh 
cells and FDCs observed in the aged GC response revealed that these individual alterations to 
the GC in silico could recapitulate several aspects of the aged GC phenotype. However, in an 
in vivo setting, the changes in these physiological parameters could be influencing the aged GC 
outcomes simultaneously. Thus, to examine if these physiological changes could together be 
contributing to the aged GC phenotype, in silico simulations were performed with the Bcinflow 
and LEDA models by combining the previously altered parameters into one simulation. Firstly, 
I simulated an increasing number of T cells, 800 and 1200 cells, together with a decrease in the 
FDC network size, as shown in Figure 5.5 A, and assessed the impact on GC B cell expansion, 
output and affinity.  
 Altering both T cell number and FDC network size resulted in distinct outcomes of GC 
B cell expansion and number of output cells produced between the two hyphasma models. 
Simulations performed with the Bcinflow model indicated that the total number of GC B cells 
was significantly reduced at day 7 when altering T cell and FDC numbers (Figure 5.5 B-C). 
However, in the LEDA model, increasing the number of T cells appeared to have a stronger 
influence on the total number of GC B cells which were significantly increased irrespective of 
the reduction in the FDC network (Figure 5.5 B-C). Furthermore, the total number of produced 
cells at day 21 increased when a higher number of T cells were present in the system (Figure 
5.5 D-E). Nevertheless, affinity within the GC at day 7 was significantly decreased in 
simulations containing 1200 T cells in both hyphasma models (Figure 5.5 F-G). This was also 
reflected in the affinity of the output cells which was significantly decreased at day 21 (Figure 
5.5 H-I). These results indicate that simulating an increased number of T cells together with a 
reduced FDC network does not fully recapitulate the aged GC phenotype. While simulating 
both of these effects together appears to decrease affinity maturation as observed in the aged 
GC in vivo, the tendency of high T cell numbers to increase the magnitude of the GC response 
appears to counteract the effects that reducing the FDC network alone had on the total number 
of GC B cells and output cells. Therefore, it is unlikely that both of these physiological changes 
 162 
work together to fully influence the aged GC phenotype due to the increased number of 






Figure 5.5 The combined effects of increased T cell numbers and reductions in FDC 
network size on the Bcinflow and LEDA GC models 
 
A. Legend table outlining the parameter changes for each simulation B. Total number of B cells 
generated throughout the GC reaction and C. at day 7 after GC formation simulated with the 
Bcinflow model (left) and LEDA model (right) D. Total number of produced output cells 
throughout the GC reaction and E. at day 21 after GC formation F. Mean affinity of GC B cells 
during the GC reaction and G.  at day 7 after GC formation H. Mean affinity of output cells 
during the GC reaction and I. at day 21 after GC formation. The full lines in the kinetic plots 
represent the mean of 25 simulations and shaded areas represent the standard deviation. For 
graphs, bar height represents the mean and error bars represent standard deviation. The p-values 
indicated on graphs were generated by performing a Kruskal-Wallis test with Dunn’s multiple 
























5.4.2 Increased T cell numbers together with reduced light zone localisation 
do not mimic the aged GC in silico 
  
In silico modelling of the GC revealed that an increase in the number of Tfh cells alone 
had detrimental effects on affinity maturation whilst increasing Tfh cell localisation towards 
the dark zone, as observed in the aged GC in vivo, resulted in a lower magnitude of GC B cell 
expansion and output. Given both these GC outcomes are characteristic of the aged GC 
phenotype, I postulated that a combination of both an increase in Tfh cell number and aberrant 
DZ localisation in silico may be able to fully recapitulate the aged GC response irrespective of 
a change to the FDC network. To examine this possibility, simulations were performed using 
both hyphasma models in which the number of T cells was increased to 1200 cells and their 
movement towards the DZ was biased as shown in Figure 5.6 A.  
The change in both of these Tfh cell parameters in silico resulted in an increase number 
of total GC B cells at day 7 which was only reduced when Tfh cells were fully polarised to the 
DZ (Figure 5.6 B-C). Likewise, the total number of produced output cells were significantly 
increased at day 21 with a significant reduction observed only upon complete polarisation of T 
cells to the DZ (Figure 5.6 D-E). However, even when the increased number of T cells were 
completely polarised to the DZ they had no effect on the affinity of GC B cells and on the 
affinity of output cells, whilst T cells with no bias for direction of movement and a chemotaxis 
value of negative 0.1 displayed marginal effects on affinity maturation which were significant 
only in simulations performed with the LEDA model (Figure 5.6 F-I). Together these results 
did not replicate the aged GC phenotype, as the effect on B cell expansion, output and affinity 
maturation did not correspond to the effects observed in vivo in aged mice. This suggests that 
both these changes to the Tfh cell compartment alone are not able to fully account for the GC 
















Figure 5.6 The combined effects of increased T cell number with GC dark zone 
localisation on the Bcinflow and LEDA GC models 
 
A. Legend table outlining the parameter changes for each simulation B. Total number of B cells 
generated throughout the GC reaction and C. at day 7 after GC formation simulated with the 
Bcinflow model (left) and LEDA model (right) D. Total number of produced output cells 
throughout the GC reaction and E. at day 21 after GC formation F. Mean affinity of GC B cells 
during the GC reaction and G.  at day 7 after GC formation H. Mean affinity of output cells 
during the GC reaction and I. at day 21 after GC formation. The full lines in the kinetic plots 
represent the mean of 25 simulations and shaded areas represent the standard deviation. For 
graphs, bar height represents the mean and error bars represent standard deviation. The p-values 
indicated on graphs were generated by performing a Kruskal-Wallis test with Dunn’s multiple 































5.4.3 Increased dark zone localisation of T cells and a decreased FDC 
network in the GC in silico lead to smaller GCs and impaired affinity  
 
Simulation of the Tfh cell defects we observed in the aged GC in vivo did not 
recapitulate the aged phenotype in silico, suggesting that the defects observed in the FDC 
compartment are required to replicate the aged GC in silico. Therefore, I next aimed to 
investigate whether a decrease in the FDC network together with an aberrant Tfh cell 
localisation could account for the deterioration of the aged GC response. To do this, the FDC 
network size along with T cell polarisation was altered in the Bcinflow and LEDA models as 
stated in Figure 5.7 A.  
The changes in both of these physiological parameters in silico resulted in a significant 
reduction of total GC B cells at day 7 after GC formation (Figure 5.7 B-C). Interestingly, 
simulations performed where T cells had a chemotaxis weight of zero also displayed diminished 
GC B cell expansion which had not been affected when simulating this parameter on its own, 
indicating that a reduction in FDC network size is a strong driver of reduced GC B cell 
expansion. This was reflected in the number of total output cells produced which were 
significantly decreased at day 21 in both hyphasma models (Figure 5.7 D-E). On the other hand, 
the affinity of GC B cells and output cells was only reduced in simulations performed with the 
LEDA model, in which we had previously observed that affinity of B cells was more sensitive 
to physiological changes compared to the Bcinflow model (Figure 5.7 F-I). Though simulations 
where T cells were completely polarised to the DZ in the Bcinflow model also displayed a 
defect in affinity of GC B cells (Figure 5.7 G). These results suggest that a reduction in the 
FDC network together with aberrant Tfh cell localisation, replicate the decreased magnitude of 
the GC response observed in aged mice and likely impact affinity maturation of the GC. 
Therefore, changes in both these cellular factor(s) could together be contributing to the 














Figure 5.7 The combined effects of reductions in FDC network size and GC dark 
zone localisation of T cells on the Bcinflow and LEDA GC models 
 
A. Legend table outlining the parameter changes for each simulation B. Total number of B cells 
generated throughout the GC reaction and C. at day 7 after GC formation simulated with the 
Bcinflow model (left) and LEDA model (right) D. Total number of produced output cells 
throughout the GC reaction and E. at day 21 after GC formation F. Mean affinity of GC B cells 
during the GC reaction and G.  at day 7 after GC formation H. Mean affinity of output cells 
during the GC reaction and I. at day 21 after GC formation. The full lines in the kinetic plots 
represent the mean of 25 simulations and shaded areas represent the standard deviation. For 
graphs, bar height represents the mean and error bars represent standard deviation. The p-values 
indicated on graphs were generated by performing a Kruskal-Wallis test with Dunn’s multiple 































5.4.4 Increasing T cell numbers, dark zone localisation and reducing FDC 
network together in silico results in diminished GCs and impaired affinity 
  
 Simulating the combined effect of reducing the FDC network size and increasing Tfh 
localisation to the DZ in the GC in silico clearly demonstrated defects in the total number of 
GC B cells and output cells reminiscent of the aged GC response in mice, yet the defects in 
affinity maturation were subtle. To test whether a more pronounced defect in affinity could be 
induced in silico, I next examined whether adding a defect in increased number of T cells to 
simulations with aberrant Tfh localisation and reduced FDC network size would reduce affinity 
maturation to more clearly replicate the aged GC phenotype. For this the number of T cells 
where increased to 1200 cells and the Tfh localisation together with FDC network size were 
altered as outlined in Figure 5.8 A.  
 The changes in all three physiological parameters resulted in clear reductions in the total 
number of GC B cells (Figure 5.8 B-C). Similarly, there was a significant reduction in total 
number of output cells produced from these simulations compared to an unaltered GC (Figure 
5.8 D-E). This reduction indicated that the tendency for an increased number of T cells to 
increase the magnitude of the GC response was counteracted by the defects in FDC network 
size and Tfh localisation. The mean affinity of GC B cells appeared to only be significantly 
reduced in the Bcinflow model when Tfh cells were completely polarised to the DZ (Figure 5.8 
F-G). However in the LEDA model, affinity of GC B cells in simulations, where Tfh cells had 
a value of chemotaxis weight set to negative 0.1, was significantly reduced (Figure 5.8 F-G). 
Though this defect in affinity was not significant when simulating complete Tfh cell 
polarisation towards the DZ (p=0.0983) (Figure 5.8 G). Moreover, the affinity of the produced 
output cells from these simulations was significantly diminished in simulations performed with 
the LEDA model (Figure 5.8 H-I). Therefore, the simulations performed with the LEDA model 
indicate that in addition to the defects in the FDC network and aberrant Tfh cell localisation, 
increasing the number of Tfh cells present in the GC results in a significant defect in affinity 
maturation of the GC response in silico. Together, this data indicate that the diminished GC 
response observed in aged mice can be influenced in a multifactorial manner by aberrant 









Figure 5.8 The combined effects of reductions in FDC network size and increased 
T cell number with GC dark zone localisation on the Bcinflow and LEDA GC 
models 
 
A. Legend table outlining the parameter changes for each simulation B. Total number of B cells 
generated throughout the GC reaction and C. at day 7 after GC formation simulated with the 
Bcinflow model (left) and LEDA model (right) D. Total number of produced output cells 
throughout the GC reaction and E. at day 21 after GC formation F. Mean affinity of GC B cells 
during the GC reaction and G.  at day 7 after GC formation H. Mean affinity of output cells 
during the GC reaction and I. at day 21 after GC formation. The full lines in the kinetic plots 
represent the mean of 25 simulations and shaded areas represent the standard deviation. For 
graphs, bar height represents the mean and error bars represent standard deviation. The p-values 
indicated on graphs were generated by performing a Kruskal-Wallis test with Dunn’s multiple 

































 In silico modelling is a powerful tool which has been used to generate novel theories 
that have greatly contributed to our current understanding of GC biology. Several mathematical 
models of the GC response have also been used in the context of vaccination, to compare and 
predict the outcomes of different vaccination strategies (Meyer-Hermann, 2018; Robert, 
Marschall and Meyer-Hermann, 2018). However, vaccination efficacy is heavily influenced by 
the immune state prior to vaccination which in the context of ageing results in poor antibody 
responses and thus elderly individuals fail to generate protective immunity upon vaccination 
(Linterman, 2014). Our phenotypic assessment of the aged GC response in vivo clearly 
demonstrated that GC magnitude, affinity maturation and structure are impaired in aged mice 
upon vaccination. Furthermore, I demonstrated that these age-associated defects in the GC 
response are unlikely to be driven by B cell-intrinsic mechanisms. Thus, to discern which B 
cell-extrinsic cellular factor is responsible for the demise of the GC response with age, in silico 
modelling of the GC was performed. From my in vivo data, I hypothesised that the defects in 
the aged GC were likely to be driven by either a defect arising from the increased presence of 
Tfh cells, aberrant localisation of Tfh cells to the DZ or the reduced size in the FDC network in 
GCs of aged mice. The data presented in this chapter describes the simulations performed by 
perturbing the physiological parameters of the hyphasma GC model in order to recapitulate the 
aged GC phenotype in silico. The results indicated that the demise of the GC response with age 
is unlikely to be driven by a single cellular factor but is rather a multifactorial process which is 
strongly influenced by structural defects in the size of the FDC network and aberrant 
localisation of Tfh cells.  
 Simulating an increased number of T cells in the GC, as observed in aged mice, resulted 
in a larger GC response at the expense of affinity maturation in silico. Several groups have 
reported that tight regulation of Tfh cell numbers in the GC is required for optimal affinity 
maturation and the prevention of autoimmunity (Vinuesa et al., 2016). In Sanroque (RoquinSan) 
mice, an increased presence of Tfh cells leads to spontaneous formation of GCs and 
autoimmunity through the breakdown of positive GC B cell selection (Vinuesa et al., 2005; 
Linterman et al., 2009). Moreover, in lupus-prone BXD2 mice the proportion of GC Tfh cells 
is positively correlated with the proportion of GC B cells and autoantibodies being produced 
(Kim et al., 2015). Whilst the hyphasma model cannot be used to indicate whether 
autoimmunity is present in silico, simulating increasing number of T cells clearly showed there 
is a positive correlation between the number of Tfh cells and GC B cells as seen in in vivo 
models of disease. This is likely due to the hyphasma model assuming that every T cell present 
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in the system is antigen specific and capable of providing survival signals to centrocytes, which 
will have an increased chance of encountering T cell help for survival when T cell numbers are 
increased in silico. However, the ageing GC phenotype is unique in that an increased presence 
of Tfh cells within the GCs of aged mice does not lead to larger GC responses but instead these 
GCs are smaller, and their output is diminished. To explain this phenotype, Sage and colleagues 
assessed the changes in Tfh cell function with age and found that Tfh cells from aged C57BL/6 
mice had a diminished capacity to promote B cell help in an antigen-specific context (Sage et 
al., 2015). Thus, by simply simulating an increase in Tfh cell numbers we assume that their 
helper function remains intact with age which may not be representative of the true nature of 
aged Tfh cells in vivo. In addition, our assessment of antigen-specific Tfh cells in aged C57BL/6 
mice revealed that these cells were not enriched in aged GCs thus implying there is an 
enrichment of bystander non-antigen specific Tfh cells with age that may have deleterious 
effects which the hyphasma model cannot account for. Nevertheless, the in silico simulations 
demonstrated that an enrichment of T cells leads to diminished affinity maturation of the GC 
output reflecting a break down in the competitive process by which B cells are positively 
selected in the GC, which could account for the loss of affinity maturation observed in aged 
mice. These simulations therefore indicated that whilst an increase in T cells could influence 
the loss of affinity maturation with age, this defect cannot fully account for the GC phenotype 
observed in aged mice implying that an additional mechanism is needed to drive the loss of GC 
magnitude with age. 
 The FDC network is significantly decreased in the GCs of aged mice. In silico 
simulations of this defect clearly showed that a reduction in FDC network size results in 
diminished GC expansion and output as well as impairing affinity maturation. In vivo, 
disruption of the FDC network in the context of viral infections has been demonstrated to cause 
diminished GC B cell responses and antibody output either by direct infection of the FDC 
network or by CD8 T cell mediated destruction of the LN architecture (Odermatt et al., 1991; 
Melzi et al., 2016). It is therefore plausible that a disruption to the FDC network could mediate 
a loss of GC B cell expansion and decreased antibody output in the context of ageing as 
predicted by in silico simulations with hyphasma, albeit through distinct underlying 
mechanisms. A possible mechanism by which the reduction of the FDC network could mediate 
diminished GC B responses in ageing is through a decrease in antigen availability within the 
GC. Whilst we did not quantify antigen presentation in vivo in aged mice, simulations of 
reduced amounts of antigen presentation in the GC in silico revealed that this defect does indeed 
mirror several aspects of the aged GC phenotype as has been demonstrated in vivo by Szakal 
and colleagues (Aydar et al., 2003). However, CR1/2-/- mice that have impaired antigen 
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presentation during GC responses do not appear to have defects in affinity maturation, although 
the size of the GC response and antibody levels are significantly reduced(Ahearn et al., 1996; 
Chen et al., 2000). This implies that reduced amounts of antigen presentation, while accounting 
for a loss of GC magnitude, may not account for the loss of affinity maturation in aged mice. 
Alternatively, FDCs are also critical in maintaining the highly specialised structure of the GC 
through the secretion of CXCL13 (Cyster et al., 2000). The CXCL13 gradient generated by the 
FDCs in the LZ creates a spatially segregated compartment that facilitates B cell-T cell 
encounters crucial for the process of positive selection (Stebegg et al., 2018). Structural defects 
leading to a reduction in the size of the LZ compartment could therefore impede B cell-T cell 
encounters reducing the efficiency of positive selection of high affinity B cell clones.  
 The structural changes observed in the LZ compartment of the aged GC did not appear 
to affect the proportion of centroblasts and centrocytes within the GC however, Tfh cell 
localisation was disrupted. Confocal microscopy revealed an increased presence of Tfh cells in 
the GC DZ of aged mice. In silico simulations of this defect demonstrated that biasing T cell 
localisation towards the DZ results in diminished GC B cell expansion and output with an 
increase in affinity maturation. This increase in affinity may be due to constant T cell help being 
concentrated in the B-cell rich DZ in the hyphasma model. Tfh cells are conventionally believed 
to localise to the LZ through their high expression of the CXCL13 chemokine receptor, CXCR5 
(Stebegg et al., 2018). In this compartment, interactions in which centrocytes present antigen 
to Tfh cells are necessary for high affinity clones to receive Tfh-derived survival signals such 
as IL-21 that will allow them to recirculate to the DZ and undergo further rounds of proliferation 
and mutation (Zotos et al., 2010; Gitlin, Shulman and Nussenzweig, 2014). An aberrant 
localisation of Tfh cells towards the DZ, is therefore likely to disrupt the essential processes 
that occur in the LZ and in silico modelling predicts this has detrimental consequences on GC 
B cell expansion and output. Along with CXCR5, Tfh cells express CXCR4, a chemokine 
receptor important for the DZ localisation of centroblasts, and a small proportion of Tfh cells 
have been found to localise to the DZ (Allen et al., 2004; Crotty, 2011). Yet, little is known 
about the role and function of these DZ Tfh cells. Nevertheless, the simulations indicate that 
Tfh cell localisation within the GC can strongly influence GC outcomes and could account for 
the loss of GC magnitude in aged mice. 
 Individual simulations of the age-associated defects observed in vivo were not able to 
replicate the aged GC phenotype in silico with the exception of the reduction in FDC size. 
Given the dynamic nature of the GC, the changes in the physiological parameters tested could 
be influencing the outcomes of the aged GC response in vivo simultaneously. Therefore, to 
investigate the possibility of synergistic effects of these parameters on the aged GC, simulations 
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were performed by combining the alterations to each parameter into a single simulation. 
Simulations combining an increase in T cell number with either localisation or FDC defects 
revealed that T cell numbers in the GC have a strong capacity to determine GC size regardless 
of the detrimental effects that aberrant Tfh localisation and loss FDC have on GC B cell 
expansion when simulated on their own. Moreover, combining the observed defects in Tfh cells 
into one simulation critically highlighted that these defects do not fully mimic the aged GC 
phenotype in silico and emphasised the crucial role that defects in the FDC network have on 
the aged GC response. While simulations of reduced FDC network size combined with aberrant 
Tfh localisation reduce the magnitude of the GC response, the effects on affinity maturation 
were mild. It was only by adding a defect in T cell number that affinity maturation became 
significantly altered in silico to better recapitulate the aged GC phenotype. These simulations 
suggest that a synergistic interaction of defects in both Tfh cells and FDCs is likely to cause 
diminished GCs in aged mice. Adoptive transfer studies performed by Haynes and colleagues 
have demonstrated that both age-related defects in CD4+ T cells and the LN microenvironment 
can contribute to diminished humoral responses, as the transfer of CD4+ T cells from aged mice 
into young mice and the transfer of young CD4+ T cells into aged mice both result in poor GC 
responses (Eaton et al., 2004; Lefebvre et al., 2012). Haynes and colleagues reported that 
expression of CXCL13 is diminished in the splenic B cell follicles of aged mice after 
immunisation, however they did not assess changes in the stroma (Lefebvre et al., 2012). Here 
we show a clear defect in the FDC network in the GCs of aged mice that simulations predicted 
lead to poor GC responses. Together with a possible defect in CXCL13 expression, this 
reduction in the FDC network within aged GCs could reduce chemotaxis of Tfh cells towards 
the LZ leading to aberrant Tfh localisation which, in silico, results in diminished GC responses. 
This data therefore suggests that the deterioration of the GC response in aged mice is a 
multifactorial process that is heavily influenced by changes in GC structure.  
 The use of in silico modelling facilitates the testing of multiple hypotheses without the 
need for multiple testing in vivo, however the theories generated from such modelling will be 
subject to the assumptions and limitations of the model. In hyphasma, the number of T cells 
present in the GC in silico remains constant throughout the simulation. By simulating the 
outcomes of a constant increase in the number of T cells with hyphasma we assume that this 
defect is a causative agent of the defects observed in the aged GC rather than itself being an 
outcome of an alternative mechanism which could be driving the increase of Tfh cells in the 
aged GC. Hence, it would be beneficial to simulate T cell dynamics as an outcome of GC 
reactions in silico for further hypothesis testing. Furthermore, T follicular regulatory (Tfr) cells 
are not simulated in hyphasma, which have been previously reported to be enriched with 
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increased suppressive capacity in the lymph nodes of aged C57BL/6 mice upon immunisation 
(Sage et al., 2015). Therefore, in silico modelling with hyphasma cannot account for possible 
mechanisms by which Tfr cells could be supressing aged GC responses in vivo.  Nevertheless, 
I did not observe any significant increases in the proportion or total number of Tfr cells in aged 
C57BL/6 mice after immunisation and there was no significant difference in the number of Tfr 
cells present within the GCs of aged BALBc mice, as quantified by confocal microscopy. Thus, 
the contribution of Tfr cells to the deterioration of the aged GC is unclear and as the precise 
mechanisms by which these cells control GC responses have not been elucidated in vivo it 
would be difficult to accurately simulate the effects of these cells in silico.  
An unexpected challenge from these in silico simulations was the stringency by which 
affinity maturation was regulated in hyphasma. Due to the observed loss of affinity maturation 
in aged mice, the mean affinity of GC B cells and output cells after each simulation was assessed 
upon perturbation of hyphasma. Initial simulations performed with the Bcinflow model 
revealed that alterations in several physiological parameters of the model were not able to 
significantly impact affinity maturation with the exception of increases in T cell number. It was 
therefore necessary to conduct simulations in parallel with the LEDA model, in which affinity 
appeared to be more sensitive to changes to its physiological parameters, as well as performing 
statistical analysis at set timepoints of each simulation to clearly discern changes in affinity. 
While the differences in affinity between the Bcinflow and LEDA models of hyphasma are 
beyond the scopes of this project, the stringency by which affinity maturation is regulated in 
silico could be evidence of the tight regulation and efficiency of affinity maturation during 
optimal GC responses in vivo which may only be broken down by the influence of multiple 
factors throughout the ageing process.  
Together, the data generated from in silico modelling of the aged GC indicate that the 
demise of the GC with age is a multifactorial process that can be driven by defects in both Tfh 
cells and a reduction of the FDC network. The simulations performed with hyphasma predicted 
that a structural defect in the FDC network of aged GCs are could be a strong driver of the age-
related GC demise, along with an increased number of T cells localising towards the DZ. Given 
the critical role of FDCs in the maintenance of GC structure through secretion of CXCL13 in 
the LZ, an age-associated disruption to the LZ compartment could lead to aberrant Tfh cell 
localisation to the DZ and interfere with essential B cell-T cell interactions resulting in the poor 
GC responses in aged mice as predicted in silico. Yet little is known about the role of Tfh 
localisation in the DZ. The prospect of this aberrant Tfh cell localisation driving a reduction in 
the magnitude of GC responses as seen in the context of ageing is therefore an intriguing and 






The role of CXCR4 in Tfh cell localisation 
6.1 Preamble 
In vivo phenotypic assessment of the GC response in aged mice clearly showed an age-
associated loss of magnitude, quality and altered GC structure upon vaccination. However, by 
adoptively transferring B cells from aged mice into young mice, I demonstrated that these cells 
remain functionally intact with age and thus the age-associated demise of the GC response is 
unlikely to be driven by a B cell intrinsic defect. The GCs of aged mice have a reduction of the 
FDC network area and an increased presence of Tfh cells in the GC dark zone (DZ). In silico 
modelling of these structural defects predicted that a reduction in the FDC network and aberrant 
Tfh cell localisation to the DZ results in diminished GC B cell expansion, output and affinity 
maturation as observed in vivo in aged mice. Although Tfh cells express CXCR4, the receptor 
critical for DZ localisation of GC B cells, they largely localise to the GC light zone (LZ) through 
their expression of CXCR5 where they promote the positive selection of centrocytes. Therefore, 
these simulations suggest that the localisation of Tfh cells within the GC may play a role 
determining the outcome of GC responses. To validate this in silico prediction in vivo, I next 
investigated the expression of CXCR4 in Tfh cells from aged mice and its role in Tfh cell 
localisation within the GC.  
CXCR4 is a chemokine receptor belonging to the large superfamily of G-protein 
coupled receptors that selectively binds the CXC chemokine Stromal Cell-Derived Factor 1 
(SDF-1), also known as CXCL12 (Busillo and Benovic, 2007). CXCR4 signalling plays a role 
in several biological processes and has been implicated in a number of diseases such as HIV, 
WHIM syndrome and cancer metastasis (Busillo and Benovic, 2007). The first biological role 
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of the CXCR4/CXCL12 axis was described by Nagasawa and colleagues in the mid 1990s when 
they identified CXCL12 as a novel stromal factor capable of promoting the proliferation of 
bone marrow B cell progenitors in vitro and demonstrated its critical role in B cell 
lymphopoiesis in CXCL12 deficient mice which present with late gestational lethality 
(Nagasawa, Kikutani and Kishimoto, 1994; Nagasawa et al., 1996). During this time, CXCR4 
was discovered by a separate group as a cofactor for HIV-1 entry into CD4+ T cells (Feng et 
al., 1996), after which two independent studies demonstrated that CXCL12 is capable of 
inhibiting CXCR4-mediated HIV-1 entry in vitro, thus establishing CXCL12 as the putative 
ligand for CXCR4 (Bleul et al., 1996; Oberlin et al., 1996). Subsequently, two separate groups 
reported that CXCR4 deficient mice display a severe reduction in B cell lymphopoiesis, 
diminished myelopoiesis, abnormal development of the cerebellum and postnatal lethality; a 
phenotype which is nearly identical to that of CXCL12 deficient mice highlighting the almost 
exclusive relationship between this receptor-ligand pair (Ma et al., 1998; Zou et al., 1998). In 
addition to its critical role in B cell lymphopoiesis, studies specifically targeting CXCR4 
deletion in the B cell lineage reported a role for CXCR4 in the retention of immature B cell 
precursors in the bone marrow during B cell development as well as in guiding mature B cells 
to the Peyer’s patches and the peritoneal cavity (Nie et al., 2004; Beck et al., 2014). 
Interestingly, CXCR4 and CXCL2 deficient mice did not display a defect in T cell 
lymphopoiesis yet the expansion of CD3-CD4-CD8- triple negative and CD4+CD8+ double 
positive (DP) T cell precursors in the thymus was reduced during embryogenesis in these mice 
indicating that CXCR4 also plays a role in T cell development (Ara et al., 2003).  
 During T cell development in the thymus, T cell precursors express CXCR4 at the 
CD44+CD25+ DN2 stage through to the CD4+CD8+ DP stage (Ara et al., 2003; Plotkin et al., 
2003). Throughout these developmental stages, the CXCR4/CXCL12 axis guides the migration 
of thymocytes across the distinct regions of the thymic cortex where critical events for early 
thymocyte development take place (Plotkin et al., 2003; Janas et al., 2010; Trampont et al., 
2010). Additionally, studies using artificial thymus organoids and pharmacological blockade 
of CXCR4/CXCL12 mediated migration revealed that this axis is critical for thymic egress of 
T cells (Poznansky et al., 2002; Vianello et al., 2005). It was therefore believed that the study 
of CXCR4 in peripheral T cells by specifically targeting CXCR4 deletion to the T cell lineage 
would be challenging due to its role in thymic development and exit. However, Luca and 
colleagues demonstrated that the migration of mature T cells to the periphery is unaffected in 
Cd4CreCxcr4fl/fl mice, which contain normal numbers of mature CD4+ and CD8+ T cells in the 
spleen, and that CXCR4 expression is not essential past the DP stage of thymic development 
(Lucas et al., 2017). Nevertheless, further phenotyping of these mice is required to better 
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understand the role of CXCR4 guidance of mature T cells to peripheral lymphoid organs other 
than the spleen. Together these studies indicate that CXCR4 plays an important role in the 
development and migration of mature B and T lymphocytes during homeostatic conditions yet 
the CXCR4/CXCL12 axis also plays a crucial role in lymphocyte guidance during immune 
responses.  
 In the GC reaction, CXCL12 produced by reticular cells (CRCs) guides and retains 
CXCR4+ centroblasts in the DZ where they proliferate and undergo somatic hypermutation 
(Allen et al., 2004). As GC B cells proliferate, they downregulate CXCR4 and begin to 
upregulate CXCR5 which facilitates their movement towards the CXCL13 gradient secreted by 
FDCs in the LZ (Allen et al., 2004; Bannard, Robert M. Horton, et al., 2013). Migration to the 
LZ is critical for GC B cells to acquire antigen from FDCs and present it to Tfh cells for positive 
selection, therefore the shuttling of GC B cells to and from the DZ and LZ is functionally 
necessary for optimal GC responses (Mesin, Ersching and Victora, 2016). Tfh cells also express 
CXCR4 and CXCR5 which have been shown to determine their localisation within the GC 
(Elsner, Ernst and Baumgarth, 2012). However, the functional role of Tfh cells in mediating 
the positive selection of high affinity GC B cell clones has been shown to occur within the LZ  
and thus little is known of their role in the GC DZ (Gabriel D Victora et al., 2010; Mesin, 
Ersching and Victora, 2016).  
Our in silico simulations predicted that an increased localisation of Tfh cells to the GC 
DZ would be detrimental to the expansion of GC B cells and the total output of the GC response, 
suggesting this defect could be a major contributor to the demise of the GC in aged mice. To 
test this hypothesis in vivo, I first assessed the expression of CXCR4 on Tfh cells from aged 
mice and their sensitivity to CXCL12-mediated chemotaxis. In addition, to attempt to bias Tfh 
cell localisation to the GC DZ as seen in aged mice, CXCR4 was overexpressed in CD4+ OT-
II T cells via retroviral transduction after which these cells were adoptively transferred into 
wild type mice and Tfh differentiation was assessed upon immunisation with OVA. Lastly, to 
further examine the role of CXCR4 in Tfh cell biology and localisation we generated a strain 
of CreERT2 Cxcr4fl/fl OT-II mice which ubiquitously express a Cre recombinase fused to a 
mutant of the human oestrogen receptor that binds the synthetic oestrogen receptor ligand 4-
hydroxytamoxifen. In these mice, all cell types exposed to tamoxifen excise the floxed Cxcr4 
gene, yet through CD4+ T cell enrichment and adoptive transfer of these cells into wild type 
mice we can selectively examine the effects of CXCR4 deletion on Tfh cells upon immunisation 
with OVA. Using this approach, I was able to assess the activation, differentiation and 
localisation of CXCR4 deficient Tfh cells by flow cytometry and confocal microscopy. This 
chapter describes the results from the aforementioned experiments that were performed to better 
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understand the role of CXCR4 in Tfh cell localisation and the effects this could have on the 
ageing GC response. 
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6.2 Age-associated increase in CXCR4 expression and CXCL12 
sensitivity of Tfh cells  
6.2.1 CXCR4 expression of follicular T cells is increased in aged BALB/c mice 
 
Tfh cells express both CXCR4 and CXCR5 which in the context of influenza infection has 
been shown to influence their DZ and LZ localisation, respectively (Elsner, Ernst and Baumgarth, 
2012). To determine whether the increased Tfh cell DZ localisation observed in aged GCs could be 
mediated by altered CXCR4 expression, 8-12 week old adult and 90-95 week old aged BALB/c mice 
were immunised subcutaneously with NP-KLH and the draining inguinal lymph nodes were collected 
14 days after immunisation (outlined in Figure 6.1 A). Using this approach, I examined the age-
associated changes in CXCR4 expression of key GC cell types by flow cytometry (gating strategy 
outlined in Figure 6.1 B).  
As we had previously observed, aged mice displayed a significant reduction in the proportion 
of CD4+ T cells 14 days after immunisation (Figure 6.2 A-B). Though in this particular experiment, 
there were no significant differences in the total number of CD4+ T cells between younger adult and 
aged mice (Figure 6.2 C). The proportion of CXCR4+CD4+ T cells was significantly increased in 
aged mice (Figure 6.2 D-E) which caused a slight increase in the total number of CXCR4+CD4+ T 
cells in aged mice (Figure 6.2 F). The median fluorescence intensity (MFI) of CXCR4 was also 
significantly increased in CD4+ T cells from aged mice (Figure 6.2 G) indicating there is an age-
associated increase in protein expression of CXCR4 in CD4+ T cells in aged mice 14 days after 
immunisation.  
The proportion of PD1+CXCR5+ Foxp3- Tfh cells was significantly increased in aged mice as 
I had previously shown in our kinetic studies, though the trend for differences in cellularity was not 
significant (Figure 6.3 A-C). Interestingly, the proportion of CXCR4+ Tfh cells was significantly 
increased in aged mice compared to young mice (Figure 6.3 D-E). This increase was reflected in the 
total number of CXCR4+ Tfh cells which were increased in aged mice (Figure 6.3 F). The MFI of 
CXCR4 was also significantly increased in Tfh cells from aged mice (Figure 6.3 G) indicating that 
these cells express higher levels of CXCR4 upon vaccination with age. Similarly, the proportion as 
well as the total number of Foxp3+PD1+CXCR5+ Tfr cells were significantly increased in aged mice 
(Figure 6.4 A-C). These cells also appeared to have an age-associated increase in the expression of 
CXCR4 as the proportion and total number of CXCR4+ Tfr cells together with the MFI of CXCR4 
were significantly increased in aged mice (Figure 6.4 D-G). In contrast, assessment of the Ki67+Bcl6+ 
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GC B cell population of young and aged mice showed that while aged mice have a decreased 
proportion of GC B cells (Figure 6.5 A-B) and similar cellularity (Figure 6.5 C), there was no 
significant difference in the proportion and total number of CXCR4+ GC B cells as well as the MFI 
of CXCR4. This suggests that the increase in CXCR4 expression is a T cell specific defect in aged 
mice and confirmed our previous finding where we observed no age-related differences in the 
CXCR4+CD86- centroblast population. Together these results indicate that follicular T cells in aged 
mice express higher levels of CXCR4 compared to young mice which could contribute to the aberrant 





























Figure 6.1 Experimental outline and gating strategy for assessment of CXCR4 
expression during the GC response 
 
A. Experimental approach for which adult and aged BALB/c mice were subcutaneously immunised 
with NP-KLH in alum and inguinal lymph nodes were taken 14 days after immunisation for flow 
cytometry B. Gating strategy for the identification of helper T cells (CD4+B220-), B cells (B220+CD4-
), GC B cells (Bcl6+Ki67+B220+CD4-), Tfh cells (Foxp3-PD1+CXCR5+), Tfr cells 





Figure 6.2 CXCR4 expression on CD4+ T cells from adult and aged BALB/c mice 
 
A. Representative flow cytometry plots identifying CD4+ helper T cells and B220+ B cells in young 
and aged BALB/c mice at day 14 post-immunisation. Numbers adjacent to gates indicate percentage 
of CD4+ T helper cells and B220+ B cells B. Quantification of the frequency and C. total number of 
CD4+ T helper cells D.  Representative flow cytometry plots identifying CXCR4+CD4+ T cells in 
young and aged BALB/c mice at day 14 post-immunisation, including an FMO control for CXCR4 
staining E. Quantification of the frequency, F. and total number of CXCR4+CD4+ T cells G. Median 
fluorescence intensity (MFI) of CXCR4 in CD4+ T cells in young and aged BALB/c mice. In each 
experiment there were 8-10 mice per age group, and the data presented are representative of two 
independent experiments. Bar height represents the mean and p values indicated on graphs were 




Figure 6.3 CXCR4 expression on Tfh cells from adult and aged BALB/c mice 
 
A. Representative flow cytometry plots identifying PD1+CXCR5+Foxp3- Tfh cells in young and aged 
BALB/c mice at day 14 post-immunisation. Numbers adjacent to gates indicate percentage of 
PD1+CXCR5+Foxp3- Tfh cells B. Quantification of the frequency and C. total number of 
PD1+CXCR5+Foxp3- Tfh cells D.  Representative flow cytometry plots identifying CXCR4+ 
PD1+CXCR5+Foxp3- Tfh cells in young and aged BALB/c mice at day 14 post-immunisation, 
including an FMO control for CXCR4 staining E. Quantification of the frequency, F. and total 
number of CXCR4+ PD1+CXCR5+Foxp3- Tfh cells G. Median fluorescence intensity (MFI) of 
CXCR4 in PD1+CXCR5+Foxp3- Tfh cell population in young and aged BALB/c mice. In each 
experiment there were 8-10 mice per age group, and the data presented are representative of two 
independent experiments. Bar height represents the mean and p values indicated on graphs were 




Figure 6.4 CXCR4 expression on Tfr cells from adult and aged BALB/c mice 
 
A. Representative flow cytometry plots identifying PD1+CXCR5+Foxp3+ Tfr cells in young and aged 
BALB/c mice at day 14 post-immunisation. Numbers adjacent to gates indicate percentage of 
PD1+CXCR5+Foxp3+ Tfr cells B. Quantification of the frequency and C. total number of 
PD1+CXCR5+Foxp3+ Tfr cells D.  Representative flow cytometry plots identifying CXCR4+ 
PD1+CXCR5+Foxp3+ Tfr cells in young and aged BALB/c mice at day 14 post-immunisation, 
including an FMO control for CXCR4 staining E. Quantification of the frequency, F. and total 
number of CXCR4+ PD1+CXCR5+Foxp3+ Tfr cells G. Median fluorescence intensity (MFI) of 
CXCR4 in PD1+CXCR5+Foxp3+ Tfr cell population in young and aged BALB/c mice. In each 
experiment there were 8-10 mice per age group, and the data presented are representative of two 
independent experiments. Bar height represents the mean and p values indicated on graphs were 




Figure 6.5 CXCR4 expression on GC B cells from adult and aged BALB/c mice 
 
A. Representative flow cytometry plots identifying Ki67+Bcl6+ GC B cells in young and aged 
BALB/c mice at day 14 post-immunisation. Numbers adjacent to gates indicate percentage of 
Ki67+Bcl6+ GC B cells B. Quantification of the frequency and C. total number of Ki67+Bcl6+ GC B 
cells D.  Representative flow cytometry plots identifying CXCR4+ Ki67+Bcl6+ GC B cells in young 
and aged BALB/c mice at day 14 post-immunisation, including an FMO control for CXCR4 staining 
E. Quantification of the frequency, F. and total number of CXCR4+ Ki67+Bcl6+ GC B cells G. 
Median fluorescence intensity (MFI) of CXCR4 in Ki67+Bcl6+ GC B cell population in young and 
aged BALB/c mice. In each experiment there were 8-10 mice per age group, and the data presented 
are representative of two independent experiments. Bar height represents the mean and p values 
indicated on graphs were generated by performing an unpaired Mann-Whitney U test.  
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6.2.2 CXCL12 chemotactic migration is increased in Tfh cells from aged BALB/c 
mice 
  
 During the GC response, CXCR4 expression on GC B cells facilitates their migration and 
localisation to the DZ by guiding these cells towards the CXCL12 gradient produced by resident 
CRCs in the DZ (Allen et al., 2004; Bannard, Robert M. Horton, et al., 2013). Therefore, I next aimed 
to determine whether the observed increase in CXCR4 expression on Tfh cells from aged mice results 
in enhanced CXCL12-mediated migration. To do this, 8-12 week old and 90-95 week old BALB/c 
mice were immunised subcutaneously with NP-KLH and total lymphocytes were isolated from the 
draining inguinal lymph nodes for CXCL12 chemotaxis assays at day 14 post immunisation (Figure 
6.6 A). 1.5x106 lymphocytes were seeded into transwells containing media supplemented with 
CXCL12 at increasing concentrations of 10, 30, 100 and 300 ng/ml in the lower compartment. To 
account for background migration, cells were also allowed to migrate in media without CXCL12. In 
order to acquire an accurate count of input cells being seeded into each transwell, 1.5x106 cells were 
seeded onto separate wells (Figure 6.6 A). Cells were allowed to migrate to the lower transwell 
compartment in culture for 2.5 hours after which they were counted by flow cytometry and follicular 
T cell migration was calculated as a percentage of the total follicular T cell number present in the 
input well (gating strategy outlined in Figure 6.6 B).  
 These chemotaxis assays revealed that PD1+CXCR5+ Foxp3- Tfh cells from aged mice have 
a greater capacity to migrate towards CXCL12 than Tfh cells from young mice (Figure 6.6 C). The 
percentage of Tfh cell migration towards CXCL12 in cells from aged mice appeared to be slightly 
increased at lower concentrations of CXCL12 but was clearly enhanced when CXCL12 was present 
at a concentration of 300ng/ml. Indeed, the migration of young Tfh cells appeared to reach a plateau 
when CXCL12 was present at the higher concentrations of 100 to 300ng/ml, likely due to chemokine 
desensitisation, yet Tfh cells from aged mice continued to migrate at a greater capacity with 
increasing concentrations of CXCL12. This suggests that Tfh cells from aged mice have a much 
higher threshold for CXCL12 desensitisation than Tfh cells from young mice, which could be 
attributed to the increased expression of CXCR4 in these cells that allows them to continue migrating 
towards CXCL12 at higher concentrations. On the other hand, Foxp3+PD1+CXCR5+ Tfr cells from 
aged mice did not appear to have a significantly enhanced capacity for CXCL12 migration compared 
to Tfr cells from young mice despite the age-related increase in CXCR4 expression (Figure 6.6 D). 
This data indicates that Tfh cells, but not Tfr cells, from aged mice have an enhanced capacity for 
CXCL12-mediated migration compared to Tfh cells from young mice and thus it is this follicular T 
cell type that is likely overrepresented in the DZ of aged GCs.  
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Together, these results suggest that an increase in CXCR4 expression on Tfh cells from aged 
mice confers an increased capacity for these cells to migrate towards CXCL12. Therefore, enhanced 
activity of the CXCR4/CXCL12 axis in Tfh cells from aged mice is the likely mechanism by which 




















































Figure 6.6 CXCL12 chemotaxis assays of Tfh and Tfr cells from adult and aged BALB/c 
mice 
 
A. Experimental approach for which adult and aged BALB/c mice were subcutaneously immunised 
with NP-KLH in alum and inguinal lymph nodes were taken 14 days after immunisation for culture 
in transwell plates with increasing concentrations of CXCL12 for 2.5hrs B. Gating strategy used to 
identify Tfh cells (Foxp3-PD1+CXCR5+), Tfr cells (Foxp3+PD1+CXCR5+) which migrated to the 
lower compartment of the transwells. C. Percentage of Tfh cells from the total input of cells that 
migrated to increasing concentrations of CXCL12 D. Percentage of Tfh cells from the total input of 
cells that migrated to increasing concentrations of CXCL12. In each experiment there were 4-5 mice 
per age group, and the data presented are representative of two independent experiments. Each 
symbol represents the mean ± SD. P values indicated on graphs were generated by performing a two-
way ANOVA with Sidak’s multiple comparisons test. 
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6.3 Overexpression of CXCR4 in transgenic OT-II CD4+ T cells  
6.3.1 Validation of the retroviral transduction system for the overexpression of 
CXCR4 in CD4+ OT-II T cells. 
 
 Assessment of CXCR4 expression and CXCL12 migration of Tfh cells from aged mice 
revealed that the activity of the CXCR4/CXCL12 axis is enhanced in Tfh cells with age and therefore 
explains the aberrant DZ localisation observed in aged GCs. In light of this finding, I next aimed to 
study the role of Tfh cells in the DZ by overexpressing CXCR4 in CD4+ T cells from transgenic OT-
II mice and to assess whether inducing aberrant Tfh cell localisation to the DZ could replicate the 
defects observed in the aged GC response. To do this, I first subcloned Cxcr4 from an expression 
vector, pcDNA3-CXCR4-HA provided by the Balabanian Lab, into the retroviral pMSCV-IRES-
GFP II (pMIG-II) vector. The subcloned pMIG-II-CXCR4-GFP vector and the empty pMIG-II vector 
(referred to as pMIG-II-EV-GFP) were then used to transfect packaging PLAT-E cells for retroviral 
production. To overexpress CXCR4, retroviral transduction was performed on CD4+ T cells which 
had been isolated from the spleen and skin-draining lymph nodes of 8-12 week old unimmunised OT-
II mice and stimulated with anti-CD3/CD28 antibodies in culture for 48hrs (outlined in Figure 6.7 
A). Transduced cells were then cultured in the presence of IL-2 to undergo further expansion for 48 
hours after which transduction efficiency was assessed. Using this method, ~65-70% transduction of 
OT-II cells with either the empty or CXCR4 retroviral vector was attained, and I confirmed that cells 
transduced with the pMIG-II-CXCR4-GFP vector had at least 20-fold higher CXCR4 expression than 
cells transduced with the empty vector (Figure 6.7 B). Transduced CD4+TCRVa2+ OT-II cells were 
then sorted based on their expression of CXCR4 and the green fluorescence protein (GFP) reporter 














Figure 6.7 Experimental outline and gating strategy for the overexpression of CXCR4 
in CD4+ OT-II cells by retroviral transduction  
 
A. Experimental approach for which adult and aged BALB/c mice were subcutaneously immunised 
with NP-KLH in alum and inguinal lymph nodes were taken 14 days after immunisation for flow 
cytometry B. Gating strategy for the assessment of transduction efficiency in CD4+ OT-II cells 
transduced with pMIG-II-EmptyVector (EV)-GFP or pMIG-II-CXCR4-GFP, identifying transduced 
OT-II (TCRVa2+GFP+ cells) and their expression of CXCR4, numbers adjacent to gates indicate 
percentages C. Sorting strategy of pooled CD4+ OT-II cells transduced with pMIG-II-EmptyVector 
(EV)-GFP (CD4+TCRVa2+CXCR4-GFP+)  or pMIG-II-CXCR4-GFP 
































6.3.2 CXCR4 overexpression limits LN entry of CD4+ T cells and restricts Tfh cell 
differentiation  
 To examine the role of CXCR4 overexpression in Tfh cell differentiation and function in vivo, 
the sorted GFP+CD4+TCRVa2+ OT-II cells were adoptively transferred into congenic C57BL/6 wild 
type recipients and left to rest in the host for 24 hrs prior to immunisation with OVA (Figure 6.8 A). 
The draining inguinal LNs were then taken 10 days after immunisation and Tfh cell differentiation 
of CD45.1+GFP+ donor cells, transduced with either the pMIG-II empty vector (Group A) or the 
CXCR4 vector (Group B), were analysed by flow cytometry (gating strategy outlined in Figure 6.8 
B).  
Surprisingly, CD45.1+GFP+ OT-II cells transduced with the pMIG-II-CXCR4 vector were 
present at significantly lower proportions and total cell numbers in the inguinal LNs of recipient mice 
compared to cells transduced with the empty vector (Figure 6.9 A-C), even though an equal number 
of pMIG-II-EV and pMIG-II-CXCR4 transduced cells were transferred into recipient mice. This 
indicated that overexpression of CXCR4 in CD4+ T cells is likely to restrict LN entry and thus many 
of these cells fail to successfully migrate into the draining LN. While the proportion of CXCR4 
expressing cells was significantly higher in pMIG-II-CXCR4 transduced cells than in the empty 
vector controls there were no significant differences in the total number due to the scarcity of these 
cells in the LN (Figure 6.9 D-F). Moreover, the CXCR4 expression of these pMIG-II-CXCR4 
transduced cells appeared lower than the original expression prior to adoptive transfer, however 
intracellular staining of CXCR4 would be required to determine whether the lowered expression of 
CXCR4 in these cells is due to receptor recycling. Further analysis of the CD45.1+GFP+ transferred 
cells revealed that there was little to no PD1+CXCR5+ Tfh cell differentiation in cells transduced with 
pMIG-II-CXCR4, as Tfh cells were present in lower proportions and significantly lower numbers 
compared to those transduced with the empty vector (Figure 6.9 G-I). This indicated that the few 
CD4+ T cells overexpressing CXCR4 that manage to enter the LN are not able to differentiate into 
PD1+CXCR5+ Tfh cells.  
To determine whether the defect in LN homing and Tfh cell differentiation was the result of 
a poor immune response in the animals that received pMIG-CXCR4 transduced OT-II cells, the host 
GC response was analysed. This showed that there were no significant differences in the proportion 
and total cell number of CD95+CD38-CD45.2+B220+ GC B cells (Figure 6.9 J-L) as well as in the 
proportion and total cell number of PD1+CXCR5+CD45.2+CD4+ Tfh cells between the two groups of 
recipient mice (Figure 6.9 M-O). This showed that the reduced migration of CD4+ T cells 
overexpressing CXCR4 and their inability to differentiate into Tfh cells was not influenced by a 
difference in the immune response of the host mice. In addition, CD45.1+GFP+ cells transduced with 
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pMIG-II-CXCR4 were not enriched in the spleen, Peyer’s patches or the CXCL12-rich bone marrow 
(Figure 6.10 A-C). This indicated that there was no preferential migration of pMIG-II-CXCR4 
transduced cells to other lymphoid organs. 
 Together these data suggest that overexpression of CXCR4 in CD4+ OT-II T cells limits their 
entry into the LN and restricts Tfh cell differentiation of the few cells that enter the LN. This showed 
that overexpressing CXCR4 in CD4+ T cells prior to Tfh cell differentiation prevents the study of 
these cells in the context of the GC response. Therefore, a system in which CXCR4 overexpression 
can be induced once Tfh cell commitment has occurred would be necessary to study the role of 





























Figure 6.8 Experimental outline and gating strategy for the adoptive transfer of 
retrovirally transduced CD4+ OT-II T cells into C57BL/6 mice 
 
A. Experimental approach for the adoptive transfer of CD4+ OT-II cells transduced with pMIG-II-
EV-GFP or pMIG-II-CXCR4-GFP into adult C57BL/6 mice which were subcutaneously immunised 
24 hrs later with OVA in alum  and inguinal lymph nodes were taken 10 days after immunisation for 
flow cytometry B. Gating strategy for the identification of CD45.1+GFP+ transferred OT-II cells, 
CD4+ OT-II T cells (CD4+CD45.1+GFP+), OT-II Tfh cells (PD1+CXCR5+ CD4+CD45.1+GFP+), 






Figure 6.9 Assessment of adoptively transferred CD4+GFP+ OT-II T cells 
 
A. Representative flow cytometry plots identifying CD45.1+GFP+ transferred OT-II cells in inguinal 
LNs of young C57BL/6 recipient mice at day 10 post-immunisation with OVA. Numbers adjacent to 
gates indicate percentage of each cell population B. Quantification of the frequency and C. total 
number of CD45.1+GFP+ transferred OT-II cells D.  Representative flow cytometry plots identifying 
CXCR4+CD4+CD45.1+GFP+ OT-II cells in inguinal LNs of young C57BL/6 recipient mice E. 
Quantification of the frequency and F. total number of CXCR4+CD4+CD45.1+GFP+ OT-II cells G.  
Representative flow cytometry plots identifying OT-II Tfh cells in inguinal LNs of young C57BL/6 
recipient mice H. Quantification of the frequency and I. total number of OT-II Tfh cells J.  
Representative flow cytometry plots identifying host GC B cells in inguinal LNs of young C57BL/6 
recipient mice K. Quantification of the frequency and L. total number of host GC B cells M.  
Representative flow cytometry plots identifying host Tfh cells in inguinal LNs of young C57BL/6 
recipient mice N. Quantification of the frequency and O. total number of host Tfh cells. In each 
experiment there were 3-7 mice per group, and the data presented are representative of two 
independent experiments. Bar height represents the mean and p values indicated on graphs were 





































Figure 6.10 Assessment of adoptively transferred CD4+GFP+ OT-II T cells in lymphoid 
organs of recipient C57BL/6 mice  
 
Representative flow cytometry plots identifying CD45.1+GFP+ transferred OT-II cells in the A. 
spleens B. Peyer’s patches and C. bone marrow of young C57BL/6 recipient mice at day 10 post-
immunisation with OVA. Numbers adjacent to gates indicate percentage of each cell population. Data 





6.4 Inducible deletion of CXCR4 in Tfh cells and the effects on the GC 
response 
6.4.1 Validation of the Cre-ERT2 Cxcr4fl/fl tamoxifen deletion model  
 
While I was unable to use the overexpression of CXCR4 on CD4+ OT-II cells as a means to 
induce DZ localisation on Tfh cells, an alternative way of studying the role of CXCR4 in Tfh cell 
localisation and function is by specifically deleting Cxcr4 in CD4+ T cells. To do this we established 
a strain of CreERT2 Cxcr4fl/fl OT-II mice in which all cells delete Cxcr4 upon administration of 
tamoxifen. The advantage of using this system is that Cxcr4 deletion in peripheral lymphoid organs 
would occur on mature lymphocytes from which CD4+ T cells can be isolated and adoptively 
transferred for the study of Tfh cells, thereby avoiding any defects that deletion of Cxcr4 could have 
on T cell development in the thymus. To validate CXCR4 deletion in this mouse model in vivo, 
tamoxifen was administered to CreERT2WT and CreERT2HET Cxcr4fl/fl mice by oral gavage in 3 doses, 
48 hrs apart.   Additionally, a mouse from a Foxp3CreERT2 Cxcr4fl/fl strain was also used to verify the 
efficiency of tamoxifen-induced CXCR4 deletion in a separate system. The mesenteric LNs (mLNs), 
inguinal LNs (iLNs) and spleens from these mice were dissected 7 days after the last tamoxifen dose 
and CXCR4 deletion on lymphocytes was analysed by flow cytometry (outlined in Figure 6.11 A). 
In the msLNs of tamoxifen treated mice, CXCR4 deletion was evident in the Ki67+Bcl6+ GC 
B cell populations of the CreERT2HET Cxcr4fl/fl mouse compared to the CreERT2WT and Foxp3CreERT2 
controls (Figure 6.11 B). Similar deletion of CXCR4 was observed in the population of 
PD1+CXCR5+Foxp3- Tfh cells and PD1+CXCR5+Foxp3+ Tfr cells in the CreERT2HET Cxcr4fl/fl with 
CXCR4 deletion only being present in the Tfr cell population of the Foxp3CreERT2 control mouse 
(Figure 6.11 C-D). Whilst these results were promising, the deletion of CXCR4 in lymphocytes of 
the iLN and spleen appeared to be less efficient. In the iLNs, CXCR4 deletion was only evident in 
CD44+CD62L- memory T cells, as CD62L+CD44- naïve T cells displayed similar CXCR4 surface 
expression compared to the CreERT2WT and Foxp3CreERT2 controls (Figure 6.12 A). In the 
Foxp3+CD4+ regulatory T cell (Treg) compartment CXCR4 deletion was also not observed though, 
Treg cells from the Foxp3CreERT2 control appeared to downregulate CXCR4 expression slightly 
(Figure 6.12 B). A similar CXCR4 deletion pattern was observed in the spleen where only 
CD44+CD62L- memory T cells and not naïve or regulatory T cells, appeared to downregulate surface 
expression of CXCR4 compared to the CreERT2WT control (Figure 6.13 A-B). These results indicated 
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that only activated lymphocytes downregulated surface CXCR4 expression upon tamoxifen 
administration. However, for an adoptive transfer of CXCR4 deficient CD4+ T cells, we would need 
to ensure CXCR4 deletion in naïve T cells to adequately Tfh cell differentiation. With this in mind, 
naïve T cells were sorted from the iLNs of CreERT2WT and CreERT2HET Cxcr4fl/fl mice treated with 
tamoxifen as in (Figure 6.11 A) to assess the genomic deletion of Cxcr4 by real time qPCR (sorting 
strategy outlined in Figure 6.14 A). This revealed that the relative expression of Cxcr4 transcripts 
was clearly reduced in cells from CreERT2HET Cxcr4fl/fl mice compared to the CreERT2WT control 
(Figure 6.14 B), despite high levels of CXCR4 protein expression. These data suggest that expression 
of the CXCR4 protein at the surface of naïve T cells is long-lived. Therefore, an activation or 
proliferation event may be required for cells to recycle surface CXCR4 for deletion to be evident at 
the protein level.  
To establish a more time-efficient method of deleting Cxcr4 in T cells from CreERT2 Cxcr4fl/fl 
mice, additional validation of this system was performed in vitro. An initial titration experiment 
where 4-hydroxy (OH) tamoxifen was administered at concentrations of 50, 100 and 200nM for 15, 
24 or 48 hrs to total lymphocytes isolated from a Foxp3CreERT2 Cxcr4fl/fl mouse (Figure 6.15 A), 
indicated that the CXCR4 MFI in Foxp3+CD4+ Treg cells is reduced after 48hrs in culture with either 
50, 100 or 200nM of tamoxifen compared to CreERT2WT control cells (Figure 6.15 B). Therefore to 
delete Cxcr4 in the CreERT2 Cxcr4fl/fl system, CD4+ T cells from either CreERT2WT and CreERT2HET 
Cxcr4fl/fl mice were cultured for 48 hrs with 200nM of 4OH-tamoxifen (Figure 6.15 C). Assessment 
of surface CXCR4 expression on these cells by flow cytometry confirmed our previous findings that 
naïve T cells from CreERT2HET Cxcr4fl/fl mice do not downregulate CXCR4 protein expression after 
tamoxifen exposure and in this in vitro system there were no changes in CXCR4 protein expression 
of CD44hi memory and CD44int effector T cells (Figure 6.15 D). Nevertheless, as I had previously 
observed that naïve T cells delete Cxcr4 after tamoxifen exposure, these cells were adoptively 
transferred into congenic C57BL/6 recipient mice which were then subcutaneously immunised with 
OVA to determine whether activation of these cells would result in downregulation of CXCR4 at the 
protein level (Figure 6.15 C). Ten days after immunisation, the iLNs were dissected for flow 
cytometric analysis. In both recipient groups, the proportion of transferred CD45.1+CD45.2- OT-II 
cells was comparable, which indicated that migration to the LN of CD4+ T cells from CreERT2HET 
Cxcr4fl/fl mice is unaltered (Figure 6.15 E). Furthermore, deletion of the CXCR4 protein was evident 
in both CD4+CD45.1+ T cells and PD1+CXCR5+CD4+CD45.1+ Tfh cells from CreERT2HET Cxcr4fl/fl 
donor mice (Figure 6.15 E). This result indicated that although CD4+ T cells from CreERT2HET 
Cxcr4fl/fl mice express high levels of surface CXCR4 protein upon 4-OH tamoxifen administration in 
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vitro, these cells are able to downregulate CXCR4 after immunisation when transferred into mice in 
vivo and subsequently differentiate into CXCR4 deficient Tfh cells.  
Together these results indicate that in the CreERT2 Cxcr4fl/fl model, administration of 
tamoxifen clearly deletes Cxcr4 at the genomic level in naïve CD4+ T cells though protein expression 
is only downregulated upon activation of these cells, likely due to a long half-life of the CXCR4 
protein at the cell surface. Nonetheless upon adoptive transfer and subsequent immunisation, cells 
from CreERT2HET Cxcr4fl/fl mice are able to migrate to the LN and give rise to CXCR4 deficient Tfh 
cells. Therefore, tamoxifen induced deletion of CXCR4 in CD4+ T cells from CreERT2HET Cxcr4fl/fl 
















Figure 6.11 In vivo validation of tamoxifen-induced deletion of CXCR4 in the mesenteric 
LNs of CreERT2Cxcr4fl/fl mice 
 
A. Experimental approach of tamoxifen-induced deletion of CXCR4 by oral gavage given to 
CreERT2Cxcr4fl/fl and Foxp3Cre-ERT2Cxcr4fl/fl mice in 3 doses, 48 hrs apart after which CXCR4 
deletion was assessed in lymphocytes of the mesenteric LNs, inguinal LNs and spleen taken 7 days 
after the last dose. Representative plots indicating CXCR4 deletion in B. GC B cells 
(Bcl6+Ki67+B220+CD4-), C. Tfh cells (Foxp3-PD1+CXCR5+CD4+B220-) and D. Tfr cells 
(Foxp3+PD1+CXCR5+ CD4+B220-) in the mesenteric LNs of tamoxifen treated mice. Numbers 









































Figure 6.12 In vivo validation of tamoxifen-induced deletion of CXCR4 in the inguinal 
LNs of CreERT2Cxcr4fl/fl mice 
 
Representative plots indicating CXCR4 deletion in A. T memory cells (CD44+CD62L-Foxp3-
CD4+B220-), T naïve cells (CD44-CD62L+Foxp3-CD4+B220-) and B. regulatory T cells 
(Foxp3+CD4+B220-) in the inguinal LNs of tamoxifen treated mice. Numbers adjacent to gates 




Figure 6.13 In vivo validation of tamoxifen-induced deletion of CXCR4 in the spleens 
LNs of CreERT2Cxcr4fl/fl mice 
 
Representative plots indicating CXCR4 deletion in A. T memory cells (CD44+CD62L-Foxp3-
CD4+B220-), T naïve cells (CD44-CD62L+Foxp3-CD4+B220-) and B. regulatory T cells 
(Foxp3+CD4+B220-) in the spleens of tamoxifen treated mice. Numbers adjacent to gates indicate 





Figure 6.14 Naïve T cells from CreERT2HetCxcr4fl/fl mice delete CXCR4 at the 
transcriptional level upon tamoxifen administration 
 
A. Sorting strategy of naïve CD62L+CD44-CD4+B220- T cells from inguinal lymph nodes of 
CreERT2Cxcr4fl/fl mice treated with 3 doses of tamoxifen 48 hrs apart B. Cxcr4 expression of sorted 
naïve CD62L+CD44-CD4+B220- T cells in arbitrary units normalised to expression of the house 
























Figure 6.15 In vitro validation of tamoxifen-induced deletion of CXCR4 in the CD4+ T 
cells isolated from CreERT2Cxcr4fl/fl mice 
 
A. Experimental approach of 4-OH tamoxifen titration on cells isolated from Foxp3Cre-ERT2Cxcr4fl/fl 
mice which were treated with 50, 100, 200nM of 4-OH tamoxifen for 15, 24 or 48 hours. Cells from 
control mice were cultured in plain media and CXCR4 deletion was assessed by flow cytometry B. 
Quantification of the CXCR4 MFI in tamoxifen-treated regulatory T cells (Foxp3+CD4+B220-) from 
Foxp3Cre-ERT2Cxcr4fl/fl mice. Bar height indicates mean +SD, data is representative of four technical 
replicates. C. Experimental outline of in vitro 4-OH tamoxifen treatment of CD4+ T cells isolated 
from CreERT2Cxcr4fl/fl mice which were treated with 200nM of 4-OH tamoxifen for 48 hrs after 
which CXCR4 deletion was assessed by flow cytometry and cells were adoptively transferred into 
young C57BL/6 recipient mice from which inguinal LNs were dissected 10 days after subcutaneous 
immunisation with OVA. D. Representative flow cytometry plots displaying CXCR4 expression on 
T memory cells (CD44hiCD62L-Foxp3-CD4+B220-), T effector cells (CD44intCD62L-Foxp3-
CD4+B220-), T naïve cells (CD44-CD62L+Foxp3-CD4+B220-) gated on CD4+TCRVa2+ cells. 
Numbers adjacent to gates indicate percentage of each cell population. E. Flow cytometry plots from 
each C57BL/6 recipient displaying transferred OT-II cells (CD45.1+CD45.2-), CD4+ OT-II T cells 
(CD4+B220-CD45.1+CD45.2-) CXCR4+CD4+ OT-II T cells (CXCR4+CD4+B220-CD45.1+CD45.2-), 
OT-II Tfh cells (PD1+CXCR5+CD4+B220-CD45.1+CD45.2-) and CXCR4+ OT-II Tfh cells 
(CXCR4+PD1+CXCR5+CD4+B220-CD45.1+CD45.2-). Numbers adjacent to gates indicate 


























6.4.2 Activation of CD4+ T cells lacking CXCR4 is unaltered upon immunisation 
 
After tamoxifen-induced deletion of CXCR4 in the CreERT2 Cxcr4fl/fl system was validated, 
I next aimed to determine if CXCR4 deficiency alters the early activation events of CD4+ T cells 
required for Tfh cell commitment upon immunisation, as well as to examine the precise timing of 
CXCR4 protein deletion occurs in tamoxifen-treated cells from CreERT2HET Cxcr4fl/fl mice. To do 
this, CD4+ T cell enrichment was performed on lymphocytes isolated from the skin-draining LNs and 
spleens of CreERT2WT and CreERT2HET Cxcr4fl/fl mice and cultured in the presence of 4OH- 
tamoxifen for 48hrs (Figure 6.16 A). After tamoxifen administration, cells were labelled with cell 
trace violet (CTV) and the proportion of TCRVa2+CD4+ T cells was assessed by flow cytometry to 
adjust the number of cells for adoptive transfer into congenic 8-12 week old B6SJL (CD45.1) 
recipient mice to 5x105 TCRVa2+ cells per mouse. This also confirmed that cells from CreERT2HET 
Cxcr4fl/fl mice had comparable expression of CXCR4 as cells from CreERT2WT mice prior to adoptive 
transfer (Figure 6.16 B). The recipient mice were then immunised subcutaneously with OVA and the 
iLNs were dissected 2.5 days after immunisation. The early proliferation and activation events of 
donor cells were then analysed by flow cytometry based on the intensity of the CTV dye, which is 
diluted every time a cell undergoes division (gating strategy outlined in Figure 6.16 C).  
Using this approach, the transferred CD45.2+CD45.1- OT-II cell populations could be 
identified in the dLNs of recipient mice which received either CreERT2WT Cxcr4fl/fl (group A) or 
CreERT2HET Cxcr4fl/fl (group B) cells confirming the success of the adoptive transfer (Figure 6.17 A). 
Furthermore, the proportion and total cell number of the transferred CD45.2+CD45.1- OT-II cell 
populations was comparable between both recipient groups, confirming there is no defect in LN 
homing of CD4+ T cells from CreERT2HET Cxcr4fl/fl donors 2.5 days after immunisation (Figure 6.17 
B). Proliferation of CD4+CD45.2+CD45.1- T cells was assessed by quantifying the proportion and 
number of cells which diluted the CTV dye, as well as by quantifying the proportion and number 
cells at each CTVlo peak representative of individual division events. This analysis showed that there 
were no significant differences in the proportion and total cell number of CD4+CD45.2+CD45.1- 
proliferating T cells between the two recipient groups (Figure 6.18 A-B). Consequently, there were 
no significant differences in the proportion and total cell number of CD4+CD45.2+CD45.1- T cells at 
each division event between the two recipient groups (Figure 6.18 C). This suggests that CXCR4 
deficient CD4+ T cells from CreERT2HET Cxcr4fl/fl donors are able to undergo proliferation to the 
same capacity as CD4+ T cells from CreERT2WT donors upon activation.  
To determine the point at which surface CXCR4 protein expression is lost in CD4+ T cells 
from CreERT2HET Cxcr4fl/fl donors, CXCR4+CD4+CD45.2+ T cells were quantified at each division 
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event. This revealed that at 2.5 days after immunisation, CXCR4 is not expressed in CD4+ T cells 
from either CreERT2WT control or CreERT2HET Cxcr4fl/fl donors prior to cell division (Figure 6.19 A). 
Furthermore, CreERT2WT control cells only begin to upregulate CXCR4 expression again after at 
least four divisions have occurred, while CXCR4 expression of CreERT2HET Cxcr4fl/fl cells remains 
significantly reduced as the proportion and total number of CXCR4+CD4+CD45.2+ T cells is 
significantly reduced after division 4 in mice that received CreERT2HET Cxcr4fl/fl cells (Figure 6.19 
B). This result suggests that CD4+ T cells could be internalising CXCR4 immediately after activation 
or perhaps surface CXCR4 expression could be facilitating migration to the LN resulting in ligand-
mediated protein degradation after which the CXCR4 protein is only upregulated again in control 
cells.  
Additionally, the expression of ICOS, CXCR5, Bcl6 and PD-1 markers were assessed at each 
cell division event to determine whether CXCR4 deficiency could influence early Tfh cell 
commitment. The proportion of ICOS+CD4+CD45.2+ T cells was slightly increased in the first three 
division events in cells from CreERT2HET Cxcr4fl/fl donors, however no significant differences in the 
total number of ICOS+CD4+CD45.2+ T cells were observed between the two recipient groups (Figure 
6.20 A-B). Similarly, the proportion of CXCR5+CD4+CD45.2+ T cells appeared unaltered between 
the two groups with only a slight delay in the expression of CXCR5 during the first division event in 
CreERT2HET Cxcr4fl/fl cells, and there were no significant differences observed in the total number of 
these  CXCR5+ cells between the two recipient groups (Figure 6.21 A-B). Likewise, the proportion 
and total cell number of Bcl6+CD4+CD45.2+ T cells appeared unaffected between the two groups of 
recipient mice (Figure 6.22 A-B). Interestingly, the proportion and total cell number of 
PD1+CD4+CD45.2+ T cells appeared to be slightly decreased after the fifth division event in mice 
which received CreERT2HET Cxcr4fl/fl cells with a statistically significant difference observed at 
division 6, though by the seventh division event there was no difference in the proportion and total 
number of PD1+CD4+CD45.2+ T cells between the two groups (Figure 6.23 A-B). These results 
indicated that CXCR4 deficient CD4+ T cells were equally capable of upregulating Tfh cell markers 
upon activation compared to cells from CreERT2WT control mice, though with a subtle reduction in 
PD1 expression.  
Together these data indicate that CXCR4 deficient CD4+ T cells from CreERT2HET Cxcr4fl/fl 
donors are able to proliferate at an equal capacity to cells from CreERT2WT donors upon activation in 
vivo. Moreover, these results confirmed the genomic deletion of Cxcr4 in CD4+ T cells from 
CreERT2HET Cxcr4fl/fl prevents them from upregulating CXCR4 after activation and that these cells 
are able to upregulate Tfh cell markers equally to CreERT2WT control cells. Therefore, CXCR4 
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deficiency in CD4+ T cells does not alter their early activation upon immunisation, enabling me to 















































Figure 6.16 Experimental outline and gating strategy for adoptive transfer of tamoxifen-
treated CTV-labelled CreERT2Cxcr4fl/fl CD4+ T cells  
 
A. Experimental outline of in vitro 4-OH tamoxifen treatment of CD4+ T cells isolated from 
CreERT2Cxcr4fl/fl mice which were treated with 200nM of 4-OH tamoxifen for 48 hrs after which 
cells were labelled with cell trace violet (CTV) and adoptively transferred into young B6SJL recipient 
mice from which inguinal LNs were isolated 2.5 days after subcutaneous immunisation with OVA 
B. Representative flow cytometry plots displaying CXCR4 expression on CD4+TCRVa2+ cells. 
Numbers adjacent to gates indicate percentage of each cell population C. Gating strategy for the 
identification of displaying transferred OT-II cells (CD45.2+CD45.1-), CD4+ OT-II T cells 
(CD4+B220- CD45.2+CD45.1-), Proliferating cells (CTVloCD4+B220- CD45.2+CD45.1-) and the 








































Figure 6.17 Transferred OT-II cells in LNs of young B6SJL recipient mice 
 
A. Representative flow cytometry plots identifying CD45.2+CD45.1- transferred OT-II cells in 
inguinal LNs of young B6SJL recipient mice at day 2.5 post-immunisation with OVA. Numbers 
adjacent to gates indicate percentage of each cell population B. Quantification of the frequency (left) 
and total number (right) of transferred CD45.2+CD45.1- OT-II cells. In each experiment there were 
5-8 mice per recipient group, and the data presented are representative of two independent 
experiments. Each symbol represents a mouse and the mean is indicated by the bar graph height. The 




Figure 6.18 The proportion and total number of proliferating CD4+ OT-II cells are not 
affected by the loss of CXCR4 
 
A. Representative flow cytometry plots identifying CD4+ OT-II cells which have diluted CTV 
indicating proliferation in inguinal LNs of young B6SJL recipient mice at day 2.5 post-immunisation 
with OVA. Numbers adjacent to gates indicate percentage of each cell population B. Quantification 
of the frequency (left) and total number (right) of proliferating CD4+ OT-II cells C. Quantification of 
the frequency (left) and total number (right) of proliferating CD4+ OT-II cells at each division event. 
In each experiment there were 5-8 mice per recipient group, and the data presented are representative 
of two independent experiments. Each symbol represents a mouse and the mean is indicated by the 
bar graph height. The p values indicated on graphs were generated by performing a two-way ANOVA 









































Figure 6.19. CXCR4 expression of proliferating CD4+ OT-II cells  
 
A. Representative flow cytometry plots identifying CXCR4+CD4+ OT-II cells which have diluted 
CTV indicating proliferation in inguinal LNs of young B6SJL recipient mice at day 2.5 post-
immunisation with OVA. Numbers adjacent to gates indicate percentage of each cell population B. 
Quantification of the frequency (top) and total number (bottom) of proliferating CXCR4+CD4+ OT-
II cells at each division event. In each experiment there were 5-8 mice per recipient group, and the 
data presented are representative of two independent experiments. Each symbol represents a mouse 
and the mean is indicated by the bar graph height. The p values indicated on graphs were generated 








































Figure 6.20 ICOS expression of proliferating CD4+ OT-II cells 
 
A. Representative flow cytometry plots identifying ICOS+CD4+ OT-II cells which have diluted CTV 
indicating proliferation in inguinal LNs of young B6SJL recipient mice at day 2.5 post-immunisation 
with OVA. Numbers adjacent to gates indicate percentage of each cell population B. Quantification 
of the frequency (top) and total number (bottom) of proliferating ICOS+CD4+ OT-II cells at each 
division event. In each experiment there were 5-8 mice per recipient group, and the data presented 
are representative of two independent experiments. Each symbol represents a mouse and the mean is 
indicated by the bar graph height. The p values indicated on graphs were generated by performing a 










































Figure 6.21 CXCR5 expression of proliferating CD4+ OT-II cells 
 
A. Representative flow cytometry plots identifying CXCR5+CD4+ OT-II cells which have diluted 
CTV indicating proliferation in inguinal LNs of young B6SJL recipient mice at day 2.5 post-
immunisation with OVA. Numbers adjacent to gates indicate percentage of each cell population B. 
Quantification of the frequency (top) and total number (bottom) of proliferating CXCR5+CD4+ OT-
II cells at each division event. In each experiment there were 5-8 mice per recipient group, and the 
data presented are representative of two independent experiments. Each symbol represents a mouse 
and the mean is indicated by the bar graph height. The p values indicated on graphs were generated 









































Figure 6.22 Bcl6 expression of proliferating CD4+ OT-II cells 
 
A. Representative flow cytometry plots identifying Bcl6+CD4+ OT-II cells which have diluted CTV 
indicating proliferation in inguinal LNs of young B6SJL recipient mice at day 2.5 post-immunisation 
with OVA. Numbers adjacent to gates indicate percentage of each cell population B. Quantification 
of the frequency (top) and total number (bottom) of proliferating Bcl6+CD4+ OT-II cells at each 
division event. In each experiment there were 5-8 mice per recipient group, and the data presented 
are representative of two independent experiments. Each symbol represents a mouse and the mean is 
indicated by the bar graph height. The p values indicated on graphs were generated by performing a 










































Figure 6.23 PD-1 expression of proliferating CD4+ OT-II cells 
 
A. Representative flow cytometry plots identifying PD1+CD4+ OT-II cells which have diluted CTV 
indicating proliferation in inguinal LNs of young B6SJL recipient mice at day 2.5 post-immunisation 
with OVA. Numbers adjacent to gates indicate percentage of each cell population B. Quantification 
of the frequency (top) and total number (bottom) of proliferating PD1+CD4+ OT-II cells at each 
division event. In each experiment there were 5-8 mice per recipient group, and the data presented 
are representative of two independent experiments. Each symbol represents a mouse and the mean is 
indicated by the bar graph height. The p values indicated on graphs were generated by performing a 




































6.4.3 CD4+ T cells lacking CXCR4 give rise to phenotypically intact Tfh cells upon 
immunisation 
 
Upon establishing that CXCR4 deficiency does not alter the activation of CD4+ T cells, I next 
aimed to assess the effects of CXCR4 deficiency on Tfh cell differentiation during the GC response. 
To do this, tamoxifen-induced deletion of Cxcr4 on enriched CD4+ T lymphocytes isolated from 
CreERT2WT and CreERT2HET Cxcr4fl/fl mice was performed in vitro, as described above (Figure 6.24 
A). After tamoxifen administration, the proportion of TCRVa2+CD4+ T cells was assessed by flow 
cytometry to adjust the number of cells for adoptive transfer into congenic 8-12 week old B6SJL 
recipient mice to 5x104 TCRVa2+ cells per mouse. As previously demonstrated, cells from 
CreERT2HET Cxcr4fl/fl mice had comparable surface protein expression of CXCR4 as cells from 
CreERT2WT mice prior to adoptive transfer (Figure 6.24 B). Recipient mice were subcutaneously 
immunised with OVA and iLNs were taken 10 days after immunisation for flow cytometric analysis 
of Tfh cell populations.  
Using CD45 congenic markers, the transferred CD45.2+CD45.1- OT-II cell populations could 
be identified in the dLNs of recipient mice which received either CreERT2WT Cxcr4fl/fl (group A) or 
CreERT2HET Cxcr4fl/fl (group B) cells (Figure 6.25 A). The proportion and total cell number of the 
transferred CD45.2+CD45.1- OT-II cell populations was comparable between both recipient groups, 
confirming again that there is no defect in LN homing of CD4+ T cells from CreERT2HET Cxcr4fl/fl 
donors 10 days after immunisation (Figure 6.25 B). The proportion and total number of 
CD4+CD45.2+CD45.1- T cells were also comparable between the two recipient groups (Figure 6.26 
A-B) and a clear deletion of CXCR4 could be observed in CD4+ T cells from CreERT2HET Cxcr4fl/fl 
donors (Figure 6.26 C-D). Along with CXCR4, the expression of the Tfh cell markers CXCR5, ICOS, 
Bcl6 and PD1 was also assessed in CXCR4 deficient CD4+ T cells as well as the proliferation marker, 
Ki67. This showed that there were no significant differences in the MFI of CXCR5, ICOS and PD1 
between CD4+CD45.2+CD45.1- T cells in both recipient groups, however the MFI of Bcl6 and Ki67 
was significantly reduced in CXCR4 deficient CD4+ T cells (Figure 6.26 E-I). This suggests that 
CXCR4 deficient CD4+ T cells may not have the same proliferative capacity and expression of the 
follicular transcription factor Bcl6 as control CreERT2WT cells 10 days after immunisation.  
Assessment of the Tfh cell population revealed that the proportion and absolute number of 
PD1+CXCR5+CD4+CD45.2+ Tfh cells was not significantly different between both recipient groups 
(Figure 6.27 A-B). It was clear that PD1+CXCR5+CD4+CD45.2+ Tfh cells from CreERT2HET Cxcr4fl/fl 
donors did not express CXCR4 (Figure 6.27 C-D), thereby indicating that CXCR4 deficiency does 
not affect Tfh cell differentiation. Furthermore, there were no significant differences in the expression 
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of ICOS, Ki67 and Bcl6 in these cells between the two groups as measured by MFI (Figure 6.27 E-
G) which implied that CXCR4 deficient Tfh cells remain phenotypically intact upon immunisation. 
As CD4+CD45.2+CD45.1- T cells from CreERT2HET Cxcr4fl/fl appeared to have a reduction in Bcl6 
expression, the Tfh cell population was also gated and analysed as Bcl6+CXCR5+ cells. This showed 
that though there was a trend for a lower proportion of Bcl6+CXCR5+CD4+CD45.2+ Tfh cells in 
recipients that received CreERT2HET Cxcr4fl/fl cells this difference was not statistically significant and 
the absolute number of these cells was comparable to those from CreERT2WT donors (Figure 6.28 A-
B). In addition, while expression of CXCR4 was clearly ablated in Bcl6+CXCR5+CD4+CD45.2+ Tfh 
cells from CreERT2HET Cxcr4fl/fl donors (Figure 6.28 C-D), expression of ICOS, Ki67 and PD1 was 
not altered in these cells (Figure 6.28 E-G) thus confirming that CXCR4 deficiency does not alter the 
Tfh cell phenotype. The GC response of the host mice was also analysed, for which there were no 
significant differences in the proportion and total number of Ki67+Bcl6+B220+CD45.1+ GC B cells 
and PD1+CXCR5+CD4+CD45.1+ Tfh cells, confirming that our observations were not influenced by 
differences in the immune responses of the recipient mice (Figure 6.29 A-D).  
These results indicate that the loss of CXCR4 does not affect Tfh cell differentiation, as 
measured by flow cytometry, and that these CXCR4-deficient Tfh cells remain phenotypically intact. 
Yet, flow cytometric analysis does not account for the spatial distribution of CXCR4 deficient Tfh 



























Figure 6.24 Experimental outline and gating strategy for adoptive transfer of tamoxifen-
treated CreERT2Cxcr4fl/fl CD4+ T cells  
 
A. Experimental outline of in vitro 4-OH tamoxifen treatment of CD4+ T cells isolated from 
CreERT2Cxcr4fl/fl mice which were treated with 200nM of 4-OH tamoxifen for 48 hrs after which 
cells were adoptively transferred into young B6SJL recipient mice from which inguinal LNs were 
dissected 10 days after subcutaneous immunisation with OVA B. Representative flow cytometry plots 
displaying CXCR4 expression on CD4+TCRVa2+ cells. Numbers adjacent to gates indicate 
percentage of each cell population C. Gating strategy for the identification of displaying transferred 
OT-II cells (CD45.2+CD45.1-), CD4+ OT-II T cells (CD4+B220-CD45.2+CD45.1-), PD1+CXCR5+ 
OT-II Tfh cells (CD4+B220-CD45.2+CD45.1-), Bcl6+CXCR5+ OT-II Tfh cells (CD4+B220-







































Figure 6.25 Transferred OT-II cells in LNs of young B6SJL recipient mice 
 
A. Representative flow cytometry plots identifying CD45.2+CD45.1- transferred OT-II cells in 
inguinal LNs of young B6SJL recipient mice at day 10 post-immunisation with OVA. Numbers 
adjacent to gates indicate percentage of each cell population B. Quantification of the frequency (left) 
and total number (right) of transferred CD45.2+CD45.1- OT-II cells. In each experiment there were 
5-8 mice per recipient group, and the data presented are representative of two independent 
experiments. Each symbol represents a mouse and the mean is indicated by the bar graph height. The 










Figure 6.26 CXCR4 expression on CD4+ OT-II T cells in LNs of young B6SJL recipient 
mice 
 
A. Representative flow cytometry plots identifying CD4+ OT-II T cells in inguinal LNs of young 
B6SJL recipient mice at day 10 post-immunisation with OVA. Numbers adjacent to gates indicate 
percentage of each population B. Quantification of the frequency (left) and total number (right) of 
CD4+ OT-II T cells C.  Representative flow cytometry plots identifying CXCR4+CD4+ OT-II T cells 
in inguinal LNs of young B6SJL recipient mice at day 10 post-immunisation with OVA D. 
Quantification of the frequency (left) and total number (right) of CXCR4+CD4+ OT-II T cells. Median 
fluorescence intensity (MFI) of E. CXCR5, F. ICOS, G. Bcl6, H. Ki67 and I. PD1 in CD4+ OT-II T 
cells of B6SJL recipient mice. In each experiment there were 5-8 mice per age group, and the data 
presented are representative of two independent experiments. Bar height represents the mean and p 




Figure 6.27 CXCR4 expression on PD1+CXCR5+ OT-II Tfh cells in LNs of young B6SJL 
recipient mice 
 
A. Representative flow cytometry plots identifying PD1+CXCR5+ OT-II Tfh cells in inguinal LNs of 
young B6SJL recipient mice at day 10 post-immunisation with OVA. Numbers adjacent to gates 
indicate percentage of each population B. Quantification of the frequency (left) and total number 
(right) of PD1+CXCR5+ OT-II Tfh cells C.  Representative flow cytometry plots identifying 
CXCR4+PD1+CXCR5+ OT-II Tfh cells in inguinal LNs of young B6SJL recipient mice at day 10 
post-immunisation with OVA D. Quantification of the frequency (left) and total number (right) of 
CXCR4+PD1+CXCR5+ OT-II Tfh cells. Median fluorescence intensity (MFI) of E. ICOS, F. Ki67 
and G. Bcl6 in PD1+CXCR5+ OT-II Tfh cells of B6SJL recipient mice. In each experiment there were 
5-8 mice per age group, and the data presented are representative of two independent experiments. 
Bar height represents the mean and p values indicated on graphs were generated by performing an 




Figure 6.28 CXCR4 expression on Bcl6+CXCR5+ OT-II Tfh cells in LNs of young B6SJL 
recipient mice 
 
A. Representative flow cytometry plots identifying Bcl6+CXCR5+ OT-II Tfh cells in inguinal LNs of 
young B6SJL recipient mice at day 10 post-immunisation with OVA. Numbers adjacent to gates 
indicate percentage of each population B. Quantification of the frequency (left) and total number 
(right) of Bcl6+CXCR5+ OT-II Tfh cells C.  Representative flow cytometry plots identifying 
CXCR4+Bcl6+CXCR5+ OT-II Tfh cells in inguinal LNs of young B6SJL recipient mice at day 10 
post-immunisation with OVA D. Quantification of the frequency (left) and total number (right) of 
CXCR4+Bcl6+CXCR5+ OT-II Tfh cells. Median fluorescence intensity (MFI) of E. ICOS, F. Ki67 
and G. PD1 in Bcl6+CXCR5+ OT-II Tfh cells of B6SJL recipient mice. In each experiment there were 
5-8 mice per age group, and the data presented are representative of two independent experiments. 
Bar height represents the mean and p values indicated on graphs were generated by performing an 





Figure 6.29 GC response of B6SJL recipient mice 
 
A. Representative flow cytometry plots identifying host Ki67+Bcl6+ GC B cells in inguinal LNs of 
young B6SJL recipient mice at day 10 post-immunisation with OVA. Numbers adjacent to gates 
indicate percentage of each population B. Quantification of the frequency (left) and total number 
(right) of Ki67+Bcl6+ GC B cells C.  Representative flow cytometry plots identifying host 
PD1+CXCR5+ Tfh cells in inguinal LNs of young B6SJL recipient mice at day 10 post-immunisation 
with OVA D. Quantification of the frequency (left) and total number (right) of PD1+CXCR5+ Tfh 
cells. In each experiment there were 5-8 mice per age group, and the data presented are representative 
of two independent experiments. Bar height represents the mean and p values indicated on graphs 










6.4.4 Absence of CXCR4 expression polarises Tfh cells to the GC light zone  
 
Upon determining that CXCR4 deficiency does not alter the efficiency of Tfh cell 
differentiation after immunisation, I next aimed to determine whether the loss of CXCR4 would have 
any effects on the localisation of Tfh cells within the GC compartments. To do this, iLNs from each 
of the recipient mice in the aforementioned adoptive transfer experiments were taken and stained for 
confocal microscopy. For each mouse, six sections from the centre of the LN were stained and each 
GC identified was analysed on Cell Profiler as done in Section 3.4.2. These LN sections were stained 
with IgD-FITC, CD45.2-A700, CD35-BV421 and Ki67-AF568 in order to identify the B cell follicle, 
transferred OT-II cells, the FDC network and proliferating GC B cells, respectively (Figure 6.30 A-
B).  
Quantification of the total GC area showed that GCs from B6SJL mice that received 
CreERT2HET Cxcr4fl/fl OT-II cells were significantly smaller than those that received CreERT2WT OT-
II cells (Figure 6.30 C). In contrast, the total LZ area defined as the CD35+ FDC network appeared 
to remain unperturbed between the two groups of recipient mice (Figure 6.30 D). However, as the 
GCs from CreERT2HET Cxcr4fl/fl recipients were smaller, the percentage of the LZ area within the GC 
was significantly greater in these mice (Figure 6.30 E). This was confirmed by quantification of the 
total and percentage of DZ area which was significantly smaller in GCs from CreERT2HET Cxcr4fl/fl 
recipients (Figure 6.30 F-G), which therefore contributes to the overall reduction in GC area in these 
mice. These results suggest that CXCR4 deficiency in Tfh cells may be causing a contraction of the 
DZ region of the GC and thus contribute to an overall decrease in GC size, despite no obvious 
reductions in GC B cell numbers being observed by flow cytometry.  
Within the GCs of B6SJL mice that received CreERT2HET Cxcr4fl/fl OT-II cells, the total 
number of CD45.2+ T cells was significantly reduced compared to CreERT2WT recipients (Figure 6.31 
A). The number of CD45.2+ T cells relative to GC size remained significantly reduced in CreERT2HET 
Cxcr4fl/fl recipients (Figure 6.31 B), indicating that the reduced number of CD45.2+ T cells in the GC 
was not due to a smaller GC area. Therefore, even though quantification of Tfh cells from 
CreERT2HET Cxcr4fl/fl recipients by flow cytometry previously indicated that the loss of CXCR4 does 
not alter the number of Tfh cells, these results indicate that the retention of these cells within the GC 
may be impaired. Quantification of the CD45.2+ T cell number between the LZ and DZ compartments 
of the GC revealed that the total number CD45.2+ T cells were significantly reduced in both 
compartments in the GCs of recipient mice that received CreERT2HET Cxcr4fl/fl OT-II cells as well as 
when normalised to the LZ or DZ area, likely due to the absolute reduction of  CD45.2+ T cells in 
these GCs (Figure 6.31 C-D, F-G). However, the percentage of CD45.2+ T cells, in recipient mice 
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that received CreERT2HET Cxcr4fl/fl OT-II cells, localising to the LZ was significantly higher 
compared to CreERT2WT controls and thus the proportion of these cells localising to the DZ was 
significantly diminished (Figure 6.31 E and H). Therefore, these data indicate that the loss of CXCR4 
polarises Tfh cells towards the LZ and restricts localisation to the DZ.  
Together these results show that CXCR4 deficiency in Tfh cells can have detrimental effects 
on the size of the GC DZ and the overall GC area as well as on Tfh cell retention in the GC. Moreover, 
the loss of CXCR4 polarises Tfh cells to the LZ region and limits their localisation to the DZ. 
Therefore, CXCR4 expression is required for DZ localisation of Tfh cells and may also influence 
































Figure 6.30 Confocal microscopy analysis of GCs in the inguinal lymph nodes of 
CreERT2WTCxcr4fl/fl and CreERT2HetCxcr4fl/fl recipient mice 
 
Representative confocal images of inguinal lymph nodes at 20x magnification taken at day 10 post-
immunisation from four different B6.SJL mice that received either A. CreERT2WTCxcr4fl/fl or B. 
CreERT2HetCxcr4fl/fl tamoxifen treated OT-II cells. LN sections were stained for IgD (green), CD35 
(white), CD45.2 (magenta) and Ki67 (blue). GCs were identified as IgD-Ki67+ regions within the 
IgD+ B cell follicles, the LZ was defined as the region occupied by CD35+ FDCs and the DZ was 
defined as the Ki67+CD35- region within the GC C. Quantification of GC size in mm2 D. 
Quantification of the LZ area in mm2 and E. as a percentage of GC area F Quantification of the DZ 
area in mm2 and G. as a percentage of GC area. Quantification was performed using Cell Profiler 
software. Additional representative confocal images used for analysis can be found in Appendix 9.4. 
In each experiment there were 5-8 mice per age group, and the data presented are representative of 
two independent experiments. Each symbol represents a GC and the p values indicated on graphs 






































Figure 6.31 Confocal microscopy analysis of CD45.2+ OT-II T cell in the GCs of 
CreERT2WTCxcr4fl/fl and CreERT2HetCxcr4fl/fl recipient mice 
 
A. Quantification of CD45.2+ T cell numbers in the GCs of B6.SJL mice that received either 
CreERT2WTCxcr4fl/fl or CreERT2HetCxcr4fl/fl tamoxifen treated OT-II cells B. Quantification of 
CD45.2+ T cell numbers per mm2 of GC C. CD45.2+ T cell numbers in the LZ D. Quantification of 
CD45.2+ T cell numbers per mm2 of LZ E. Percentage of total CD45.2+ T cells in the LZ F. CD45.2+ 
T cell numbers in the DZ G. Quantification of CD45.2+ T cell numbers per mm2 of DZ H. Percentage 
of total CD45.2+ T cells in the DZ. Quantification was performed using Cell Profiler software. In 
each experiment there were 5-8 mice per age group, and the data presented are representative of two 
independent experiments. Each symbol represents a GC and the p values indicated on graphs were 





































6.5 Discussion   
 
The GC response of aged mice is severely diminished upon vaccination and it is 
structurally different to GCs in adult mice, as demonstrated in our initial kinetic experiments. 
In addition, I demonstrated that the B cell intrinsic influence on the age-related deterioration of 
the GC response was likely to be minimal as these cells remain functionally intact with age 
when transferred into younger adult mice.  In silico modelling of the B cell-extrinsic defects 
observed in aged mice in vivo such as the reduction of the FDC network and aberrant 
localisation of Tfh cells to the DZ, predicted that these two defects could indeed be major 
drivers of the age-associated GC deterioration. Whilst little is known about the role of Tfh cells 
in the DZ, in silico modelling predicted that this defect alone could reduce GC B cell expansion 
and cellular output of the GC response. To validate this prediction in vivo, I aimed to investigate 
a mechanism by which Tfh cells from aged mice are able to localise to the DZ and to examine 
their role in this compartment. The results clearly showed that Tfh cells from aged mice have 
higher expression of CXCR4 and increased migration to CXCL12, which is expressed in the 
GC DZ, thus explaining the increased presence of Tfh cells in the GC DZ of aged mice. 
Moreover, deletion of CXCR4 on Tfh cells demonstrated that the expression of this chemokine 
receptor is critical for their DZ localisation, as CXCR4 deficient Tfh cells were polarised to the 
LZ during the GC response in vivo.   
 CXCR4 expression has been shown to be essential for DZ localisation of GC B cells, 
where they are able to undergo proliferation and somatic hypermutation of the immunoglobulin 
receptor genes (Allen et al., 2004). I therefore postulated that overexpression of this chemokine 
receptor could be a mechanism by which aged Tfh cells are over represented in the DZ of aged 
GCs. Upon immunisation, both Tfh and Tfr cells from aged mice had increased expression of 
CXCR4 compared to those from young mice. Yet, only Tfh cells from aged mice had a 
significantly increased capacity to migrate in response to the CXCR4 ligand, CXCL12. 
Expression of CXCL12 is most abundant in the medullary region of LNs and very little is 
actually expressed within GCs (Cyster, 2005). However, the low amounts of CXCL12 in the 
GC is most abundant in the DZ where it is expressed by the stromal network of CRCs (Allen et 
al., 2004). Therefore, the increased capacity of aged Tfh cells to migrate to CXCL12 through 
an increase in CXCR4 expression is the likely mechanism by which these cells have increased 
localisation to the DZ in aged GCs. Interestingly, the CXCL12 chemotaxis assays additionally 
showed that Tfh cells from aged mice are able to continue migrating with increasing 
concentrations of CXCL12 past the point at which Tfh cells from young mice become 
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unresponsive to CXCL12. Under normal conditions, the duration and magnitude of CXCR4 
signalling is tightly regulated and in part terminated by the internalisation and degradation of 
CXCR4 upon CXCL12 exposure, which then renders the cells unresponsive to CXCL12, a 
process referred to as desensitisation (Busillo and Benovic, 2007). The observed ability of Tfh 
cells from aged mice to continue migrating to high concentrations of CXCL12 could therefore 
indicate an age-associated molecular defect in CXCL12 induced desensitisation of CXCR4 in 
Tfh cells. Accordingly, an age-associated defect in this molecular pathway has been reported 
in CD4+ T cells isolated from peripheral blood of elderly human donors (Cané, Ponnappan and 
Ponnappan, 2012). CD4+ T cells from older donors were found to have increased expression of 
CXCR4 and enhanced migration to CXCL12 due to aberrant regulation of CXCL12-induced 
endocytosis of CXCR4 and altered ubiquitination of the receptor (Cané, Ponnappan and 
Ponnappan, 2012). This regulatory pathway could therefore be impaired in a similar manner in 
Tfh cells from aged mice. Furthermore, a separate study has reported that CXCL13 is also 
capable of mediating CXCR4 desensitisation in vitro by activating protein kinase C which is 
involved in CXCR4 ubiquitination and lysosomal trafficking (Caballero et al., 2019). As we 
observed a reduction in the FDC network and larger DZ compartments within GCs of aged 
mice, it would be tempting to speculate that this could lead to reduced expression of CXCL13 
and greater expression of CXCL12 which may prevent CXCR4 desensitisation in Tfh cells and 
bias their localisation towards the DZ. While identifying the expression of these chemokines in 
the GC is known to be technically challenging, it may be possible to do this through laser-
microdissection followed by qPCR or through fluorescence in situ hybridisation of CXCL13 
and CXCL12 (Allen et al., 2004). Therefore, with the use of either of these techniques, it would 
be beneficial to discern whether the CXCL12 and CXCL13 gradients are altered within the GCs 
of aged mice to further understand the molecular mechanisms by which Tfh cell localisation is 
altered in ageing. Nevertheless, my results clearly identified that the activity of the 
CXCR4/CXCL12 axis is enhanced in Tfh cells from aged mice which likely mediates their 
enrichment in the DZ and could then have detrimental effects on the GC response as predicted 
by in silico modelling. 
   To determine whether this defect in increased CXCR4 expression of Tfh cells from 
aged mice does in fact result in aberrant DZ localisation and leads to diminished GC responses 
as predicted in silico, CXCR4 was overexpressed by retroviral transduction in CD4+ OT-II cells 
which were then adoptively transferred into wild type congenic recipients. Interestingly, 
CXCR4 overexpression appeared to limit LN entry of CD4+ T cells upon immunisation, as very 
few of these cells could be detected in the draining LNs by flow cytometry compared to control 
cells transduced with an empty vector. CXCR4 has been shown to promote LN entry of CD4+ 
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naïve T cells, yet this is believed to be a minor signal compared to CCR7-mediated homing as 
T cells deficient in CXCR4 only exhibit defects in homing when CCR7 signalling is absent 
(Okada et al., 2002). Here, my results suggest that tight regulation of CXCR4 may be necessary 
for appropriate LN homing of naïve CD4+ T cells. To confirm this, it would be necessary to 
assess the differences in LN homing 24 hrs after transfer, prior to immunisation, as it is also 
possible that CXCR4 simply restricts activation and expansion of naïve CD4+ T cells once they 
have entered the LN, which in the absence of a migration defect may explain the low numbers 
of these cells detectable by flow cytometry. Accordingly, the few CD4+ T cells overexpressing 
CXCR4 that were able to enter the LN did not differentiate into Tfh cells. CD4+ T cell 
movement to the T-B border is known to be necessary for the cognate T-B cell interactions 
required for Tfh cell differentiation to occur (Stebegg et al., 2018). Overexpression of CXCR4 
may sequester these CD4+ T cells to the CXCL12-rich medullary region or restrict them to the 
T cell zone where FRCs also produce CXCL12 thereby preventing their movement to the T-B 
border. It would therefore be beneficial to determine the LN localisation of these cells by 
confocal microscopy, to better understand how CXCR4 overexpression may be preventing Tfh 
cell differentiation. Furthermore, the overexpression of CXCR4 did not appear to cause an 
accumulation of these cells in the spleen, bone marrow and Peyer’s patches and thus it is 
unlikely that the migration of these cells is biased to lymphoid organs other than the LNs. Yet, 
the presence of these cells in the blood was not assessed which would be necessary to determine 
if there are defects in exiting the blood stream.  
 While these results indicated that tight regulation of CXCR4 is essential prior to Tfh 
cell differentiation, my original aim was to study CXCR4 overexpression on Tfh cells and the 
effects of their aberrant localisation to the DZ in the context of a GC response. Thus, to 
determine if such a defect could replicate features of the ageing GC phenotype, as predicted in 
silico, it would be necessary to use a system in which CXCR4 overexpression could be induced 
after Tfh cell commitment has occurred. To do this, CXCR4 cDNA could be cloned into an 
inducible overexpression retroviral vector designed by the Clevers laboratory, pMSCV-loxp-
dsRed-loxp-eGFP-Puro-WPRE (Koo et al., 2012). In this retroviral vector system, a gene of 
interest can be cloned behind a loxp flanked dsRed stop cassette for the subsequent retroviral 
transduction of OT-II cells expressing a tamoxifen-inducible Cre recombinase (Koo et al., 
2012). Tamoxifen administration would then promote the excision of the dsRed stop cassette 
and induce the expression of the gene cloned into the vector (Koo et al., 2012). This method 
has already been successfully used to induce overexpression of Bach2 on Tfh cells, by 
administering tamoxifen 4 days after immunisation (Lahmann et al., 2019). Therefore, this 
could be a feasible system to use for the inducible overexpression of CXCR4 after Tfh cell 
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commitment which would then allow us to study the effects of aberrant Tfh cell localisation in 
the DZ and assess if this defect can replicate the ageing GC phenotype.  
  An alternative way of studying the role of CXCR4 expression in Tfh cells is through 
the specific ablation of CXCR4 in these cells. For this, we used CreERT2Cxcr4fl/fl OT-II mice 
in which Cxcr4 could be deleted in all cells through tamoxifen treatment in vitro, yet by CD4+ 
T cell enrichment and adoptive transfer into wild type congenic mice CXCR4 deficiency was 
restricted to CD4+ OT-II cells thereby isolating this defect in Tfh cells upon immunisation. 
While CXCR4 has been implicated in promoting T cell homing to the LN (Okada et al., 2002), 
no obvious defects in LN migration of tamoxifen-treated CD4+ T cells from 
CreERT2HETCxcr4fl/fl mice were observed. However, I observed that upon tamoxifen treatment 
naïve CD4+ T cells from CreERT2HETCxcr4fl/fl mice do not downregulate surface protein 
expression of CXCR4 after 48hrs in vitro despite Cxcr4 mRNA being reduced in these cells 
which indicated that CXCR4 protein may have a low turnover rate and activation of these cells 
was required for loss of CXCR4 at the protein level. Thus, it is possible that a delay in CXCR4 
protein downregulation is an unexpected advantage of using this system as cells may be able to 
partially use this receptor to home to the LNs upon transfer thereby allowing us to study CXCR4 
deficiency without defects in LN homing. Using this approach, I demonstrated that the loss of 
CXCR4 on CD4+ T cells does not impact proliferation and upregulation of Tfh cell markers 
upon activation, 2.5 days after immunisation. Consequently, 10 days after immunisation 
CXCR4 deficiency did not impact Tfh cell differentiation or the expression of PD1, Ki67, Bcl6 
and ICOS, as observed by flow cytometry. This implied that the loss of CXCR4 had no effect 
on total Tfh cell numbers during the GC response. However, when the spatial distribution of 
CXCR4 deficient Tfh cells within the GC was assessed by confocal microscopy, we saw that 
these cells were restricted to the LZ region indicating that CXCR4 expression is necessary for 
DZ localisation of Tfh cells. Another striking feature observed by confocal microscopy was 
that far fewer CXCR4 deficient T cells were present within the GC compared to T cells in the 
GCs from control mice. This result indicated that despite no differences in cells with a Tfh cell 
surface phenotype being observed by flow cytometry, CXCR4 may be partially involved in 
localising Tfh cells to the GC itself and not just the DZ. Though, further assessment of the 
distinct LN regions needs to be carried out to determine where Tfh cells may be localising in 
these mice if not within the GC. Retention of Tfh cells in the GC has previously been attributed 
to the expression of both S1PR2 and CXCR5. Genetic ablation of both CXCR5 and S1PR2 in 
Tfh cells has been shown to impair GC localisation of these cells resulting in significantly 
reduced GC responses (Moriyama et al., 2014). Yet, CXCR5 deficiency alone has been shown 
to only mildly reduce the number of Tfh cells in the GC though this still causes a slight reduction 
 251 
in the size of the GC response (Arnold et al., 2007). Similarly, S1PR2 deficiency in Tfh cells 
does not fully eliminate them from the GC and these cells are still able to support GC responses 
(Moriyama et al., 2014). It would therefore be interesting to study the combined loss of CXCR4 
with S1PR2 or CXCR5 to further elucidate the role of CXCR4 in GC Tfh cell localisation and 
determine whether combined ablation with the aforementioned markers can completely drive 
Tfh cells away from the GC.  
 Confocal microscopy also revealed that deficiency of CXCR4 in Tfh cells resulted in 
smaller DZ regions and an overall decrease in GC size. This observation hints at a possible role 
for DZ Tfh cells in sustaining the DZ compartment whether by interactions with centroblasts 
or the stromal network of CRCs. While little is known about the role of Tfh cells in the DZ, a 
previous study has reported that CXCR4+ T cells are able to produce IL-21 which could be 
important for the maintenance of GC B cells in the DZ (Weinstein et al., 2016). Although, a 
separate group reported that Tfh cells of Il21r -/- mice, which have poor GC responses, 
overexpress CXCR4 and that IL-21/IL-21receptor interactions significantly reduce CXCR4 
expression (Zotos et al., 2010; Jandl et al., 2017). It is therefore possible that during a normal 
GC response, a proportion of Tfh cells in the DZ may play a role in sustaining this compartment 
which in the context of ageing could be dysregulated due to enhanced activity of 
CXCR4/CXCL12 signalling and have detrimental effects on the GC outcome. However, a 
major limitation to the adoptive transfers presented here is that they were done into wild type 
recipient mice which are able to generate endogenous Tfh cells that can drive GC responses 
thereby masking the effects CXCR4 deficiency of Tfh cells could have on the GC. Thus, a 
precise conclusion on the direct impact CXCR4 deficiency of Tfh cells has on the GC response 
cannot be made yet. For this it would be necessary to perform adoptive transfers of tamoxifen-
treated CD4+ T cells from CreERT2HETCxcr4fl/fl mice into recipients which are unable to 
generate Tfh cells on their own such as Cd4CreBcl6fl/fl or Sh2d1a-/- mice (Crotty et al., 2003; 
Hollister et al., 2013). In addition, immunisation of these recipient mice with NP-OVA would 
be beneficial in order to investigate the effects of CXCR4 deficient Tfh cells on antigen specific 
GC B cells, SHM and affinity maturation. Alternatively, co-transferring tamoxifen-treated 
CD4+ T cells from CreERT2HETCxcr4fl/fl cells alongside B cells from B1.8i mice, which are 
specific for the NP hapten, into wild type recipients could also provide insights into the effects 
CXCR4 deficiency of Tfh cells have on antigen-specific GC B cell expansion and affinity 
maturation upon NP-OVA immunisation. 
  In this chapter, I have demonstrated that the CXCR4/CXCL12 signalling axis is 
enhanced in Tfh cells from aged mice and contributes to the increased DZ localisation of these 
cells in ageing as I also showed that ablation of CXCR4 on Tfh cells restricts DZ entry.  
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Nevertheless, further experiments are required to determine whether increased DZ localisation 
of Tfh cells replicates the deterioration observed in the GC response of aged mice and to 
determine the effects that CXCR4 deficiency on Tfh cells has on the GC response. However, 
the data presented here supports the notion for a role of Tfh cells in the DZ that may be 







































7.1 Ageing is detrimental to several elements of the GC 
response but has minimal effects on B cell function 
 
 Vaccination of elderly individuals results in poor antibody responses and thus they fail 
to generate protective immunity that is as effective as that generated in younger adults (Govaert 
et al., 1994). One of the critical pathways involved in the production of vaccine-specific 
antibodies is the germinal centre (GC) response. The GC is a specialised microenvironment that 
generates long-lived antibody secreting plasma cells and memory B cells which provide life-
long protection upon vaccination (Stebegg et al., 2018). However, the GC response is severely 
affected by ageing and it is therefore critical to thoroughly study the age-associated demise of 
this process in order to gain insights into the poor vaccination outcomes in older persons 
(Linterman, 2014). The age-associated defects in the GC have been studied for many years by 
several groups focusing on different stages of the GC response and on the intrinsic effects of 
specific cell types (Kosco et al., 1989; Szakal et al., 1990; Yang, Stedra and Cerny, 1996; Eaton 
et al., 2004; Lefebvre et al., 2012). Yet despite these efforts, the mechanisms and main 
contributors to the age-dependent demise of the GC response remain elusive. Here, I first aimed 
to characterise the age-dependent changes in the GC response in vivo in mice using a kinetic 
approach. Upon vaccination with NP conjugated to protein, I examined the changes in key GC 
cell types by flow cytometry, affinity maturation of NP-specific serum antibodies, NP-specific 
antibody secreting cells in the bone marrow and SHM of NP+ GC B cells. Furthermore, the 
structural changes of the GC were assessed by confocal microscopy. Using this approach, I 
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demonstrated that the magnitude, quality and structure of the GC response upon vaccination 
are all significantly affected by age.  
  The ageing process results in a reduction of naïve CD4+ T and B-lymphocytes in the 
periphery and the LN microenvironment has been shown to have a reduced ability to support 
the homeostatic proliferation and homing of naïve T-lymphocytes in aged mice (Lazuardi et 
al., 2005; Becklund et al., 2016). Here, I showed that the lymph nodes from aged mice were 
smaller than those of younger mice upon vaccination which resulted in diminished absolute 
numbers of CD4+ T and B-lymphocytes in aged mice at the peak of the GC response. This 
reduction could be explained by the previously reported age-associated differences in 
lymphocyte homing to secondary lymphoid organs affecting the recruitment of these cells upon 
immunisation (Wols et al., 2010; Becklund et al., 2016), but also suggests that aged 
lymphocytes are not able to undergo clonal expansion to the same extent as cells from young 
mice. Thus, the total numbers of all GC cell types analysed were significantly lower in aged 
mice than in younger adults at the peak of the response, with the exception of Tfr cells in 
BALB/c mice, indicating a significant reduction in the magnitude of the GC response with age.  
 Several groups have rigorously studied the effects of ageing on GC B cell function and 
reported defects in GC B cell proliferation, somatic hypermutation (SHM), and antibody output 
(Whisler, Williams and Newhouse, 1991; Miller and Kelsoe, 1995; Yang, Stedra and Cerny, 
1996; Lu and Cerny, 2002). As previously reported, the proportion of GC B cells in aged mice 
in our study was significantly decreased confirming that the aged GC response is not as robust 
as it is young mice. However, the proportion of centroblasts and centrocytes within the GC B 
cell population was not affected by age. Additionally, GC B cells appeared to be more prone to 
apoptosis with age as there was an enrichment of Caspase 3+ GC B cells in the GCs of aged 
mice as quantified by confocal microscopy. Though this observation could also be due to 
aberrant clearance of apoptotic GC B cells by tingible body macrophages (Kranich et al., 2008). 
The proportion of antigen-specific GC B cells was reduced in aged mice and as a consequence 
the number of NP-specific IgG1 secreting cells in the bone marrow were significantly reduced 
at day 21. While Kosco and colleagues reported age-related defects in antibody production 
during the early phases of the GC response (Kosco et al., 1989), here I showed that the titres of 
antigen-specific IgG1 in the serum of aged mice were significantly decreased throughout the 
21-day period of the kinetic study. The quality of these antibodies was also significantly 
affected by age as affinity maturation was reduced in the serum of aged mice. SHM is the 
process by which GC B cells can acquire higher affinity for antigen and has previously been 
reported to be almost absent in aged mice (Miller and Kelsoe, 1995). Here, I observed that GC 
B cells from aged mice are still able to undergo SHM, albeit with a slight reduction in mutation 
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frequency, and that the most striking differences were found in the frequency of high affinity 
inducing mutations which were decreased in GC B cells from aged mice highlighting a possible 
defect in the affinity-based selection process of the GC response with age. Together these 
results indicated that not only the magnitude but also the quality of the GC response is 
significantly reduced with age. 
 The formation and maintenance of the GC is dependent on T cell help from T follicular 
helper (Tfh) cells (Vinuesa et al., 2016). Age-associated changes in these cells have been 
postulated to be one of the major contributors to the demise of the GC as adoptive transfer 
experiments of CD4+ T cell from aged mice into young hosts demonstrated that these cells are 
less capable of promoting adequate GC responses in a young microenvironment (Eaton et al., 
2004). In addition, Sage and colleagues described an increase in both Tfh and Tfr cells in aged 
mice upon immunisation for which the poor GC responses were attributed to decreased Tfh cell 
helper function together with increased Tfr cell suppression, tested in vitro (Sage et al., 2015). 
While I confirmed by flow cytometry that the proportion of Tfh cells is increased in aged 
C57BL/6 and BALB/c mice, the differences in Tfr cells were not consistent between the two 
strains. Therefore, the Tfr cell contribution to the deterioration of the GC response is unclear. 
Interestingly, assessment of antigen-specific Tfh cells in C57BL/6 mice using MHC-II tetramer 
staining revealed that these cells are not enriched in aged mice indicating that the increased 
proportion of Tfh cells with age could be due to an increased presence of Tfh cells that are not 
antigen-specific. Or, that these cells are of low affinity and are not detectable using MHC-II 
tetramers which lack CD4 to stabilise their binding. Quantification of Tfh cells by confocal 
microscopy confirmed there was a slight increase in the number within the GCs of aged mice 
when normalised to the size of the GC.  However, the most striking difference was in the 
number of Tfh cells localising to the DZ which was significantly increased in the GCs of aged 
mice. Given the critical role that Tfh cells have been shown to play in affinity-based positive 
selection of GC B cells within the LZ compartment (Gabriel D Victora et al., 2010), this result 
indicated that this process could be significantly affected in ageing by the aberrant localisation 
of Tfh cells to the DZ. 
 Confocal microscopy additionally revealed changes in the FDC network of GCs from 
aged mice. Age-associated changes in the microenvironment have previously been implicated 
in the phenotype of the aged GC response, as CD4+ T cells from young mice transferred into 
aged mice were unable to generate adequate GC or Tfh cell responses in the aged 
microenvironment (Lefebvre et al., 2012). In this study the changes in specific stromal subsets 
or other cells important for the GC response were not characterised (Lefebvre et al., 2012). 
Here, I demonstrated that the CD35+ FDC network in aged GCs is significantly diminished 
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upon vaccination. The acquisition of antigen presented on the FDC network is a critical first 
step for centrocytes with newly mutated Ig receptors to test their affinity for antigen and to 
subsequently undergo positive selection by Tfh cells (Miller et al., 2002). The age-dependent 
structural defect in the FDC network could therefore interfere with the first steps of positive 
selection through decreased interactions with centrocytes or through reduced antigen 
presentation, which has been shown to be significantly altered with age (Aydar et al., 2003), 
and thus result in decreased affinity maturation.   
 Together, the in vivo data obtained from this initial kinetic study showed that the 
magnitude, quality and structure of the GC response are significantly altered with age through 
the changes observed in GC B cells, Tfh cells and the FDC network. However, several of the 
defects I observed in the aged GC response such as reduced GC B cell expansion, antibody 
production and a reduced number of class switch cells had previously been attributed to B cell 
intrinsic defects by different groups who tested this in vitro (Whisler, Williams and Newhouse, 
1991; Frasca et al., 2004; Blaeser, McGlauchlen and Vogel, 2008). In light of this, I 
hypothesised that B cell intrinsic changes with age could be driving the GC deterioration 
observed and sought to assess this in vivo. By adoptively transferring B cells with a transgenic 
BCR from young or aged mice into young recipients, I was able to show that B cells from aged 
mice can differentiate into GC B cells and undergo class switch recombination equally to B 
cells from young mice. Therefore, B cells appear to remain functionally intact throughout the 
process of ageing. Though, further testing of the frequency of SHM in these transferred cells is 
necessary, as the expression of AID, the enzyme critical for mediating the SHM process 
(Masamichi Muramatsu et al., 2000), has been reported to be reduced in B cells from aged mice 
and humans (Frasca et al., 2004, 2008). Nevertheless, these findings indicated that the observed 
demise of the GC response in aged mice is likely driven by B cell-extrinsic factors such as the 
defects observed in Tfh cells and FDCs. Though the age-associated effects and functional 
changes of several other B cell extrinsic factors that are involved in the GC response were not 
assessed. Such factors could include the role of tangible body macrophages in the clearance of 
apoptotic GC B cells (Kranich et al., 2008), which if functionally altered by age could explain 
the increased presence of apoptotic GC B cells in the GCs of aged mice. Subcapsular sinus 
macrophages also play a role in the GC response by delivering immune complexes to B cells 
and FDCs (Phan et al., 2007) and thus an age associated defect in these cells could have 
detrimental effects in the GC response.  
While the role of these factors in the age-dependent demise of the GC is beyond the 
scope of this project, the in vivo data generated here identified defects in several elements of 
the aged GC response and indicated that ageing has minimal effects on B cell function. 
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Therefore, this in vivo data provided a foundation for the generation of hypotheses to be tested 
by in silico modelling to further investigate which is the main cellular factor(s) driving the 
deterioration of the GC response with age. 
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7.2 In silico modelling predicts the age-associated demise of the 
GC is a multifactorial process 
 
 The data generated in vivo clearly demonstrated that the GC response is diminished with age 
and that the B cell intrinsic contributions to this age-dependent demise are minimal. However, despite 
excluding B cell intrinsic defects as a major causative factor, an overwhelming number of possible 
mechanisms remained to be explored in order to determine the causative agent driving the 
deterioration of the GC response with age. In silico modelling is a powerful tool that has been used 
to predict novel concepts in GC biology and by which several hypotheses can be tested without the 
need to test in vivo (Meyer-Hermann, Maini and Iber, 2006). Therefore, I next aimed to use in silico 
modelling of the GC response to determine which cellular factor(s) drive the GC defects observed in 
aged mice. To do this, I tested the consequence of the observed defects in Tfh cell number, Tfh 
localisation and the reduction of the FDC network on the outcomes of the GC response in silico to 
determine which defect best replicates the GC phenotype observed in aged mice. The results indicated 
that the aged GC phenotype is not caused by defects in a single cellular factor but is likely a 
multifactorial process heavily influenced by the structural defects observed in vivo. 
 The number of Tfh cells present in the GC response positively correlates with the number of 
GC B cells and if this balance is disrupted it can cause deleterious effects, as seen in various models 
of autoimmunity (Linterman et al., 2009; Kim et al., 2015). Consequently, in silico simulations 
increasing the number of Tfh cells in the GC as seen in aged mice revealed that whilst this has 
detrimental effects on affinity maturation, the number of GC B cells will always increase due to the 
positive correlation between these cells. This indicated that an increase in Tfh cell numbers is unlikely 
to cause the unique aged GC phenotype whereby the positive correlation between Tfh and GC B cells 
appears to be broken. Moreover, the decrease in affinity observed in this simulation was due to the 
assumption that all Tfh cells are capable of mediating B cell help in silico (Meyer-Hermann, Maini 
and Iber, 2006), however as we observed no increases in antigen-specific Tfh cells in aged mice in 
vivo this effect on affinity may not be biologically relevant. On the other hand, the aberrant 
localisation of Tfh cells in silico resulted in diminished GC responses, likely due to disrupting the 
known role these cells play in positive selection in the LZ (Gabriel D Victora et al., 2010), yet this 
defect did not appear to have an effect on affinity. Reducing the FDC network size also had a 
significant effect on the magnitude of the GC response in silico and mild effects on affinity maturation 
indicating this could be one of the major drivers of the GC phenotype observed in aged mice. A 
mechanism by which reduced the reduced FDC network could impact the outcomes of the GC 
response may be through reduced antigen presentation, which has been shown to be altered in aged 
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mice (Aydar et al., 2003). Simulating reduced antigen presented on FDCs resulted in diminished GCs 
with minimal effects on affinity. Therefore, these results showed that simulating the individual 
defects in Tfh cells and FDCs could not fully replicate the aged GC phenotype, indicating that a single 
cellular factor is unlikely to account for the age-dependent demise of the GC. 
 To better understand the consequences of the defects Tfh cells and FDCs could 
simultaneously be having in vivo, simulations were combined by altering these defects together in 
silico. This demonstrated that combining the effects of a reduced FDC network and an increased 
number of Tfh cells localising to the DZ resulted in GC outcomes that mirror the aged GC phenotype. 
Though interestingly, combining the Tfh cell defects alone could not replicate the aged GC phenotype 
highlighting the importance of the FDC defects. Therefore, these results indicate that the demise of 
the GC response in aged mice is unlikely to be caused by a single cellular factor but is rather a 
multifactorial process that can be driven by defects in both Tfh cells and a reduction of the FDC 
network.   
 The role of FDCs in the maintenance and regulation of the GC response is well established. 
FDCs provide essential cytokines such as IL-15 and IL-6 important for B cell proliferation and class 
switch recombination as well as playing a critical role in antigen presentation, which has been shown 
to be diminished in the GCs of aged mice (Wu et al., 2009; Park et al., 2014). FDCs also maintain 
the GC structure through the secretion of CXCL13 in the LZ and thus age-associated defects in this 
compartment could have a detrimental effect on many of the aforementioned FDC functions, as 
predicted in silico. On the other hand, little is known of the role of Tfh cells in the DZ and an aberrant 
localisation of Tfh cells to this compartment has not previously been implicated in ageing of the GC. 
Therefore, the prospect that aberrant localisation of Tfh cells to the DZ could alone reduce the 
magnitude of GC responses, as predicted in silico, provided an intriguing and novel concept to test in 
vivo.  
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7.3 CXCR4 expression on Tfh cells determines DZ localisation 
and is dysregulated in the ageing GC 
 
 In silico modelling of the defects observed in aged mice in vivo such as the reduction of the 
FDC network and aberrant localisation of Tfh cells to the DZ, predicted that these two B cell-extrinsic 
defects could be major drivers of the age-associated GC demise. While the role of Tfh cells in the DZ 
has not been elucidated, in silico modelling predicted that an imbalance of Tfh cells present in the 
DZ could alone reduce GC B cell expansion and the cellular output of the GC response. To validate 
this prediction in vivo, I next aimed to determine a mechanism by which Tfh cells from aged mice 
have an increased localisation to the DZ and subsequently investigate their role in this compartment. 
The results clearly indicated that CXCR4 expression and CXCL12 migration is enhanced in Tfh cells 
from aged mice thereby explaining their increased presence in the GC DZ. In addition, deletion of 
CXCR4 on Tfh cells showed that the expression of this receptor is critical in mediating Tfh cell DZ 
localisation as CXCR4 deficient Tfh cells were polarised to the LZ during the GC response in vivo.  
  CXCR4 expression in GC B cells has been shown to be critical for their localisation to the 
DZ, where a network of CRCs generates a CXCL12 chemokine gradient that retains centroblasts in 
the DZ for proliferation and SHM (Allen et al., 2004). Therefore, I hypothesised that the enhanced 
expression of CXCR4 could cause Tfh cells to localise to the DZ in aged mice. Upon immunisation, 
Tfh cells from aged mice displayed higher expression of CXCR4 than those from young mice and 
had an enhanced capacity to migrate towards CXCL12 ex vivo. The same defect has previously been 
reported in CD4+ T cells from elderly human donors, whereby the CXCR4/CXCL12 signalling axis 
is dysregulated through poor induction of CXCL12-induced endocytosis and ubiquitination of 
CXCR4 that is necessary to limit CXCR4 signalling (Cané, Ponnappan and Ponnappan, 2012). This 
molecular mechanism could therefore explain the enhanced activity of the CXCR4/CXCL12 axis 
observed in Tfh cells from aged mice that had an increased threshold for CXCL12 desensitisation 
and thereby facilitate an increase in their DZ localisation. To further test the importance of CXCR4 
in Tfh cell localisation and determine whether aberrant DZ localisation is detrimental to the GC 
response, as predicted in silico, CXCR4 was overexpressed in CD4+ OT-II cells. In contrast to 
previous reports implicating CXCR4 in promoting naive T cell homing to LNs (Okada et al., 2002), 
the overexpression of CXCR4 on CD4+ T cells resulted in restricted LN entry and Tfh cell 
differentiation upon transfer to young congenic hosts immunised with OVA. This result indicated 
that tight regulation of CXCR4 is required for adequate LN homing and successful Tfh cell 
commitment. In light of this, it would be interesting to investigate if under homeostatic conditions, 
naïve CD4+ T cells from aged mice also express high levels of CXCR4 and whether this could have 
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an impact, albeit not as pronounced as in retroviral overexpression of CXCR4, in the reduced LN 
homing and recruitment of CD4+ T cells observed in aged mice (Becklund et al., 2016). Still, this 
result indicated that to induce aberrant localisation of Tfh cells in the DZ and validate the in silico 
predictions, CXCR4 overexpression would need to be induced once Tfh cell differentiation has been 
established. 
 An alternative method by which to study the role of CXCR4 expression in Tfh cells is through 
specific deletion of CXCR4 in these cells, which was done using CreERT2 Cxcr4fl/fl OT-II mice. 
Tamoxifen-treated CD4+ T cells from these mice were adoptively transferred into wild type congenic 
mice which were then immunised with OVA. Assessment of CXCR4 deficient CD4+ T cells 2.5 days 
after immunisation showed that the loss of CXCR4 does not affect proliferation or the upregulation 
of Tfh cell commitment markers upon activation thereby enabling the study of CXCR4 deficiency in 
fully differentiated Tfh cells at later timepoints. Ten days after immunisation, analysis by flow 
cytometry revealed that CXCR4 deficiency does not affect Tfh cell differentiation, as there were no 
defects in absolute numbers of these cells, nor does it affect the expression of Tfh cell markers such 
as Bcl6, ICOS and PD1. However, examination of these CXCR4 deficient Tfh cells by confocal 
microscopy revealed that very few of them were actually present within the GC and that they were 
restricted to the LZ compartment. This result indicated that that expression of CXCR4 is necessary 
for Tfh cells to enter the DZ. Therefore, the overexpression of this receptor in Tfh cells from aged 
mice is the likely mechanism by which these cells are overrepresented in the DZ. In addition, the 
reduced presence of CXCR4 deficient Tfh cells within the GC indicated that this receptor may be 
involved in the retention of Tfh cells to the GC, a role previously attributed to CXCR5 and S1PR2 
(Moriyama et al., 2014). It would therefore be interesting to investigate whether the combined 
ablation of CXCR4 with either of these receptors could completely eliminate Tfh cells from the GC. 
Furthermore, as the loss of CXCR4 reduces localisation of Tfh cells in the GC, it would be tempting 
to speculate that higher expression of CXCR4 in Tfh cells from aged mice could mediate their overall 
accumulation in the GC as I had previously observed by confocal microscopy. However, inducible 
overexpression of CXCR4 on Tfh cells would be required to formally test this.  
   The adoptive transfers presented here were limited in that they were performed into wild type 
mice capable of generating their own Tfh cells, thus masking they effects of CXCR4 deficiency of 
Tfh cells on the GC response. However, CXCR4 deficiency of Tfh cells resulted in smaller DZ 
regions and an overall decrease in GC size which hints at a possible role of Tfh cells in maintaining 
the GC DZ compartment. This could be through IL-21 delivery to centroblasts in the DZ as CXCR4+ 
Tfh cells have been shown to secrete this cytokine (Weinstein et al., 2016). Therefore, it is possible 
that during a normal GC response, a small proportion of Tfh cells in the DZ may play a role in 
maintaining this compartment, which in the context of ageing is dysregulated due to increased 
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CXCR4/CXCL12 signalling thereby having detrimental effects on the GC response. The regulation 
of CXCR4 expression on Tfh cells has been attributed to FDCs which have been shown to induce 
RGS13 and RGS16 to limit the responsiveness of these cells to CXCL12 (Estes et al., 2004). 
Furthermore, CXCL13 which is produced by FDCs has also been shown to dampen CXCR4/CXCL12 
signalling by promoting CXCR4 internalisation and degradation in vitro (Caballero et al., 2019). 
Thus, the observed reduction in the FDC network in the GCs of aged mice could lead to reduced 
CXCL13-mediated desensitisation of CXCR4 in Tfh cells and increased Tfh cell responsiveness to 
CXCL12 resulting in their aberrant localisation to the DZ. To better understand the relationship 
between FDC-mediated regulation of CXCR4 on Tfh cells it would be interesting to determine if the 
CXCL13 gradient is altered in the GCs of aged mice and if aged Tfh cells express reduced mRNA 
levels of RGS13 and 16.    
Together the results presented indicate that the CXCR4/CXCL12 signalling axis is enhanced 
in Tfh cells from aged mice and contributes to the increased DZ localisation of these cells in ageing 
as ablation of CXCR4 on Tfh cells restricts DZ entry. However, further experiments are required to 
determine if inducing the DZ localisation of Tfh cells can replicate the age-associated deterioration 
of the GC response and to determine the effects CXCR4 deficient Tfh cells have on the GC response. 
Nevertheless, this data supports the notion for a role of Tfh cells in the DZ that could be dysregulated 
in ageing and thus contribute to poor GC responses as predicted in silico.   
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7.4 Future directions 
 
 In silico modelling revealed that the observed aberrant Tfh cell localisation to the DZ in the 
GCs of aged mice could contribute to the reduced magnitude of the aged GC response. While I 
attempted to validate this hypothesis in vivo through the retroviral overexpression of CXCR4 in Tfh 
cells this was unsuccessful due to poor LN homing and Tfh cell differentiation of these cells. 
Therefore, to formally establish the aberrant localisation of Tfh cells as a major contributor to the 
demise of the GC with age it would be necessary to clone CXCR4 into an inducible retroviral vector 
for the transduction of CreERT2 CD4+ OT-II cells (Koo et al., 2012). These cells could then be 
adoptively transferred into Tfh deficient mice, such as Cd4CreBcl6fl/fl mice, and overexpression of 
CXCR4 could be induced by tamoxifen administration after immunisation and Tfh cell commitment. 
With this approach it would then be critical to assess GC B cell expansion, SHM, antibody output, 
affinity maturation and GC B cell apoptosis to determine if aberrant DZ localisation of Tfh cells can 
mirror the defects observed in the GC response of aged mice. Similarly, the effects of CXCR4 
deficiency of Tfh cells on the GC response remains to be explored. This should be done by adoptive 
transfer of CXCR4 deficient OT-II CD4+ T cells into Cd4CreBcl6fl/fl mice that are not able to generate 
their own Tfh cells, and subsequently investigate the effects on GC B cell expansion, the proportion 
of centroblasts and centrocytes, SHM, affinity maturation of the antibody output and GC structure to 
further characterise the role of Tfh cells in the DZ.  
 In silico modelling also predicted that the reduction of the FDC network observed in the GCs 
of aged mice could be a major driver of the age-dependent GC demise. To validate this prediction in 
vivo and to further explore the role of FDC-mediated regulation of Tfh cell localisation, adoptive 
transfers of young OT-II T and B1.8i B-lymphocytes into aged mice should be performed. In this 
manner, the effects of the aged FDC network on the outcomes of the GC response as well as on Tfh 
cell localisation could be assessed to further elucidate the mechanisms by which the aged 
microenvironment contributes to the demise of the GC response.   
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7.5 Broader implications of this project 
 
The demise of the GC response with age has been studied for many years and intrinsic 
defects in B cells, CD4+ T cells and the lymphoid microenvironment have all been postulated 
to be major contributors to the defects observed in ageing by several groups (Eaton et al., 2004; 
Frasca et al., 2008; Lefebvre et al., 2012; Sage et al., 2015). Yet the precise mechanisms by 
which defects in these cell types contribute to the age-dependent GC demise have not been 
elucidated. Here I show that the effects of ageing on B cell function in vivo are minimal and 
that B cell extrinsic defects in Tfh cells and the FDC network could be the main contributors to 
the poor GC responses in aged mice. Indeed, in silico modelling of the combination of these B 
cell-extrinsic defects revealed that the age-dependent demise of the GC response is likely to be 
a multifactorial process in which defects in Tfh cell localisation and the reduced FDC network 
can work together to mediate the aberrant outcomes of the GC response in aged mice. In light 
of this finding, vaccination strategies targeted to elderly individuals could consider the 
multifactorial nature of the GC demise and include the use of adjuvants that not only target 
individual cell types, such as the Tfh cells but also boost the functions of FDCs (Linterman and 
Hill, 2016). Lastly, this is the first study to implicate aberrant Tfh cell localisation to the GC 
DZ by enhanced activity of the CXCR4/CXCL12 axis as a possible mechanism by which the 
GC response could be disrupted in ageing.  
7.6 Concluding remarks 
 
The GC response is critical in generating long-lived protective humoral immunity upon 
vaccination; however this process is significantly affected by ageing contributing to poor 
vaccination efficacy in the elderly. In this project I used a combination of in vivo and in silico 
tools to demonstrate that the age-associated demise of the GC is a multifactorial process that is 
unlikely to be driven by B cell intrinsic effects of ageing but rather by the reduction in FDC 
network size and CXCR4-driven aberrant localisation of Tfh cells to the GC DZ. In addition, 
through inducible deletion of CXCR4 I showed that the expression of this receptor is necessary 
for Tfh cell localisation to the DZ region of the GC, for which further research is necessary to 
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Appendix 9.1 Identification of Foxp3+ Tfr cells in the GCs of young and aged 
BALB/c mice by confocal microscopy 
 
Representative confocal images of GCs at 20x magnification within inguinal LNs taken from 
young (top panel) and aged (bottom panel) BALB/c mice at day 14 post-immunisation. LN 
sections were stained for IgD, CD35, CD3 and Foxp3. GCs were identified as IgD- regions 
containing CD35+ FDCs and Tfr cells were defined as CD3+Foxp3+ cells which are marked by 
white stars on the images. GC images for each group are derived from separate experimental 
mice. In each experiment there were 8-10 mice per age group, and the data presented are 














































Appendix 9.2 Identification of GCs in the iLNs of young and aged BALB/c mice by 
confocal microscopy 
 
Representative confocal images of GCs within inguinal lymph nodes, at 20x magnification, 
taken at day 14 post-immunisation from young (top panel) and aged (bottom panel) BALB/c 
mice. LN sections were stained for IgD (green), CD35 (white), CD3 (magenta) and Ki67 (blue). 
GCs were identified as IgD-Ki67+ regions within the IgD+ B cell follicles and GC T cells were 
identified as CD3+ cells within the IgD-Ki67+ region. The LZ was defined as the region 
occupied by CD35+ FDCs and the DZ was defined as the Ki67+CD35- region within the GC. 
GC images for each group are derived from separate experimental mice. In each experiment 







































Appendix 9.3 Identification of apoptotic Caspase 3+ cells within the GCs of young 
and aged BALB/c mice by confocal microscopy 
 
Representative confocal images of GCs within inguinal lymph nodes, at 20x magnification, 
taken at day 14 post-immunisation from young (top panel) and aged (bottom panel) BALB/c 
mice. LN sections were stained for IgD (green), CD35 (white), CD3 (magenta) and active 
Caspase (red). GCs were identified as IgD- regions containing CD35+ FDCs within the IgD+ B 
cell follicles and apoptotic GC B cells were identified as Caspase3+ cells within the GC region. 
GC images for each group are derived from separate experimental mice. In each experiment 









































9.4 Adoptively transferred CD45.2+ CXCR4-deficient T cells in the 
GCs of B6SJL recipient mice 
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Appendix 9.4 Confocal microscopy for the identification of adoptively transferred 
CD45.2+ CXCR4-deficient T cells in the GCs of B6SJL recipient mice 
 
Representative confocal images of inguinal lymph nodes at 20x magnification taken at day 10 
post-immunisation from six different B6.SJL mice that received either CreERT2WTCxcr4fl/fl (top 
panel) or CreERT2HetCxcr4fl/fl (bottom panel) tamoxifen treated OT-II cells. LN sections were 
stained for IgD (green), CD35 (white), CD45.2 (magenta) and Ki67 (blue). GCs were identified 
as IgD-Ki67+ regions within the IgD+ B cell follicles, the LZ was defined as the region occupied 
by CD35+ FDCs and the DZ was defined as the Ki67+CD35- region within the GC. In each 
experiment there were 5-8 mice per age group, and the data presented are representative of two 
independent experiments. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
